Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3027273	vb-ahco3	mmol/l (mmol/l)	9322	33740	0.00%
3027273	vb-shco3	mmol/l (mmol/l)	6832	20792	0.00%
3027273	vp-shco3	mmol/l (mmol/l)	1157	6215	0.00%
3027273	vb-ahco3	— (—)	932	1637	100.00%	Distribution not available
3027273	vb-hco3	mmol/l (mmol/l)	332	1204	0.00%
3027273	vb-ahco3vt	— (—)	260	347	100.00%	Distribution not available
3027273	vb-he-tase,vb-hco3	mmol/l (mmol/l)	240	330	0.00%
3027273	vb-ahco3vt	mmol/l (mmol/l)	215	326	0.00%
3027273	vb-shco3	— (—)	135	183	100.00%	Distribution not available
3027273	vb-hco3	— (—)	120	144	100.00%	Distribution not available
3027273	vp-hco3st	mmol/l (mmol/l)	45	123	0.00%
3027273	vb-vekaas5,chco3	mmol/l (mmol/l)	43	73	0.00%
3027273	vp-shco3	— (—)	37	46	100.00%	Distribution not available
3027273	vbhco3pika	mmol/l (mmol/l)	24	26	0.00%
3027273	vp-hco3st	— (—)	7	9	100.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Heart failure,strict

2739

6914

3.08

307.65

5.6

2.6

25.37

25.17

mmol/l

1.68

2659

6728

Heart failure and antihypertensive medication

1438

1793

5.83

307.65

6.3

2.4

25.37

25.53

mmol/l

0.68

1398

1754

Abnormalities of breathing

3535

9278

2.34

307.65

4.5

3.1

25.39

25.09

mmol/l

4.99

3429

8981

Fever of other and unknown origin

2441

8241

2.89

307.65

5.2

2.9

25.08

25.18

mmol/l

0.71

2370

7989

Dyspnoea

3766

13108

2.30

307.65

4.5

3.2

25.44

25.16

mmol/l

4.61

3657

12706

Implicit bacterial Sepsis

2179

6827

3.18

307.65

6.5

2.8

25.02

25.22

mmol/l

1.34

2100

6646

Pain in throat and chest

3292

9009

2.31

307.65

3.8

3.1

25.38

25.12

mmol/l

3.93

3189

8720

Covid-19 suspected case

1825

2512

8.66

307.65

3.9

3.3

25.62

25.09

mmol/l

7.47

1813

2416

Glucagon-like peptide-1 (GLP-1) analogues

2867

8291

3.07

307.65

4.3

3.3

24.88

25.36

mmol/l

9.40

2792

8029

Codes for special purposes

2815

6892

4.51

307.65

4.4

3.5

25.48

25.06

mmol/l

8.25

2768

6673

Explicit Sepsis

2267

7405

3.17

307.65

6.6

2.8

24.70

25.22

mmol/l

8.26

2180

7200

Cerebrovascular diseases (FINNGEN)

1264

2248

4.26

307.65

4.1

2.2

25.19

25.53

mmol/l

2.60

1232

2183

Type 1 diabetes, wide definition

1075

2837

4.08

307.65

6.2

3.1

24.86

25.28

mmol/l

3.07

1038

2732

Angina pectoris

2713

7980

2.42

307.65

4.3

3.1

25.33

25.30

mmol/l

0.16

2629

7767

Type 1 diabetes, wide definition, subgroup 1

1057

2562

4.47

307.65

6.2

3.2

24.86

25.28

mmol/l

2.94

1021

2469

Bacterial Sepsis

2426

7527

3.10

307.65

6.4

2.8

25.05

25.23

mmol/l

1.35

2338

7328

Anaemias

991

818

8.58

307.65

7.2

2.3

24.73

25.41

mmol/l

4.83

952

784

Type 2 diabetes, definitions combined, including avohilmo

3894

9514

2.52

307.65

3.6

3.0

25.13

25.44

mmol/l

5.81

3791

9194

All-cause Heart Failure

2890

8396

2.65

307.65

5.4

3.1

25.39

25.11

mmol/l

2.98

2802

8168

Other (not insulin) diabetes medications

4056

10268

2.48

307.65

3.8

3.1

25.10

25.41

mmol/l

5.63

3951

9935

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

4566

9971

2.95

307.65

4.3

3.0

25.00

25.43

mmol/l

11.43

4443

9640

Provisional assignment of new diseases of uncertain etiology

2810

6884

4.51

307.65

4.4

3.5

25.47

25.06

mmol/l

8.02

2763

6665

Diabetes mellitus

4616

10312

2.80

307.65

4.3

3.0

25.06

25.41

mmol/l

7.43

4482

9964

Other bacterial diseases

4786

11819

2.97

307.65

5.4

2.8

25.04

25.33

mmol/l

5.63

4644

11462

Care involving dialysis

647

1078

7.34

307.65

18.5

2.8

23.59

25.07

mmol/l

20.72

638

1038

Septicaemia

2219

7051

3.28

307.65

6.6

2.8

24.70

25.25

mmol/l

8.89

2136

6844

Endocrine, nutritional and metabolic diseases

2965

5701

2.73

307.65

4.3

2.6

25.04

25.40

mmol/l

5.52

2856

5506

Diseases of arteries, arterioles and capillaries (FINNGEN)

1038

1672

4.63

307.65

6.1

2.3

24.90

25.49

mmol/l

4.83

1007

1627

Type 2 diabetes, definitions combined

3882

9663

2.50

307.65

3.6

3.0

25.12

25.45

mmol/l

6.21

3780

9345

Atrial fibrillation and flutter with reimbursement

1245

1714

5.01

307.65

3.9

2.2

25.33

25.52

mmol/l

0.86

1205

1668

Diabetes medication

4649

10829

2.73

307.65

4.2

3.1

25.06

25.38

mmol/l

6.53

4515

10470

Implicit Sepsis

3520

10611

2.73

307.65

5.5

2.8

25.05

25.30

mmol/l

3.10

3405

10326

Cardiovascular diseases (excluding rheumatic etc)

2166

3863

3.36

307.65

4.8

2.4

25.09

25.30

mmol/l

1.73

2090

3722

Diabetes, varying definitions

4580

10317

2.78

307.65

4.3

3.0

25.08

25.40

mmol/l

6.86

4447

9968

Persons encountering health services for specific procedures and health care

4635

12208

2.45

307.65

5.3

2.7

25.19

25.21

mmol/l

0.15

4484

11831

Chronic kidney disease

2108

5574

4.29

307.65

9.9

2.7

23.72

25.40

mmol/l

73.38

2050

5408

Speech therapy

1696

4646

4.09

307.65

4.5

3.5

25.54

25.21

mmol/l

3.27

1673

4504

Biguanides

4004

10807

2.38

307.65

3.6

3.3

25.13

25.37

mmol/l

3.95

3901

10454

Any reimbursement code in KELA

1744

2824

3.18

307.65

4.2

1.9

25.08

25.41

mmol/l

3.07

1680

2727

Condition for Implicit Sepsis (Organ dysfunction codes)

3700

11349

2.48

307.65

5.2

2.8

25.01

25.34

mmol/l

5.29

3569

11048

All pneumoniae

4212

12842

2.36

307.65

4.9

3.0

25.43

25.13

mmol/l

5.56

4067

12470

Disorders of lipoprotein metabolism and other lipidaemias

3433

9716

2.32

307.65

4.2

2.9

25.16

25.35

mmol/l

2.25

3328

9444

Atrial fibrillation and flutter

1431

2148

4.64

307.65

4.4

2.2

25.34

25.54

mmol/l

1.16

1384

2084

Malaise and fatigue

2172

6863

2.78

307.65

5.0

2.9

25.29

25.16

mmol/l

0.90

2112

6658

Influenza and pneumonia

4392

12658

2.37

307.65

4.8

3.0

25.42

25.13

mmol/l

5.34

4241

12290

Hypertension

3145

6486

2.86

307.65

4.8

2.6

25.10

25.42

mmol/l

4.60

3046

6283

Pneumonia, organism unspecified

3729

12020

2.34

307.65

5.0

3.0

25.43

25.14

mmol/l

4.66

3611

11679

Nephropathy related operations

911

1950

5.52

307.65

16.0

2.9

23.67

25.23

mmol/l

32.31

890

1892

Non-invasive ventilation

956

1779

5.42

307.65

5.1

2.6

26.05

25.47

mmol/l

3.01

838

1734

Cardiac arrhythmias

2218

4523

3.38

307.65

4.1

2.7

25.31

25.40

mmol/l

0.56

2152

4372

Care involving use of rehabilitation procedures

2957

10711

2.77

307.65

4.6

2.7

25.46

25.23

mmol/l

2.71

2856

10383

Other disorders of fluid, electrolyte and acid-base balance

1715

4921

3.69

307.65

6.6

2.9

24.95

25.32

mmol/l

3.11

1664

4781

Other heart diseases, wide

3542

9372

2.43

307.65

4.6

3.0

25.25

25.24

mmol/l

0.08

3440

9081

Insulin, combination of fast acting with intermediate-acting or long-acting

3355

11024

3.01

307.65

5.3

3.1

24.90

25.24

mmol/l

5.52

3261

10677

General symptoms and signs

4374

9908

2.29

307.65

4.4

2.9

25.22

25.21

mmol/l

0.02

4239

9582

STROKE

2247

6021

2.71

307.65

4.1

2.7

25.23

25.46

mmol/l

2.39

2191

5843

Dialysis, with operation codes

926

1907

5.71

307.65

16.1

2.6

23.61

25.44

mmol/l

44.42

904

1847

Hypertension, essential

3177

6336

2.99

307.65

4.5

2.5

25.14

25.43

mmol/l

3.99

3079

6137

Cardiovascular diseases

1864

3388

3.09

307.65

4.7

2.4

25.06

25.22

mmol/l

0.97

1796

3257

Pneumonias (Asthma/COPD co-morbidities)

4202

12801

2.37

307.65

4.9

3.0

25.44

25.14

mmol/l

5.69

4061

12425

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3836

10133

2.47

307.65

4.9

2.9

25.46

25.10

mmol/l

6.57

3710

9839

Diabetes, insulin treatment (Kela reimbursement)

4791

11033

2.80

307.65

4.3

3.1

24.99

25.41

mmol/l

11.20

4661

10669

Hypertensive diseases (excluding secondary)

2107

3157

4.07

307.65

5.1

2.3

25.04

25.44

mmol/l

4.85

2037

3051

Type 2 diabetes, strict (exclude DM1)

3889

9728

2.49

307.65

3.6

3.0

25.12

25.45

mmol/l

6.36

3787

9405

Type 2 diabetes

4349

9902

2.73

307.65

4.3

3.0

25.07

25.44

mmol/l

8.01

4230

9571

Renal failure

3006

7855

3.92

307.65

8.3

2.7

23.81

25.43

mmol/l

87.17

2919

7628

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3679

12084

2.14

307.65

5.5

2.9

24.98

25.29

mmol/l

5.79

3585

11696

Other heart diseases

2019

3207

4.39

307.65

5.2

2.4

25.30

25.40

mmol/l

0.57

1947

3098

Acute renal failure

1256

3602

3.91

307.65

7.6

2.7

23.76

25.40

mmol/l

31.80

1213

3495

Heart failure, not strict

3970

9189

3.20

307.65

5.8

2.6

25.14

25.24

mmol/l

0.81

3853

8938

Insulin, fast-acting or short human

1985

6556

3.27

307.65

6.0

3.3

24.98

25.15

mmol/l

1.25

1927

6345

Bacterial infection, other or unspecified

2817

8483

3.23

307.65

6.4

2.8

25.00

25.28

mmol/l

3.49

2722

8247

Metabolic disorders

4352

10638

2.67

307.65

4.9

2.9

25.07

25.32

mmol/l

4.19

4210

10327

Insulin, intermediate and long-acting

3091

10231

3.21

307.65

5.2

3.2

24.93

25.25

mmol/l

4.44

3008

9915

Hypertensive diseases

3150

6489

2.87

307.65

4.8

2.6

25.10

25.42

mmol/l

4.54

3051

6285

Other septicaemia

2034

6428

3.38

307.65

6.7

2.8

24.60

25.24

mmol/l

10.87

1953

6235

Renal tubulo-interstitial diseases

4567

11684

3.20

307.65

6.4

2.5

24.45

25.52

mmol/l

63.34

4435

11337

Insulin medication

3344

8671

3.56

307.65

5.3

3.2

24.90

25.34

mmol/l

8.59

3250

8384

Insulin, fast-acting

1978

6077

3.53

307.65

6.0

3.2

24.97

25.19

mmol/l

1.66

1920

5884

3836

10133

2.47

307.65

4.9

2.9

25.46

25.10

mmol/l

6.57

3710

9839

Infections, IBD-co-morbidities

741

1043

5.54

307.65

7.4

2.7

24.67

25.29

mmol/l

3.60

716

1013

Heart failure, strict

2936

8504

2.66

307.65

5.5

3.1

25.37

25.12

mmol/l

2.56

2847

8271

Type 1 diabetes

1256

3359

4.02

307.65

6.5

3.1

24.74

25.28

mmol/l

4.91

1215

3237

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

4124

12864

2.35

307.65

4.9

3.0

25.45

25.13

mmol/l

5.81

3987

12486

Type 2 diabetes, wide definition

4254

8957

3.32

307.65

4.5

3.0

25.05

25.46

mmol/l

9.49

4141

8667

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3934

13517

2.17

307.65

5.5

3.0

24.81

25.35

mmol/l

16.39

3811

13112

Hypertensive heart and/or renal disease

1290

2949

3.66

307.65

5.7

2.6

24.97

25.29

mmol/l

1.96

1275

2880

Acute tubulo-interstitial nephritis

2544

9519

2.48

307.65

5.1

2.5

24.87

25.52

mmol/l

15.44

2461

9238

Antihypertensive medication - note that there are other indications

1851

3683

2.83

305.13

4.5

2.4

24.95

25.41

mmol/l

6.18

1778

3565

Presence of cardiac and vascular implants and grafts

2202

7054

2.51

302.23

4.5

3.0

25.08

25.21

mmol/l

0.86

2141

6840

Viral Sepsis

1041

3052

3.75

301.59

6.6

2.8

25.19

mmol/l

0.01

997

2966

Implicit viral Sepsis

1038

3048

3.74

299.99

6.6

2.8

25.20

25.19

mmol/l

0.01

994

2962

Certain infectious and parasitic diseases

3630

9040

2.07

296.08

4.5

2.6

25.11

25.33

mmol/l

2.95

3528

8753

Other nutritional deficiencies

2353

10283

2.33

295.44

4.2

3.3

25.38

25.21

mmol/l

1.46

2289

9964

Erysipelas

2290

9245

2.37

292.75

4.8

2.8

25.28

25.29

mmol/l

0.04

2231

8977

Hypertensive Heart Disease

1118

2780

3.54

287.92

5.2

2.6

25.13

25.27

mmol/l

0.53

1106

2714

Bleeding

3324

12258

2.05

285.21

4.9

3.2

25.07

25.29

mmol/l

2.86

3241

11887

Hyperlipidaemia, other/unspecified

1775

6790

2.63

282.27

4.4

2.9

25.24

25.29

mmol/l

0.24

1749

6608

Extracorporeal dialysis

506

928

6.79

275.80

20.0

3.1

23.73

25.12

mmol/l

14.67

500

895

Transplanted organ and tissue status

607

1294

5.38

273.70

14.1

2.9

23.76

25.24

mmol/l

18.46

591

1251

Obesity and other hyperalimentation

2239

10031

2.30

273.66

4.1

3.3

25.41

25.20

mmol/l

1.97

2183

9716

Obesity

2229

9976

2.30

273.64

4.1

3.3

25.41

25.20

mmol/l

1.94

2173

9666

Obesity due to excess calories

1735

7112

2.56

267.85

4.4

3.4

25.36

25.19

mmol/l

1.17

1697

6894

Kidney transplant status

421

668

7.78

264.52

17.7

3.1

23.23

25.09

mmol/l

19.82

414

649

Ischemic heart diseases

3038

9497

2.08

263.18

4.4

3.1

25.31

25.34

mmol/l

0.21

2954

9236

Ischaemic heart disease, wide definition

2996

9385

2.08

257.68

4.4

3.1

25.31

25.34

mmol/l

0.22

2910

9133

Complications of surgical and medical care, not elsewhere classified

3627

14030

1.91

256.98

4.8

3.2

25.05

25.28

mmol/l

3.25

3521

13600

Hard cardiovascular diseases

3043

9877

2.05

255.81

4.3

3.2

25.24

25.35

mmol/l

0.90

2968

9590

Parasetamol

2814

6863

2.15

255.47

4.0

3.0

25.03

25.24

mmol/l

2.24

2708

6657

Hypothyroidism (congenital or acquired)

715

871

4.86

253.96

4.0

2.2

25.01

25.42

mmol/l

2.08

682

836

Asthma, unspecified (mode), excluding more controls

1841

6089

2.46

252.72

4.2

2.7

25.63

25.10

mmol/l

7.89

1778

5919

Glomerular diseases

972

3068

3.48

250.93

11.7

3.2

23.92

25.23

mmol/l

25.38

954

2963

Depression medications

814

936

4.50

250.47

3.6

2.0

25.16

25.49

mmol/l

1.61

784

896

Nausea and vomiting

1183

4089

3.02

248.55

5.8

3.1

25.03

25.20

mmol/l

0.89

1140

3961

Asthma, excluding more controls

2621

6604

2.18

248.02

3.8

2.7

25.52

25.11

mmol/l

6.58

2535

6411

Hypothyroidism, levothyroxine purchases

699

867

4.78

243.88

3.6

2.2

25.05

25.42

mmol/l

1.80

668

832

Hypothyroidism and >3 levothyroxin purchases

699

867

4.78

243.88

3.6

2.2

25.05

25.42

mmol/l

1.80

668

832

Headache

2171

8373

2.23

243.42

3.8

2.9

25.24

mmol/l

0.03

2107

8097

Pure hypercholesterolaemia

2746

9167

2.08

243.39

4.1

2.9

25.15

25.34

mmol/l

1.95

2643

8920

Sub-endpoint used in defining T1D endpoints

1344

5079

2.75

237.88

6.3

3.4

24.81

25.13

mmol/l

2.31

1299

4909

Symptoms and signs involving the circulatory and respiratory systems

3500

9314

1.93

237.43

4.1

3.1

25.27

25.09

mmol/l

2.20

3388

9016

Valvular heart disease excluding rheumatic fever

1847

5849

2.41

235.90

4.5

2.9

25.13

25.18

mmol/l

0.22

1791

5688

Non-rheumatic valve diseases

1837

5810

2.41

234.71

4.5

2.9

25.14

25.19

mmol/l

0.23

1781

5651

Dialysis

346

509

8.56

234.14

18.2

3.0

23.49

25.32

mmol/l

15.32

338

493

Bacterial pneumoniae

1745

6691

2.43

233.60

5.3

2.9

25.84

25.04

mmol/l

13.25

1669

6511

Intracranial trauma

1998

6706

2.30

233.51

3.8

3.3

25.23

25.13

mmol/l

0.59

1950

6500

Paroxysmal tachycardia

771

1775

3.86

233.28

4.1

2.2

25.18

25.36

mmol/l

0.64

749

1729

Oral corticosteroids

3867

13148

1.83

231.10

4.2

3.2

25.32

25.20

mmol/l

1.18

3745

12746

Symptoms and signs involving the digestive system and abdomen

3706

10180

1.87

228.45

4.2

3.2

25.15

25.23

mmol/l

0.60

3585

9855

L04AD Calcineurin inhibitors

587

1415

4.65

225.90

12.6

3.3

23.89

25.27

mmol/l

16.32

571

1369

Asthma (only as main-diagnosis), excluding more controls

2334

6604

2.16

224.89

3.8

2.7

25.49

25.11

mmol/l

5.31

2266

6411

Abdominal and pelvic pain

3674

10174

1.86

223.24

4.1

3.1

25.19

25.23

mmol/l

0.23

3561

9849

Glomerular disorders in diseases classified elsewhere

682

1856

4.14

223.00

12.0

3.1

23.82

25.18

mmol/l

18.53

670

1794

Diseases of oesophagus, stomach and duodenum

3803

13079

1.81

221.94

4.1

3.3

25.14

25.28

mmol/l

1.56

3707

12660

Hypo-osmolality and hyponatraemia

883

2826

3.41

221.16

5.8

2.9

24.88

25.36

mmol/l

3.12

857

2749

First line medication for Crohn's disease

3958

12289

1.80

220.66

5.0

2.9

25.16

25.23

mmol/l

0.58

3839

11907

Substance abuse, excluding more controls

2083

8678

2.18

219.11

4.0

3.4

25.05

25.11

mmol/l

0.28

2012

8416

Bacterial pneumonia, not elsewhere classified

1648

6357

2.41

217.50

5.3

3.0

25.87

25.04

mmol/l

13.31

1573

6191

Non-ischemic cardiomyopathy

1301

4151

2.74

217.47

5.0

2.8

25.60

25.14

mmol/l

3.48

1267

4038

Aplastic and other anaemias

1950

8702

2.24

217.40

6.4

3.2

24.54

25.26

mmol/l

14.13

1892

8445

ILD medications: prednisolone, methylprednisolone, prednisone

3912

12672

1.79

214.92

5.1

2.9

25.14

25.23

mmol/l

0.82

3794

12277

Symptoms and signs involving cognition, perception, emotional state and behaviour

3432

13493

1.83

213.15

3.9

3.4

25.21

25.23

mmol/l

0.14

3330

13085

Asthma, unspecified (mode)

1888

6883

2.25

211.88

4.2

2.8

25.64

25.05

mmol/l

9.70

1825

6694

Asthma

2725

7461

2.01

211.19

3.8

2.8

25.50

25.07

mmol/l

7.93

2636

7249

Other diseases of intestines

3641

12001

1.81

208.68

4.1

3.2

25.20

25.22

mmol/l

0.08

3548

11610

COPD/asthma/ILD related infections

3617

10143

1.83

208.19

4.3

2.9

25.38

25.11

mmol/l

4.55

3509

9848

COPD/asthma related infections

3617

10143

1.83

208.19

4.3

2.9

25.38

25.11

mmol/l

4.55

3509

9848

Secondary hypertension

380

666

6.21

207.59

12.4

2.2

24.15

25.23

mmol/l

6.56

372

646

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

966

3374

3.05

206.50

3.8

3.4

25.24

25.38

mmol/l

0.55

943

3261

Intestinal infectious diseases

3298

14452

1.82

206.20

5.2

3.1

24.97

25.26

mmol/l

4.96

3197

14003

Heart failure and bmi 25plus

1579

4689

2.47

204.36

5.3

2.8

25.51

25.09

mmol/l

3.48

1532

4545

ILD medications

4000

12825

1.75

204.35

5.1

2.9

25.14

25.22

mmol/l

0.68

3876

12423

Diarrhoea and gastroenteritis of presumed infectious origin

2515

11971

1.97

203.59

5.3

3.1

24.92

25.25

mmol/l

4.97

2443

11591

Autoimmune diseases excluding thyroid diseases

3729

11872

1.79

203.51

4.8

3.1

25.04

25.24

mmol/l

2.56

3628

11490

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1235

2931

2.75

202.71

4.5

2.2

25.28

25.48

mmol/l

1.07

1197

2832

Other CVD (FINNGEN)

491

820

5.11

201.85

5.3

2.2

24.97

25.31

mmol/l

1.11

476

799

Inflammatory bowel disease treatment related agents

4000

13410

1.73

198.59

4.4

3.2

25.26

25.18

mmol/l

0.61

3879

12996

Other arrhythmias

2093

7852

2.10

197.90

3.6

2.9

25.38

25.24

mmol/l

1.11

2027

7621

Syncope and collapse

1681

6807

2.28

197.02

4.0

2.9

25.31

25.15

mmol/l

1.00

1627

6604

Complications of procedures, not elsewhere classified

2843

13540

1.87

194.97

4.6

3.2

25.04

25.28

mmol/l

3.11

2763

13131

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

911

3164

3.00

194.37

3.5

3.1

25.27

25.21

mmol/l

0.18

873

3073

Autoimmune diseases excluding thyroid diseases, strict definition

3594

11529

1.78

193.85

4.8

3.1

25.02

25.23

mmol/l

2.62

3500

11168

Hypothyroidism, drug reimbursement

419

543

5.74

193.34

3.5

2.0

25.42

25.40

mmol/l

0.04

397

522

Asthma (mode)

2630

7552

1.96

191.54

3.7

2.8

25.45

25.07

mmol/l

6.01

2542

7338

Bacterial pneumonia (organism specified)

1838

8073

2.17

189.95

5.3

3.2

25.77

25.05

mmol/l

11.69

1759

7847

Other neurological diseases

2725

11998

1.89

189.50

4.0

3.4

25.12

25.26

mmol/l

1.19

2654

11646

Poisoning by drugs, medicaments and biological substances

899

3156

3.00

189.37

3.8

3.4

25.36

25.22

mmol/l

0.54

865

3049

Asthma (only as main-diagnosis)

2409

7461

2.00

189.32

3.8

2.8

25.51

25.07

mmol/l

7.40

2338

7249

Covid-19 confirmed case

1135

4502

2.66

189.15

5.8

3.4

25.29

25.02

mmol/l

1.82

1097

4355

Poisoning by medicine

828

2780

3.15

189.11

3.9

3.4

25.39

25.21

mmol/l

0.63

797

2680

Other anaemias

1772

8215

2.19

187.85

5.7

3.2

24.57

25.24

mmol/l

11.03

1718

7971

Other and unspecified anaemias

1754

8159

2.19

185.70

5.7

3.2

24.57

25.24

mmol/l

10.94

1700

7915

Neurological diseases, wide definition

929

1497

3.20

182.97

4.0

2.6

25.18

25.23

mmol/l

0.13

902

1445

Heart failure and coronary heart disease

1565

5330

2.33

180.88

5.6

3.2

25.14

25.20

mmol/l

0.23

1513

5186

Concussion

1632

6576

2.21

180.37

3.8

3.3

25.17

25.13

mmol/l

0.15

1591

6374

Combinations of oral blood glucose lowering drugs

1145

4698

2.58

178.31

3.5

3.4

24.82

25.25

mmol/l

3.92

1128

4548

Dental caries

1081

4263

2.65

178.30

6.7

3.3

25.03

25.15

mmol/l

0.48

1046

4144

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1133

2091

2.78

177.57

3.8

2.4

25.26

25.16

mmol/l

0.37

1094

2019

Mental and behavioural disorders due to psychoactive substance use

2144

10587

1.97

175.83

4.0

3.5

25.05

25.16

mmol/l

0.69

2073

10249

Complications of medical and surgical care

2578

13603

1.86

175.17

4.9

3.2

25.15

25.26

mmol/l

0.81

2497

13200

Asthma, hospital admission 2, infections

2091

10739

1.98

173.90

4.4

3.4

25.70

25.13

mmol/l

10.32

2023

10422

Asthma-related infections

2091

10739

1.98

173.90

4.4

3.4

25.70

25.13

mmol/l

10.32

2023

10422

Dentinal caries

978

3750

2.75

172.99

6.7

3.3

25.04

25.15

mmol/l

0.40

947

3648

Substance abuse

2083

10419

1.97

171.17

4.0

3.5

25.05

25.16

mmol/l

0.65

2012

10089

Diseases of arteries, arterioles and capillaries

2584

10698

1.87

170.46

5.4

3.2

24.75

25.31

mmol/l

11.55

2498

10408

Other disorders of teeth and supporting structures

955

3683

2.76

169.57

5.5

3.3

25.34

25.20

mmol/l

0.56

928

3591

Major coronary heart disease event

2692

10042

1.85

169.18

4.3

3.3

25.12

25.30

mmol/l

1.81

2614

9762

Disorders of gallbladder, biliary tract and pancreas

3410

13125

1.72

167.14

4.2

3.3

25.10

25.27

mmol/l

1.77

3319

12721

Diverticular disease of intestine

2609

9615

1.86

167.06

4.1

3.2

25.16

25.28

mmol/l

1.05

2553

9331

Dizziness and giddiness

2622

11972

1.83

166.46

3.9

3.4

25.25

25.23

mmol/l

0.06

2551

11623

Major coronary heart disease event excluding revascularizations

2515

9595

1.88

165.57

4.5

3.2

25.12

25.28

mmol/l

1.40

2447

9328

Coronary atherosclerosis

2438

8573

1.90

164.39

4.5

3.1

25.13

25.31

mmol/l

1.59

2359

8339

Abnormalities of heart beat

1241

5415

2.36

162.55

3.8

3.0

25.44

25.09

mmol/l

3.06

1206

5246

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

622

1937

3.40

161.59

3.8

3.3

25.22

25.23

mmol/l

0.02

597

1873

All influenza

988

3962

2.63

160.78

5.3

3.0

25.50

25.03

mmol/l

3.47

944

3850

Oxycodone

1484

6838

2.20

160.74

5.0

3.2

25.36

25.23

mmol/l

0.71

1424

6673

Hypokalaemia

558

1646

3.71

160.24

6.3

2.9

26.26

25.45

mmol/l

3.82

537

1600

General examination and investigation of persons without complaint and reported diagnosis

2342

6656

1.92

159.30

4.4

2.9

25.04

25.25

mmol/l

1.94

2280

6442

Psychiatric diseases

3699

11277

1.68

158.68

3.9

3.3

25.26

25.22

mmol/l

0.33

3579

10942

GASTRO-related operations

2666

7415

1.84

158.25

4.3

2.6

25.06

25.36

mmol/l

3.98

2581

7173

Any gastric operation

2666

7415

1.84

158.25

4.3

2.6

25.06

25.36

mmol/l

3.98

2581

7173

Convulsions, not elsewhere classified

845

3111

2.80

157.99

4.3

3.1

25.19

24.99

mmol/l

0.91

814

3009

Medical observation and evaluation for suspected diseases and conditions

2418

6683

1.90

157.61

4.5

2.9

25.18

25.25

mmol/l

0.43

2353

6469

Statin medication

2191

6467

1.95

157.26

4.4

2.9

25.06

25.47

mmol/l

5.92

2127

6266

Fitting and adjustment of other devices

1409

6156

2.23

157.16

4.0

2.8

25.33

25.13

mmol/l

1.42

1390

5969

Unspecified kidney failure

553

1654

3.73

156.93

8.9

2.7

23.76

25.38

mmol/l

15.61

538

1599

Personality disorders, excluding more controls

794

2891

2.85

155.21

3.6

3.1

25.40

25.23

mmol/l

0.61

775

2804

Other retinal disorders

2368

10638

1.85

154.16

5.1

3.3

24.99

25.28

mmol/l

3.41

2291

10337

Cerebrovascular diseases

2715

11274

1.78

152.92

4.0

3.4

25.19

25.28

mmol/l

0.67

2648

10942

Dorsalgia

3373

11024

1.69

152.48

3.5

3.4

25.33

25.13

mmol/l

2.63

3264

10700

Mental and behavioural disorders due to alcohol

1837

9341

1.98

152.47

4.0

3.5

24.95

25.13

mmol/l

1.30

1777

9045

Episodal and paroxysmal disorders

3698

11683

1.65

151.77

3.8

3.4

25.28

25.16

mmol/l

1.16

3587

11304

Other medical care

1482

7037

2.14

151.53

4.3

2.7

25.27

25.17

mmol/l

0.40

1423

6830

Diseases of the digestive system

1765

9129

2.01

151.44

5.1

3.4

24.84

25.20

mmol/l

3.72

1714

8850

Polyarthropathies

2407

8951

1.84

150.81

4.9

3.3

25.00

25.21

mmol/l

1.97

2337

8684

2063

10294

1.90

150.10

4.1

3.5

24.88

25.17

mmol/l

2.90

1995

9969

2139

10527

1.88

149.44

4.0

3.5

24.89

25.18

mmol/l

2.94

2068

10195

Nerve, nerve root and plexus disorders

3562

13952

1.64

146.76

3.9

3.3

25.36

25.21

mmol/l

1.77

3425

13558

Insulin, fast-acting (human)

592

1903

3.31

146.25

7.8

3.0

25.00

25.22

mmol/l

0.75

575

1839

Asthma-related pneumonia

1403

6817

2.15

144.26

5.0

3.4

25.91

25.07

mmol/l

12.65

1357

6610

Pain, not elsewhere classified

909

3678

2.58

144.22

4.6

2.8

25.36

25.18

mmol/l

0.82

874

3550

Any mental disorder

3746

11740

1.63

144.11

3.9

3.3

25.29

25.20

mmol/l

0.77

3622

11396

Asthma-related pneumonia or sepsis

1404

6829

2.14

143.93

5.0

3.4

25.91

25.07

mmol/l

12.75

1358

6621

Asthma, hospital admissions 3, pneumonia

1404

6829

2.14

143.93

5.0

3.4

25.91

25.07

mmol/l

12.75

1358

6621

Alcohol use disorder, Swedish definition

1964

9894

1.90

143.91

4.1

3.5

24.90

25.18

mmol/l

2.62

1897

9585

Injuries to the head

3591

14715

1.62

143.29

3.7

3.5

25.21

mmol/l

0.04

3488

14249

Used for control exclusion in common control thyroid runs

3535

11085

1.65

142.86

4.4

3.1

25.02

25.23

mmol/l

2.93

3416

10741

Neurological diseases

2816

8257

1.75

141.96

3.8

3.3

25.23

25.10

mmol/l

1.10

2719

8014

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1620

8324

2.02

141.79

4.1

3.5

24.95

25.15

mmol/l

1.33

1565

8062

Obesity related asthma

1196

5515

2.27

141.15

4.3

3.4

25.66

25.17

mmol/l

5.02

1161

5360

Chronic lower respiratory diseases

3960

13721

1.59

140.70

3.9

3.4

25.52

25.09

mmol/l

10.42

3828

13296

Other functional intestinal disorders

1595

7766

2.02

140.65

4.5

3.3

25.32

25.18

mmol/l

0.83

1536

7524

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2286

12129

1.80

140.54

4.5

3.4

25.35

25.22

mmol/l

1.01

2234

11770

Unspecified mental disorder

1361

6597

2.13

140.02

3.6

3.5

25.64

25.17

mmol/l

4.84

1321

6394

Alcohol use disorder, ICD-based

1504

7601

2.05

138.65

4.1

3.5

24.98

25.16

mmol/l

1.10

1454

7357

GI-bleeding

1326

6428

2.16

138.32

5.0

3.4

24.82

25.15

mmol/l

2.46

1289

6234

Diseases of pulp and periapical tissues

1302

6256

2.17

137.93

5.5

3.2

25.20

25.22

mmol/l

0.05

1269

6092

Low back pain

2395

10666

1.77

136.44

3.7

3.4

25.47

25.14

mmol/l

4.66

2312

10362

ILD medications: immunosuppressive drugs

1983

10525

1.86

136.39

6.4

2.9

24.89

25.27

mmol/l

5.13

1925

10197

Unstable angina pectoris

1590

6791

2.03

135.55

4.4

3.3

25.19

25.23

mmol/l

0.15

1541

6606

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

911

3796

2.49

135.35

3.5

3.3

25.27

25.21

mmol/l

0.21

873

3671

Myocardial infarction

1871

7228

1.93

135.14

4.7

3.1

25.00

25.26

mmol/l

2.24

1816

7035

Lower back pain or/and sciatica

3350

14630

1.62

135.08

3.5

3.4

25.42

25.19

mmol/l

3.37

3246

14188

Other special examinations and investigations of persons without complaint or reported diagnosis

2354

6686

1.82

135.08

4.3

2.9

25.13

25.25

mmol/l

0.81

2275

6472

Volume depletion

474

1410

3.69

134.81

6.4

2.9

24.55

25.18

mmol/l

2.29

454

1370

Disorders of choroid and retina

2817

12425

1.70

134.80

4.8

3.3

24.96

25.30

mmol/l

5.40

2728

12075

Stroke, including SAH

2307

9826

1.79

134.26

4.1

3.4

25.20

25.25

mmol/l

0.25

2247

9543

Other diseases of the digestive system

1307

6373

2.15

134.26

5.1

3.4

24.81

25.16

mmol/l

2.64

1269

6182

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

1596

7275

2.01

134.09

3.8

3.4

25.16

25.31

mmol/l

0.93

1562

7053

Autoimmune diseases

3676

11921

1.60

133.72

4.5

3.1

25.05

25.24

mmol/l

2.63

3565

11538

Symptoms and signs involving the urinary system

2660

12377

1.71

131.69

4.8

3.3

25.14

25.25

mmol/l

0.82

2564

12025

Other pulmonary diagnosis

2590

7539

1.76

131.54

4.1

2.8

25.35

25.07

mmol/l

3.53

2500

7325

Obesity, other/unspecified

1055

4750

2.30

131.22

3.9

3.4

25.37

25.23

mmol/l

0.63

1030

4605

Schizophrenia or delusion, excluding more controls

974

4214

2.38

130.28

3.3

25.80

25.21

mmol/l

4.84

938

4094

Excluding asthma or asthma-COPD overlap

2581

7539

1.75

129.50

4.0

2.8

25.37

25.07

mmol/l

3.85

2492

7325

L04AA Selective immunosuppressants

797

3207

2.62

129.08

9.2

3.2

24.40

25.33

mmol/l

11.09

774

3104

Asthma (diagnoses ohter than nonallergic)

2810

14790

1.66

129.00

3.9

3.4

25.60

25.14

mmol/l

9.76

2718

14347

Other soft tissue disorders, not elsewhere classified

2985

11375

1.65

127.78

4.3

3.3

25.40

25.15

mmol/l

3.51

2906

11017

Suicide or other Intentional self-harm

827

3394

2.54

127.54

3.7

3.4

25.36

25.23

mmol/l

0.44

793

3285

1456

7415

2.01

127.49

4.3

3.5

25.64

25.12

mmol/l

6.92

1407

7191

Oedema, not elsewhere classified

1070

4884

2.27

127.35

5.0

2.8

25.56

25.17

mmol/l

3.10

1044

4737

Nutritional anaemias

1752

9320

1.89

126.86

5.1

3.2

24.78

25.25

mmol/l

5.79

1691

9046

COPD differential diagnosis

2569

7554

1.74

125.90

4.0

2.8

25.38

25.07

mmol/l

4.10

2479

7340

Other disorders of urethra and urinary system

2283

9978

1.76

125.79

4.5

3.2

25.23

25.21

mmol/l

0.08

2216

9669

Sulfonylureas

1403

5657

2.06

125.05

4.6

3.3

24.81

25.29

mmol/l

4.71

1374

5472

ILD differential diagnosis

2564

7552

1.73

124.88

4.0

2.8

25.38

25.07

mmol/l

4.07

2474

7338

Alcohol abuse, main dg, excluding more controls

576

1997

3.06

124.81

3.8

3.4

24.97

25.07

mmol/l

0.23

556

1943

3701

12685

1.57

123.58

4.3

3.1

25.33

25.14

mmol/l

2.40

3580

12299

Iron deficiency anaemia

1504

7838

1.97

123.30

5.2

3.3

24.79

25.25

mmol/l

4.76

1451

7606

Disorders of thyroid, IBD co-morbidities

498

1102

3.40

122.18

3.5

2.4

25.44

25.31

mmol/l

0.37

481

1068

Diabetic nephropathy, excluding more controls

773

2627

2.68

120.67

10.0

2.9

24.16

25.19

mmol/l

11.96

755

2562

Other disorders of skin and subcutaneous tissue

2303

12620

1.72

120.27

5.3

3.2

25.10

25.27

mmol/l

1.55

2233

12257

Other antidepressants

3483

11713

1.58

119.74

3.8

3.4

25.24

25.15

mmol/l

0.74

3374

11366

Stroke, excluding SAH

2172

9462

1.76

118.60

4.2

3.4

25.19

25.23

mmol/l

0.20

2117

9179

Hyperkalaemia

322

809

4.53

118.37

10.0

2.8

23.49

25.19

mmol/l

10.28

312

786

Kela-code for severe mental illness

1213

6002

2.09

118.26

3.5

25.62

25.17

mmol/l

3.94

1174

5810

Paralytic ileus and intestinal obstruction

1004

4648

2.26

117.74

4.8

3.2

25.22

25.18

mmol/l

0.12

969

4496

Tramadol

2554

9966

1.68

117.59

4.3

3.1

25.15

25.29

mmol/l

1.20

2462

9686

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

396

786

3.92

117.11

4.7

2.6

25.65

25.27

mmol/l

0.96

370

765

Problems related to lifestyle

427

1291

3.54

117.07

4.3

2.9

25.35

25.17

mmol/l

0.39

413

1250

Substance use, excluding alcohol

662

2551

2.72

116.69

4.2

3.3

25.59

25.27

mmol/l

1.37

638

2465

Myocardial infarction, without ST-elevation

1602

8071

1.91

116.67

4.9

3.4

24.92

25.16

mmol/l

1.88

1548

7845

Infections of the skin and subcutaneous tissue

1823

10322

1.81

115.41

5.4

3.4

25.08

25.18

mmol/l

0.53

1771

10009

Pain in limb

2500

11037

1.67

115.24

4.4

3.3

25.41

25.16

mmol/l

3.08

2436

10694

Peripheral artery disease

1740

7818

1.86

115.00

6.1

3.2

24.56

25.26

mmol/l

11.19

1685

7601

Transient ischemic attack

1912

9101

1.80

114.75

4.1

3.4

25.16

25.24

mmol/l

0.52

1862

8832

Gastrointestinal diseases

1768

4773

1.89

114.55

4.0

2.6

25.18

25.23

mmol/l

0.24

1706

4592

Asthma/COPD (KELA code 203)

3031

13676

1.59

114.05

3.9

3.4

25.60

25.10

mmol/l

12.14

2943

13252

Bronchitis

3388

14543

1.56

113.98

4.5

3.2

25.36

25.18

mmol/l

2.15

3279

14093

Benign neoplasm of colon, rectum, anus and anal canal

1893

7690

1.81

113.82

4.5

3.2

25.11

25.37

mmol/l

2.52

1854

7461

Presence of other functional implants

1982

8087

1.79

113.72

4.8

3.0

25.21

25.30

mmol/l

0.52

1943

7841

Benign neoplasm: Colon

1710

7299

1.86

111.99

4.6

3.2

25.02

25.37

mmol/l

3.96

1670

7083

Type 1 diabetes, strict (exclude DM2)

342

913

3.95

111.85

4.1

3.7

24.87

25.20

mmol/l

0.80

329

881

COPD (mode)

1177

4609

2.11

111.76

4.8

2.8

26.14

24.92

mmol/l

18.61

1139

4504

Examination and observation for other reasons

1910

6572

1.81

111.63

4.0

2.9

24.85

25.26

mmol/l

5.89

1866

6360

Codeine

2991

10427

1.60

111.19

3.8

3.1

25.15

25.27

mmol/l

1.02

2877

10130

Cholelithiasis, broad definition with cholecystitis

2812

12196

1.61

111.07

3.8

3.3

25.20

25.26

mmol/l

0.44

2741

11826

Disorders of lens

2267

8548

1.72

110.91

5.0

3.2

25.00

25.34

mmol/l

4.50

2199

8325

Myocardial infarction, strict

1703

6919

1.86

110.84

4.4

3.1

24.99

25.24

mmol/l

1.97

1650

6735

Type 1 diabetes, definitions combined

342

919

3.92

110.77

4.1

3.5

24.87

25.22

mmol/l

0.89

329

886

Mood disorders, excluding more controls

2897

11168

1.61

110.74

3.9

3.3

25.35

25.24

mmol/l

0.99

2788

10843

Pain (limb, back, neck, head abdominally)

2445

7365

1.69

109.96

3.9

3.3

25.22

25.11

mmol/l

0.82

2366

7115

Sciatica+with lumbago

1616

8526

1.85

109.80

3.4

25.33

25.19

mmol/l

1.00

1575

8286

Opioids

3135

10564

1.58

109.68

4.1

3.1

25.12

25.26

mmol/l

1.32

3022

10260

Genitourinary diseases

1981

5639

1.80

109.14

5.2

2.3

24.90

25.36

mmol/l

6.50

1914

5466

Conduction disorders

1026

4062

2.18

107.65

4.0

2.9

24.91

25.12

mmol/l

1.02

982

3953

Hydronephrosis

481

1648

3.14

107.45

6.3

2.6

23.92

25.52

mmol/l

15.32

470

1596

Conductive and sensorineural hearing loss

2687

11761

1.62

107.36

3.5

25.27

25.26

mmol/l

0.07

2611

11431

Viral pneumonia

500

1753

3.04

106.67

6.6

3.0

25.49

25.07

mmol/l

1.60

471

1701

Other dorsopathies, not elsewhere classified

3216

11052

1.56

105.61

3.5

25.27

25.13

mmol/l

1.43

3103

10725

Constipation

2837

13082

1.59

105.00

4.1

3.4

25.37

25.18

mmol/l

2.22

2736

12714

Gout

1136

5246

2.07

103.70

6.0

3.3

24.59

25.10

mmol/l

4.70

1102

5094

Sensorineural hearing loss

2574

11384

1.62

103.31

3.5

25.26

mmol/l

0.00

2501

11070

Coronary revascularization (ANGIO or CABG)

1672

6583

1.83

103.24

4.2

3.1

25.01

25.23

mmol/l

1.64

1614

6409

Other acute lower respiratory infections

1781

9900

1.76

103.16

5.1

3.4

25.52

25.10

mmol/l

5.52

1722

9581

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

731

3153

2.47

102.83

3.8

3.3

25.05

25.19

mmol/l

0.45

712

3059

Sleep disorders (combined)

3070

13213

1.55

101.99

3.9

3.4

25.50

25.20

mmol/l

5.16

2980

12797

Personality disorders

794

3528

2.33

101.90

3.6

3.4

25.40

25.19

mmol/l

0.83

775

3403

Gastroduodenal ulcer

1046

5190

2.10

101.76

4.7

3.3

24.68

25.10

mmol/l

2.97

1024

5028

Other and unspecified iron deficiency

1143

5861

2.03

101.48

5.2

3.3

24.71

25.23

mmol/l

5.03

1103

5688

AV-block

702

2684

2.51

101.45

4.0

2.9

24.71

25.00

mmol/l

1.22

669

2612

Disorders of adult personality and behaviour

823

3728

2.28

100.74

3.6

3.5

25.41

25.17

mmol/l

1.14

798

3600

Unknown and unspecified causes of morbidity

317

874

3.91

100.32

5.1

2.8

24.71

24.98

mmol/l

0.76

310

849

Intracranial injury

1878

10812

1.72

100.16

3.8

3.5

25.25

25.15

mmol/l

0.62

1831

10484

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1964

11830

1.70

99.71

5.0

3.3

25.09

25.26

mmol/l

1.28

1901

11494

Cholelithiasis

2669

12014

1.59

99.69

3.7

3.3

25.20

25.27

mmol/l

0.48

2603

11652

Haemorrhage from respiratory passages

1184

5717

1.99

99.09

4.7

3.1

25.13

25.04

mmol/l

0.33

1149

5550

Early onset COPD, excluding more controls

730

3178

2.40

98.97

4.8

2.8

26.34

24.94

mmol/l

14.65

711

3100

Dermatitis

1922

11609

1.70

97.87

4.2

3.4

25.14

25.26

mmol/l

0.84

1878

11253

Autoimmune diseases related-to ILD

2616

14903

1.57

97.22

4.1

3.3

25.28

25.22

mmol/l

0.43

2544

14453

Anxiety disorders, excluding more controls

2375

9856

1.63

97.12

4.2

3.2

25.42

25.26

mmol/l

1.45

2309

9567

Specific personality disorders

690

2950

2.42

96.96

3.6

3.5

25.47

25.18

mmol/l

1.23

669

2848

Other reaction to severe stress, and adjustment disorders

984

4841

2.09

96.95

4.5

3.2

25.36

25.29

mmol/l

0.27

952

4679

Alcohol dependence

970

4801

2.10

95.33

4.3

3.6

25.05

25.13

mmol/l

0.27

943

4652

Asthma, hospital admissions , main diagnosis only

2530

14644

1.58

95.13

3.9

3.4

25.50

25.18

mmol/l

4.97

2457

14188

Epilepsy

1041

5263

2.04

95.00

4.1

3.6

25.21

25.04

mmol/l

0.90

1007

5098

Spondylopathies

2583

10052

1.59

94.57

3.4

25.35

25.16

mmol/l

1.85

2502

9767

Atherosclerosis, excluding cerebral and coronary sclerosis

1600

7395

1.79

93.76

5.8

3.2

24.55

25.25

mmol/l

10.35

1548

7195

Other or unspecified ileus, impaction or obstruction

726

3241

2.36

93.47

4.8

3.3

25.39

25.18

mmol/l

0.62

704

3145

Ischaemic Stroke, excluding all haemorrhages

1990

9200

1.68

93.17

4.2

3.4

25.16

25.22

mmol/l

0.30

1937

8926

Asthma, including avohilmo

3652

14636

1.47

93.04

3.8

3.5

25.51

25.13

mmol/l

8.23

3531

14188

Osteopathies and chondropathies

1757

9968

1.72

92.38

4.8

3.3

25.27

25.30

mmol/l

0.12

1699

9675

Alcohol abuse, main dg

576

2334

2.60

92.20

3.8

3.6

24.97

25.15

mmol/l

0.47

556

2257

Glomerulonephritis

438

1554

3.04

92.18

11.7

3.3

24.05

25.21

mmol/l

9.94

431

1503

Schizophrenia or delusion

974

4875

2.06

92.06

3.3

3.6

25.80

25.20

mmol/l

5.08

938

4722

Intestinal stricture

1111

5852

1.98

91.58

4.8

3.5

25.10

25.17

mmol/l

0.22

1074

5675

Acute peritonitis

330

1004

3.64

91.24

12.3

3.3

24.09

25.09

mmol/l

4.84

324

974

Schizophrenia, schizotypal and delusional disorders

978

4923

2.05

90.97

3.3

3.6

25.80

25.21

mmol/l

4.90

942

4768

Disorders of mineral metabolism

345

1075

3.48

90.87

9.0

2.9

25.58

25.42

mmol/l

0.28

336

1041

Anaemia in chronic diseases classified elsewhere

179

351

6.21

90.73

17.1

3.2

23.56

25.28

mmol/l

8.50

174

339

Pacemaker

1299

7018

1.88

90.46

4.2

3.4

25.17

25.12

mmol/l

0.20

1253

6822

Senile cataract

2063

7871

1.67

90.29

4.7

3.2

25.05

25.32

mmol/l

2.73

2000

7668

Type 1 diabetes, strict definition, subgroup 1

243

592

4.31

90.23

3.4

4.0

24.68

25.21

mmol/l

1.19

232

576

Gout, FINNGEN

1136

6092

1.95

89.13

6.0

3.3

24.59

25.08

mmol/l

4.55

1102

5923

Vocal cord dysfunction

340

964

3.39

88.83

3.9

2.3

25.75

25.56

mmol/l

0.40

331

938

Diabetic retinopathy, excluding more controls

1126

3282

2.04

88.48

6.2

2.9

24.70

25.23

mmol/l

4.55

1089

3194

Abnormal findings on diagnostic imaging of lung

1644

9553

1.73

88.21

4.4

3.4

25.41

25.16

mmol/l

2.12

1604

9270

Disorders of calcium metabolism

288

818

3.87

88.12

8.8

2.7

25.59

25.46

mmol/l

0.18

282

792

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

607

2589

2.50

87.62

3.6

3.3

25.30

25.20

mmol/l

0.30

598

2497

Acute alcohol intoxication, ICD10

696

3137

2.32

87.27

3.8

24.90

25.13

mmol/l

0.81

674

3037

Other and unspecified dermatitis

1575

9357

1.73

85.61

4.1

3.4

25.13

25.23

mmol/l

0.59

1538

9068

Viral hepatitis, IBD co-morbidity

166

309

5.66

85.51

4.4

2.3

24.94

25.27

mmol/l

0.52

160

300

Hernia of abdominal wall, postoperative

634

2788

2.38

84.27

5.7

2.7

24.85

25.34

mmol/l

2.84

619

2709

Misadventures to patients during surgical and medical care

533

2178

2.59

84.18

5.1

3.1

25.23

25.24

mmol/l

0.01

518

2108

Benign neoplasm of colon, rectum, anus and anal canal

2056

11812

1.61

83.89

4.5

3.4

25.09

25.28

mmol/l

1.76

2013

11475

Codeine or tramadol medication

3541

13706

1.45

83.46

3.8

3.4

25.15

25.25

mmol/l

0.97

3416

13313

Abnormal findings on examination of blood, without diagnosis

1604

9021

1.72

83.29

4.7

3.5

25.05

25.10

mmol/l

0.18

1549

8764

Depression

2774

12839

1.51

83.11

4.0

3.3

25.34

25.25

mmol/l

0.66

2677

12450

COPD

1589

7827

1.73

82.90

4.9

3.3

26.03

24.99

mmol/l

19.15

1541

7610

Unspecified acute lower respiratory infection

562

2366

2.50

82.90

5.9

3.3

25.69

25.19

mmol/l

2.28

543

2287

Other bacterial intestinal infections

667

3024

2.32

82.76

7.1

3.1

24.86

25.18

mmol/l

1.36

642

2930

Fall on same level

3488

13617

1.45

82.25

4.0

3.4

25.34

25.14

mmol/l

2.56

3388

13181

Type 1 diabetes, strict definition

249

663

3.93

81.73

3.4

3.9

24.67

25.23

mmol/l

1.35

238

641

Calcific aortic valvular stenosis

1171

6385

1.87

81.19

4.6

3.4

25.03

25.12

mmol/l

0.36

1144

6199

Calcific aortic valvular stenosis, operated

1171

6385

1.87

81.19

4.6

3.4

25.03

25.12

mmol/l

0.36

1144

6199

Pulmonary heart disease, diseases of pulmonary circulation

1132

6234

1.88

81.08

4.5

3.4

25.53

25.14

mmol/l

2.82

1087

6060

Disorders of other endocrine glands

1346

7645

1.78

81.08

6.0

3.4

25.03

25.24

mmol/l

1.40

1295

7416

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

183

394

5.13

81.07

8.5

3.2

25.14

25.42

mmol/l

0.40

178

385

Acute alcohol intoxication

880

4461

2.05

80.85

3.8

3.6

24.98

25.09

mmol/l

0.38

855

4319

Calcific aortic valvular stenosis, diagnosis (helper)

1168

6376

1.87

80.66

4.6

3.4

25.03

25.12

mmol/l

0.35

1141

6190

Operations 2 for CAVS

1168

6376

1.87

80.66

4.6

3.4

25.03

25.12

mmol/l

0.35

1141

6190

Mood disorders

3044

13753

1.48

80.60

3.9

3.4

25.33

25.25

mmol/l

0.58

2931

13343

Coronary angioplasty

1336

5869

1.81

80.46

4.1

3.1

24.95

25.21

mmol/l

1.87

1288

5716

Supplementary factors related to causes of morbidity and mortality classified elsewhere

976

5130

1.97

80.43

4.4

3.5

25.36

25.14

mmol/l

1.18

943

4975

Persons encountering health services for examination and investigation

2121

6686

1.62

80.22

3.8

2.9

25.13

25.25

mmol/l

0.80

2050

6472

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

272

789

3.71

79.97

3.8

3.3

25.13

25.22

mmol/l

0.13

262

763

Other disorders of ear

2844

12905

1.49

79.76

3.5

25.25

mmol/l

0.01

2759

12518

Calcific aortic valvular stenosis, including rheumatic fever

1169

6399

1.86

79.76

4.6

3.4

25.03

25.12

mmol/l

0.39

1142

6213

Other cataract

1417

6391

1.77

79.75

4.9

3.3

25.05

25.31

mmol/l

1.95

1369

6225

Viral and other specified intestinal infections

608

2610

2.35

79.67

7.0

3.1

24.89

25.12

mmol/l

0.93

586

2509

Mood [affective] disorders

3029

13732

1.47

79.40

3.9

3.4

25.33

25.25

mmol/l

0.62

2917

13323

Other blood glucose lowering drugs, excl. Insulins

614

2739

2.36

79.37

4.2

3.3

25.23

25.28

mmol/l

0.15

598

2650

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3429

13734

1.44

79.07

5.1

3.1

25.23

25.22

mmol/l

0.05

3313

13323

DVT of lower extremities and pulmonary embolism

1424

8412

1.74

78.73

4.5

3.4

25.40

25.19

mmol/l

1.42

1379

8160

Diseases of the skin and subcutaneous tissue

3196

11078

1.47

78.08

4.4

3.1

25.12

25.22

mmol/l

0.79

3107

10700

Sleep apnoea

2759

12731

1.50

78.08

4.0

3.4

25.54

25.21

mmol/l

5.47

2688

12338

Fungal Sepsis

202

492

4.66

77.48

7.9

2.8

25.52

25.19

mmol/l

0.52

194

477

Persons encountering health services in other circumstances, wide

3749

13888

1.42

77.44

4.8

3.1

25.20

25.22

mmol/l

0.11

3617

13473

Other intervertebral disc disorders

2547

10408

1.52

77.43

3.2

3.4

25.22

25.16

mmol/l

0.33

2441

10111

Cholecystectomy

2163

12509

1.56

77.41

3.7

3.4

25.24

25.26

mmol/l

0.12

2108

12138

Factors influencing health status and contact with health services

1033

2665

1.99

77.26

3.7

2.4

25.19

25.13

mmol/l

0.17

998

2576

Finngen Rheumatological endpoints

2880

11204

1.49

77.23

3.9

3.3

25.17

25.21

mmol/l

0.28

2792

10847

Anxiety (asthma-related co-morbidities)

1496

7014

1.71

77.20

4.2

3.3

25.35

25.27

mmol/l

0.40

1457

6791

Chronic ulcer of skin, not elsewhere classified

329

1105

3.27

77.11

7.6

3.0

24.70

25.12

mmol/l

1.16

323

1070

Dipeptidyl peptidase 4 (DPP-4) inhibitors

467

1875

2.66

77.03

4.6

3.2

24.93

25.31

mmol/l

1.44

459

1813

Venous thromboembolism

1780

10876

1.63

76.97

4.5

3.3

25.35

25.22

mmol/l

0.86

1728

10566

Other chronic obstructive pulmonary disease

1520

7618

1.71

76.72

4.8

3.3

26.08

24.98

mmol/l

19.98

1473

7408

Unspecified haematuria

1444

7380

1.73

76.10

5.4

3.3

24.98

25.13

mmol/l

0.84

1403

7179

Mycoses

853

4379

2.02

75.68

4.8

3.5

25.27

25.19

mmol/l

0.26

828

4240

Benign neoplasm: Colon

1745

10770

1.63

75.48

4.6

3.4

25.03

25.26

mmol/l

2.00

1705

10467

Cervicobrachial syndrome

692

3304

2.17

74.68

3.4

25.35

25.13

mmol/l

0.99

675

3212

Emotionally unstable personality disorder

345

1195

3.01

74.50

3.6

3.3

25.27

25.24

mmol/l

0.04

336

1150

Symptoms and signs concerning food and fluid intake

367

1322

2.93

74.27

4.8

3.1

24.92

25.01

mmol/l

0.17

350

1283

Other disorders of kidney and ureter

502

2122

2.52

74.05

10.6

3.3

24.28

25.23

mmol/l

7.50

488

2052

Functional dyspepsia

827

4230

2.02

73.89

4.0

3.2

25.59

25.27

mmol/l

2.16

799

4096

Disorders resulting from impaired renal tubular function

201

508

4.53

73.70

16.9

3.2

23.40

25.01

mmol/l

8.24

196

495

Dorsopathies

3127

11118

1.46

73.58

3.6

3.5

25.31

25.13

mmol/l

2.12

3018

10788

Other disorders of glucose regulation and pancreatic internal secretion

351

1252

3.01

73.07

6.3

3.4

24.94

25.25

mmol/l

0.82

334

1207

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1764

11228

1.61

72.65

5.0

3.3

25.07

25.25

mmol/l

1.31

1705

10913

Cardiomyopathy

594

2710

2.29

72.39

4.7

2.9

24.97

25.04

mmol/l

0.19

573

2634

Non-allergic asthma (mode), excluding more controls

599

2708

2.27

72.22

3.6

2.7

25.40

24.99

mmol/l

2.11

583

2636

Pulmonary embolism

1016

5610

1.88

72.21

4.5

3.4

25.45

25.18

mmol/l

1.63

978

5455

Other diseases of urinary system

3091

12185

1.45

72.18

4.4

3.3

25.17

25.19

mmol/l

0.07

2995

11812

Neurotic, stress-related and somatoform disorders

2446

11746

1.50

72.00

4.2

3.3

25.40

25.27

mmol/l

1.09

2378

11363

Retention of urine

1219

5963

1.79

71.91

4.6

3.3

24.97

25.07

mmol/l

0.44

1170

5801

Enlarged lymph nodes

487

2043

2.48

71.85

3.8

3.0

25.20

25.08

mmol/l

0.35

474

1977

Enterocolitis due to Clostridium difficile

451

1845

2.61

71.57

8.0

3.1

24.88

25.16

mmol/l

0.74

433

1785

Diseases of liver

1077

6061

1.83

71.56

4.6

3.5

24.72

25.23

mmol/l

4.53

1039

5877

Pulmonary heart disease

1016

5627

1.87

71.51

4.5

3.4

25.45

25.19

mmol/l

1.51

978

5469

Additional codes for the location of defect, injury or illness

255

771

3.62

70.96

3.6

3.1

25.21

25.31

mmol/l

0.19

249

744

Soft tissue disorders

3167

11575

1.44

70.93

4.0

3.3

25.21

25.15

mmol/l

0.45

3064

11206

Cutaneous abscess, furuncle and carbuncle

768

3886

2.04

70.76

6.3

3.4

25.02

25.17

mmol/l

0.61

743

3760

Chronic periapical parodontitis

715

3540

2.10

70.46

6.1

3.3

25.08

25.20

mmol/l

0.40

696

3450

Other diseases of pleura

1560

8598

1.66

70.36

5.2

3.4

26.13

24.99

mmol/l

22.83

1495

8357

Streptococcal septicaemia

334

1184

3.02

70.34

6.0

2.9

25.23

25.12

mmol/l

0.21

325

1149

Dysphagia

776

3954

2.03

70.29

4.1

3.0

25.77

25.19

mmol/l

4.23

750

3839

Cough

1148

6324

1.78

70.03

4.5

3.1

25.20

25.12

mmol/l

0.36

1119

6138

Bacterial intestinal infections, IBD co-morbidities

659

3179

2.17

69.95

7.2

3.3

24.83

25.21

mmol/l

1.74

635

3085

Implicit fungal Sepsis

182

443

4.65

69.90

7.8

2.6

25.50

25.03

mmol/l

0.76

174

428

Anxiety disorders

2467

11909

1.49

69.66

4.2

3.3

25.39

25.27

mmol/l

1.04

2398

11522

Acute upper respiratory infections of multiple and unspecified sites

2117

10511

1.53

69.08

4.5

3.3

25.25

25.19

mmol/l

0.36

2052

10167

Benzodiazepine use

2977

14985

1.43

68.91

3.7

3.4

25.35

25.21

mmol/l

1.43

2891

14524

Other chronic obstructive pulmonary disease, including avohilmo

1790

9634

1.59

67.40

4.6

3.4

25.94

25.07

mmol/l

15.33

1738

9364

Sleep apnoea, including avohilmo

2840

12951

1.45

67.24

3.8

3.4

25.55

25.21

mmol/l

5.82

2755

12551

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

236

697

3.59

67.11

3.8

3.7

25.47

25.12

mmol/l

0.68

224

682

Emergency coronary revascularization (for ACS)

1943

9177

1.56

66.69

4.2

3.5

24.90

25.19

mmol/l

2.87

1873

8936

Non-selective monoamine reuptake inhibitors

1239

7161

1.72

66.60

4.0

3.3

25.60

25.25

mmol/l

2.70

1207

6959

Gastric ulcer

674

3346

2.11

66.29

4.8

3.3

24.97

25.13

mmol/l

0.54

661

3241

COPD related to multimorbidity

1384

7135

1.69

66.22

4.9

3.4

26.05

24.97

mmol/l

17.21

1338

6947

Explicit bacterial Sepsis

381

1489

2.71

66.10

6.0

2.8

25.12

25.13

mmol/l

0.02

369

1444

Disorder of lipoprotein metabolism, unspecified

504

2245

2.37

65.65

4.9

2.9

25.08

25.23

mmol/l

0.49

499

2179

Sequelae of external causes of morbidity and mortality

828

4427

1.94

65.28

4.8

3.4

25.05

25.18

mmol/l

0.46

800

4293

Acute sinusitis

1389

7963

1.66

65.03

4.1

3.3

25.34

25.22

mmol/l

0.69

1355

7705

Temporomandibular joint disorders

431

1787

2.49

64.94

3.2

2.9

25.48

25.24

mmol/l

0.84

417

1730

Benign neoplasms

2167

8183

1.52

64.73

4.2

3.2

25.14

25.21

mmol/l

0.41

2106

7891

Hypoglycaemia, other or unspecified

286

977

3.15

64.57

6.8

3.5

24.91

25.23

mmol/l

0.72

273

945

Elevated blood glucose level

330

1218

2.90

64.53

6.1

3.3

25.14

25.12

mmol/l

0.04

315

1175

Other headache syndromes

1123

6581

1.74

64.03

3.4

3.3

25.41

25.22

mmol/l

1.15

1089

6368

Schizophrenia

509

2292

2.31

63.91

3.6

25.93

25.19

mmol/l

4.02

490

2219

Diseases of peritoneum

404

1656

2.60

63.79

10.7

3.2

24.36

25.28

mmol/l

5.33

395

1603

Falls/tendency to fall

3291

11887

1.40

63.52

3.9

3.3

25.30

25.14

mmol/l

1.84

3203

11496

Cardiomyopathies, Primary/intrinsic

437

1857

2.47

63.28

4.6

3.0

24.68

25.00

mmol/l

1.04

418

1805

ILD medications: azathioprine

465

2025

2.39

63.17

8.0

2.9

24.72

25.29

mmol/l

2.69

451

1959

All anxiety disorders

1509

7629

1.62

63.12

4.2

3.3

25.34

25.21

mmol/l

0.78

1470

7378

Benign neoplasms

2939

11667

1.43

63.12

4.2

3.3

25.12

25.18

mmol/l

0.44

2862

11268

Diseases of the respiratory system

1928

6287

1.56

63.03

3.7

2.8

25.32

25.05

mmol/l

2.60

1868

6110

Tobacco use

219

651

3.66

62.47

4.6

3.4

25.73

25.05

mmol/l

1.66

214

629

Schizoaffective disorder

263

871

3.20

62.15

3.1

3.3

25.66

25.21

mmol/l

1.02

255

844

Other gastritis (incl. Duodenitis)

768

4073

1.96

62.06

4.5

3.3

24.96

25.15

mmol/l

0.76

753

3949

Missing teeth due to accident, extraction or parodontitis

441

1903

2.45

62.00

5.0

3.4

25.44

25.24

mmol/l

0.62

433

1851

Acute bronchitis

1280

7680

1.67

61.97

4.9

3.4

25.51

25.10

mmol/l

3.76

1234

7445

Focal epilepsy

690

3536

2.02

61.62

3.9

3.6

25.19

25.18

mmol/l

0.02

671

3421

Ulcer of lower limb, not elsewhere classified

542

2557

2.24

61.60

7.5

3.4

24.72

25.19

mmol/l

1.99

527

2481

Osteoporosis

879

4654

1.87

61.25

4.4

3.2

25.56

25.34

mmol/l

1.02

847

4522

Cardiomyopathy (excluding other)

448

1960

2.40

60.70

4.6

2.9

24.66

25.02

mmol/l

1.23

429

1906

Non-allergic asthma (mode)

599

2900

2.11

60.67

3.6

2.8

25.40

24.97

mmol/l

2.26

583

2828

Diabetic nephropathy

780

4184

1.97

60.57

10.0

3.5

24.15

25.02

mmol/l

9.46

760

4073

Other CVD

723

3809

1.99

60.21

5.1

3.3

25.08

25.15

mmol/l

0.24

694

3697

Gout, idiopatic and unspecified

886

4986

1.85

59.76

6.1

3.4

24.69

25.11

mmol/l

2.71

861

4836

Carpal tunnel syndrome

1732

10327

1.54

59.53

3.7

3.3

25.40

25.31

mmol/l

0.56

1674

10056

Azathioprine

465

2082

2.32

59.21

8.0

3.2

24.72

25.24

mmol/l

2.31

451

2012

Type of accident

847

4704

1.85

58.79

4.3

3.5

25.48

25.15

mmol/l

1.92

821

4560

Cytomegaloviral disease

131

283

5.32

58.69

10.6

3.3

24.10

25.15

mmol/l

2.18

122

276

Vascular disorders of the intestines

296

1091

2.93

58.38

5.4

3.1

24.58

25.22

mmol/l

1.63

283

1061

Bipolar affective disorders

491

2255

2.24

58.35

3.1

3.2

25.14

25.19

mmol/l

0.12

474

2185

Other infectious diseases

329

1280

2.75

58.19

6.5

3.3

24.98

25.14

mmol/l

0.36

324

1240

COPD, hospital admissions

1522

8319

1.59

58.17

4.9

3.4

26.10

25.01

mmol/l

19.88

1473

8084

Cytomegalovirus infection, IBD co-morbidity

131

287

5.29

57.86

10.6

3.4

24.10

25.23

mmol/l

2.47

122

280

Nonorganic sleeping disorders, excluding more controls

468

2120

2.28

57.58

3.7

3.3

25.12

mmol/l

0.02

449

2056

COPD, early/later onset

1529

8371

1.58

57.35

4.8

3.4

26.08

25.01

mmol/l

19.28

1481

8132

Peripheral artery operations in Hilmo

504

2391

2.22

56.26

8.0

3.1

24.13

25.19

mmol/l

7.47

494

2315

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

2562

10756

1.43

56.22

3.9

3.4

25.21

25.32

mmol/l

0.91

2497

10411

Malignant neoplasm, wide definition for exclusion

2562

10757

1.43

56.20

3.9

3.4

25.21

25.32

mmol/l

0.90

2497

10412

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

320

1247

2.72

56.03

5.4

3.0

25.35

25.32

mmol/l

0.04

306

1205

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

2558

10755

1.43

55.69

3.9

3.4

25.21

25.32

mmol/l

0.88

2493

10410

Early onset COPD

730

3952

1.92

55.47

4.8

3.5

26.34

25.03

mmol/l

13.25

711

3830

Organic, including symptomatic, mental disorders

1650

7876

1.55

55.24

3.7

3.6

25.27

25.15

mmol/l

0.77

1605

7659

Hypotension

626

3242

2.03

55.03

5.1

3.3

24.96

25.14

mmol/l

0.61

604

3146

Other/unspecified dorsalgia

1086

6547

1.69

54.85

3.8

3.4

25.58

25.15

mmol/l

3.99

1054

6363

Gastro-oesophageal reflux disease

1929

11725

1.48

54.73

4.2

3.3

25.18

25.29

mmol/l

0.81

1874

11365

Peripheral arterial reconstruction

660

3498

1.98

54.25

6.3

3.4

24.24

25.10

mmol/l

6.49

635

3391

Amputation

409

1815

2.40

54.22

9.1

3.3

23.99

25.12

mmol/l

6.71

397

1755

Noninfective enteritis and colitis

1308

8338

1.60

53.37

4.9

3.5

24.93

25.21

mmol/l

2.08

1265

8082

Other/unspecified cytomegaloviral diseases

112

231

5.65

53.20

11.7

3.5

23.98

25.02

mmol/l

1.92

107

224

Hernia

2743

13559

1.39

53.08

4.1

3.3

25.18

25.29

mmol/l

0.91

2661

13146

External causes of morbidity and mortality

1972

6704

1.49

53.07

3.6

3.2

25.20

25.19

mmol/l

0.06

1910

6504

Chronic pancreatitis

435

1994

2.30

52.99

5.2

3.4

24.76

25.22

mmol/l

1.75

421

1930

Hernia of abdominal wall

1367

8848

1.58

52.79

4.8

3.4

25.17

25.18

mmol/l

0.01

1334

8594

Other symptoms and signs involving cognitive functions and awareness

1369

8298

1.58

52.75

3.9

3.4

25.26

25.20

mmol/l

0.27

1332

8057

Impacted teeth

404

1649

2.34

52.75

4.6

3.6

25.21

24.90

mmol/l

1.26

396

1588

Other and unspecified drugs and medicaments

307

1210

2.70

52.69

5.5

3.2

25.38

25.29

mmol/l

0.15

294

1172

Other anxiety disorders

1042

5566

1.69

52.48

4.0

3.3

25.22

25.24

mmol/l

0.05

1014

5380

Other and unspecified nonorganic psychotic disorders

497

2394

2.14

52.34

3.2

3.6

25.78

25.17

mmol/l

2.60

475

2313

Focal epilepsy, mode (most common among epilepsy diagnosis)

596

3080

2.01

52.11

3.7

25.21

25.19

mmol/l

0.06

581

2981

Valvular operations

483

2318

2.17

52.05

4.4

3.0

25.01

25.00

mmol/l

0.01

466

2254

Chronic periodontitis

519

2565

2.11

51.84

6.8

3.3

24.74

25.22

mmol/l

2.46

504

2493

Disorders of parathyroid gland

705

3810

1.90

51.80

7.0

3.2

25.01

25.33

mmol/l

1.57

681

3714

Focal epilepsy, strict definition

624

3286

1.97

51.57

3.8

3.6

25.24

25.19

mmol/l

0.12

608

3181

Post-traumatic stress disorder

198

616

3.34

51.51

5.3

3.1

25.22

25.01

mmol/l

0.38

191

599

Other skin changes

568

2906

2.04

51.48

4.9

3.3

24.97

25.18

mmol/l

0.80

551

2812

Neoplasms

2109

7843

1.46

51.35

4.1

3.2

25.12

25.19

mmol/l

0.37

2041

7560

COPD, hospital admission 2, with asthma infections

1093

5745

1.67

51.24

5.4

3.4

26.26

24.91

mmol/l

20.39

1057

5576

Viral infections characterized by skin and mucous membrane lesions

1169

7347

1.63

50.94

4.9

3.5

25.15

25.21

mmol/l

0.23

1141

7122

Iron deficiency anaemia secondary to blood loss (chronic)

557

2842

2.04

50.86

6.0

3.1

24.92

25.19

mmol/l

0.90

541

2769

Ascites

272

1029

2.82

50.80

7.3

2.8

24.40

25.30

mmol/l

3.19

264

997

Open wound of head

1547

10218

1.52

50.25

3.7

3.6

25.06

25.15

mmol/l

0.47

1499

9903

Malignant neoplasm

2584

11123

1.40

50.16

3.8

3.4

25.21

25.32

mmol/l

0.88

2516

10769

ILD, hospital admission 2, with pulmonary infections

347

1482

2.48

50.10

5.1

2.9

25.74

25.01

mmol/l

2.66

324

1434

Gout, strict definition

651

3530

1.93

49.89

6.3

3.5

24.72

25.04

mmol/l

1.37

630

3414

Coxarthrosis [arthrosis of hip](FG)

1705

8379

1.50

49.66

3.5

3.3

25.34

25.23

mmol/l

0.59

1658

8143

Dentofacial anomalies [including malocclusion]

701

3819

1.86

49.61

4.8

3.2

25.27

mmol/l

0.00

683

3719

Certain disorders involving the immune mechanism

585

3056

1.98

49.57

5.8

3.4

24.90

25.28

mmol/l

1.95

560

2960

Cardiac arrest

202

551

3.31

49.49

6.0

2.3

24.99

25.17

mmol/l

0.30

188

536

Superficial injury of head

682

3742

1.88

49.37

3.7

3.5

25.32

25.17

mmol/l

0.55

662

3624

Diseases of the eye and adnexa

2265

8018

1.43

49.18

4.3

3.1

25.05

25.23

mmol/l

1.54

2189

7759

Behavioural syndromes associated with physiological disturbances and physical factors

777

4427

1.79

49.03

4.1

3.6

25.12

25.11

mmol/l

0.05

756

4275

Diseases of the ear and mastoid process

3341

12743

1.34

49.01

3.6

3.4

25.19

25.21

mmol/l

0.18

3247

12330

Other metabolic disorders

348

1493

2.42

48.98

4.3

2.6

25.90

25.49

mmol/l

1.43

335

1448

Deposits [accretions] on teeth

257

925

2.84

48.85

9.1

3.2

24.65

25.11

mmol/l

1.26

248

895

Coronary artery bypass grafting

959

4385

1.72

48.77

4.3

3.1

24.86

25.17

mmol/l

1.86

920

4274

Somatoform disorder

451

2156

2.16

48.73

4.0

3.2

25.53

25.27

mmol/l

0.99

437

2095

Hyperparathyroidism

629

3350

1.93

48.65

7.3

3.1

24.92

25.34

mmol/l

2.33

606

3274

Allergic asthma (mode), excluding more controls

541

2701

2.00

48.54

3.0

2.7

25.39

25.06

mmol/l

1.58

524

2623

Type1 diabetes, definitions combined, early onset

190

597

3.31

48.45

5.0

4.6

24.84

24.94

mmol/l

0.13

183

575

Congenital malformations of the urinary system

218

752

3.10

48.39

11.1

3.5

23.46

25.12

mmol/l

11.49

212

724

Other complications of surgical and medical care, not elsewhere classified

319

1335

2.51

47.92

5.2

2.9

25.21

25.35

mmol/l

0.26

303

1291

Pain in thoracic spine

435

2066

2.18

47.86

3.4

3.3

25.36

25.14

mmol/l

0.78

419

2002

Depression or dysthymia

2050

8047

1.45

47.75

3.9

3.4

25.34

25.21

mmol/l

0.96

1982

7815

Symptoms and signs involving the skin and subcutaneous tissue

1886

13199

1.44

47.74

4.1

3.4

25.20

25.25

mmol/l

0.29

1833

12801

Injuries to the thorax

1341

8834

1.55

47.73

4.1

3.5

25.40

25.12

mmol/l

2.28

1306

8572

Shoulder lesions

2322

10237

1.41

47.65

3.6

3.2

25.22

25.21

mmol/l

0.06

2241

9925

Cellulitis

648

3542

1.89

47.64

6.1

3.4

24.92

25.18

mmol/l

0.95

630

3424

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

475

2261

2.11

47.40

7.4

3.7

24.49

25.18

mmol/l

4.59

463

2181

All influenza (not pneumonia)

443

2131

2.15

47.14

4.9

2.9

25.48

25.10

mmol/l

1.28

423

2063

Recurrent or chronic depression

978

4268

1.68

47.11

3.6

3.3

25.25

25.32

mmol/l

0.30

954

4141

Other respiratory disorders and diseases

699

3933

1.84

47.09

5.5

3.5

27.18

24.94

mmol/l

28.56

656

3819

Other diseases of the respiratory system

699

3933

1.84

47.09

5.5

3.5

27.18

24.94

mmol/l

28.56

656

3819

Ventral hernia

755

4348

1.79

46.71

4.5

3.4

25.23

25.20

mmol/l

0.10

736

4224

Acute upper respiratory infections

2985

14052

1.35

46.68

4.0

3.3

25.27

25.21

mmol/l

0.45

2891

13617

Exclusions for E4_PCOS_BROAD

491

2462

2.06

46.67

5.2

3.7

25.00

25.26

mmol/l

0.86

469

2378

Panic disorder

346

1509

2.36

46.62

4.1

3.1

25.25

25.21

mmol/l

0.07

339

1452

Other disorders of skin and subcutaneous tissue, not elsewhere classified

481

2407

2.08

46.44

6.5

3.2

24.98

25.25

mmol/l

0.89

470

2337

Postprocedural endocrine and metabolic disorders, not elsewhere classified

321

1364

2.44

46.23

4.1

2.6

26.08

25.53

mmol/l

2.17

308

1323

Candidiasis

406

1910

2.21

46.06

5.3

3.2

25.45

25.27

mmol/l

0.42

394

1846

Delirium, not induced by alcohol and other psychoactive substances

422

2023

2.19

45.95

4.8

3.4

25.15

25.08

mmol/l

0.14

405

1961

Toxic effects of substances chiefly nonmedicinal as to source

354

1579

2.34

45.82

3.6

3.5

25.17

25.23

mmol/l

0.14

346

1525

Intestinal adhesions without obstruction

307

1294

2.51

45.72

4.6

3.0

24.90

25.31

mmol/l

0.86

295

1259

Spinal stenosis

1568

8378

1.50

45.61

3.5

3.4

25.29

25.15

mmol/l

0.84

1524

8159

Direct fill therapy

408

1931

2.20

45.52

8.0

3.5

25.06

25.25

mmol/l

0.46

392

1869

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

1379

7158

1.54

45.32

3.5

3.3

24.76

25.30

mmol/l

6.09

1330

6945

Leisure time condition

536

2804

1.98

45.26

4.0

3.3

25.52

25.21

mmol/l

1.23

520

2716

Use of hypnotics and sedatives

3070

13440

1.34

45.02

4.1

3.4

25.28

25.21

mmol/l

0.48

2974

13031

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

489

2498

2.05

44.73

5.5

3.6

24.31

25.16

mmol/l

4.83

471

2421

Systemic connective tissue disorders

1020

6419

1.63

44.63

4.2

3.3

25.39

25.28

mmol/l

0.48

989

6231

Unspecified dementia

450

2003

2.12

44.54

3.9

3.5

25.26

24.96

mmol/l

0.85

439

1943

Injury, poisoning and certain other consequences of external causes

1569

5286

1.51

44.31

3.5

3.1

25.14

25.21

mmol/l

0.36

1518

5114

Amputation of toe

293

1233

2.55

44.26

9.6

3.2

23.94

25.13

mmol/l

5.12

286

1194

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

283

1174

2.56

43.73

5.6

3.2

25.07

25.36

mmol/l

0.71

278

1135

Special screening examination for other diseases and disorders

262

1042

2.62

43.63

7.3

3.0

24.19

25.17

mmol/l

5.04

253

1004

Later onset COPD, excluding more controls

728

3270

1.80

43.49

4.9

2.9

25.90

24.79

mmol/l

10.27

704

3195

Sequelae with surgical and medical care as external cause

623

3469

1.86

43.43

4.9

3.5

25.09

25.23

mmol/l

0.37

601

3363

Other ulcerative colitis

200

701

3.03

43.03

5.7

3.4

25.04

25.25

mmol/l

0.34

194

678

Other viral diseases

722

4180

1.76

42.87

6.5

3.5

25.05

25.13

mmol/l

0.25

687

4037

Migraine

1036

5576

1.60

42.55

3.1

3.3

25.14

25.22

mmol/l

0.31

1003

5385

Other obstructive and reflux uropathy

159

491

3.45

42.54

8.8

2.5

23.86

25.51

mmol/l

6.06

154

477

Mental and behavioural disorders due to opioids

127

338

4.01

42.46

4.0

3.4

25.35

25.03

mmol/l

0.44

119

329

Polyneuropathies and other disorders of the peripheral nervous system

700

4066

1.78

42.28

5.8

3.5

25.53

25.12

mmol/l

2.27

681

3940

Undefined dementia

457

2128

2.07

42.26

3.9

3.3

25.27

25.03

mmol/l

0.67

446

2063

Allergic asthma (mode)

541

2836

1.91

42.09

3.0

2.8

25.39

25.05

mmol/l

1.64

524

2752

Mental and behavioural disorders due to sedatives or hypnotics

216

797

2.85

42.09

4.1

3.3

25.49

25.19

mmol/l

0.51

209

772

COPD, hospital admissions 3, with asthma pneumonia sepsis

922

4871

1.66

41.99

5.6

3.4

26.26

24.87

mmol/l

17.67

890

4726

Vitreous haemorrhage

350

1626

2.27

41.44

8.8

3.3

24.33

25.24

mmol/l

5.03

341

1576

Undetermined asthma, excluding more controls

348

1602

2.24

41.38

5.1

2.6

25.91

25.01

mmol/l

4.24

336

1554

Extreme obesity with alveolar hypoventilation

167

544

3.34

41.36

5.1

3.1

28.65

25.20

mmol/l

12.49

156

527

Spondylosis

1528

9081

1.47

41.31

3.2

3.4

25.52

25.19

mmol/l

3.38

1481

8837

Myocarditis

133

372

3.75

41.07

4.6

2.4

25.37

25.40

mmol/l

0.03

127

361

Dental caries 2 and operation codes, only avohilmo

917

8984

0.62

40.91

3.3

3.8

25.22

25.24

mmol/l

0.04

888

8684

Sequelae of cerebrovascular disease

1137

6549

1.56

40.88

4.4

3.4

25.18

25.17

mmol/l

0.03

1105

6352

Coxarthrosis

1567

7372

1.47

40.70

3.5

3.3

25.29

25.22

mmol/l

0.34

1524

7169

Adjustment and management of implanted device

599

3365

1.84

40.61

5.0

2.8

25.27

25.09

mmol/l

0.60

583

3255

Other external causes of accidental injury

2442

9056

1.37

40.41

4.0

3.3

25.27

25.15

mmol/l

0.92

2358

8778

ILD, hospital admissions 3, with pneumonia sepsis

304

1350

2.39

40.36

5.5

2.9

25.84

24.96

mmol/l

3.14

283

1309

Congenital malformations, deformations and chromosomal abnormalities

1422

9367

1.47

40.33

5.2

3.4

25.12

25.19

mmol/l

0.37

1379

9066

Disorders of the thyroid gland

2666

13178

1.34

40.32

3.5

3.4

25.23

25.19

mmol/l

0.31

2573

12803

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

723

4299

1.74

40.10

3.7

3.3

25.22

mmol/l

0.01

707

4171

Gonarthrosis [arthrosis of knee](FG)

2234

9680

1.38

39.84

3.3

3.2

25.33

25.26

mmol/l

0.44

2173

9391

Gout, unspecified

684

4022

1.77

39.77

6.2

3.4

24.71

25.10

mmol/l

2.03

664

3898

Duodenal ulcer

402

2001

2.10

39.62

4.5

3.3

24.24

25.10

mmol/l

4.12

390

1929

Symptoms and signs involving the nervous and musculoskeletal systems

1593

11247

1.44

39.61

3.8

3.5

25.48

25.18

mmol/l

2.97

1539

10924

Disorders of skin appendages

1174

7815

1.53

39.48

4.7

3.4

25.10

25.21

mmol/l

0.51

1147

7572

Hypothyroidism, strict autoimmune

1974

9471

1.40

39.46

3.6

3.0

25.20

25.22

mmol/l

0.12

1909

9197

Irritable bowel syndrome

689

4048

1.74

39.30

3.9

3.0

25.41

25.26

mmol/l

0.60

680

3912

Cirrhosis of liver, NAS

209

794

2.85

39.26

6.3

3.2

24.17

25.23

mmol/l

2.98

204

762

Diabetic retinopathy

1396

6053

1.51

39.17

5.9

3.7

24.71

25.09

mmol/l

3.20

1351

5900

Noninfectious colitis NAS

411

2070

2.06

38.89

5.4

3.3

24.67

25.33

mmol/l

3.54

398

2001

Injuries to the abdomen, lower back, lumbar spine and pelvis

1121

7379

1.54

38.87

4.1

3.5

25.47

25.15

mmol/l

2.18

1085

7160

Phobic anxiety disorders

287

1251

2.35

38.75

4.7

3.3

25.63

25.20

mmol/l

1.24

276

1205

Primary_lymphoid and hematopoietic malignant neoplasms

740

4464

1.71

38.69

4.2

3.4

24.94

25.21

mmol/l

1.38

722

4321

Other noninfective gastroenteritis and colitis

687

4060

1.73

38.46

5.6

3.5

24.92

25.18

mmol/l

1.12

663

3933

Diabetic retinopathy, strict definition

755

4043

1.72

38.34

7.6

3.6

24.66

25.08

mmol/l

2.27

728

3936

Lumbar disc prolapse

1699

9642

1.42

38.28

3.3

3.4

25.21

25.20

mmol/l

0.02

1625

9369

Infective dermatitis

366

1781

2.14

38.20

4.3

3.4

25.20

25.25

mmol/l

0.08

359

1719

Diagnoses used for exclusion with ILD

783

4808

1.67

38.14

4.5

3.5

25.45

25.10

mmol/l

2.13

746

4654

Familial hypercholesterolemia

506

2753

1.91

38.14

4.3

3.1

24.90

25.18

mmol/l

0.91

489

2675

Other specified and unspecified personality disorders

252

1050

2.49

38.08

3.3

25.27

25.21

mmol/l

0.10

245

1015

Acute pancreatitis

597

3411

1.81

38.08

5.1

3.4

24.72

25.19

mmol/l

2.64

578

3295

Other and unspecified polyneuropathies, also in other diseases

617

3570

1.79

37.93

5.7

3.4

25.40

25.13

mmol/l

1.12

601

3453

Other and unspecified myopathies

311

1434

2.29

37.70

4.5

3.3

25.15

25.18

mmol/l

0.04

305

1389

Accidents

2419

9056

1.35

37.67

3.9

3.3

25.26

25.15

mmol/l

0.82

2337

8778

Sleep disorders

540

2999

1.85

37.59

3.8

3.5

25.17

25.20

mmol/l

0.07

521

2895

Other and unspecified local infections of skin and subcutaneous tissue

303

1380

2.30

37.56

6.6

3.4

25.16

25.24

mmol/l

0.16

296

1332

Abnormal findings on diagnostic imaging of other body structures

389

1949

2.08

37.52

5.1

3.2

25.43

25.34

mmol/l

0.18

384

1893

Traumatic subdural haemorrhage

435

2227

2.00

37.45

3.8

3.2

25.30

24.82

mmol/l

2.22

425

2158

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

868

5481

1.62

37.43

3.8

3.4

25.48

25.29

mmol/l

0.93

821

5324

Other and unspecified effects of external causes

665

3926

1.73

37.30

4.3

3.6

25.05

25.17

mmol/l

0.44

642

3796

Amiodarone users

373

1859

2.12

37.02

4.3

3.5

25.22

25.10

mmol/l

0.28

362

1796

Dermatitis and eczema

3007

15347

1.30

36.77

3.9

3.4

25.19

25.22

mmol/l

0.19

2930

14852

Diseases of the musculoskeletal system and connective tissue

1488

5159

1.46

36.67

3.7

3.2

25.16

25.09

mmol/l

0.29

1430

4991

Selective serotonin reuptake inhibitors

2896

11766

1.31

36.36

3.6

3.4

25.37

25.15

mmol/l

2.75

2797

11416

Injuries to the hip and thigh

1382

8843

1.46

36.16

4.1

3.4

25.37

25.16

mmol/l

1.25

1345

8576

Undetermined asthma

348

1692

2.12

36.03

5.1

2.8

25.91

24.97

mmol/l

4.58

336

1641

Abnormal findings on examination of urine, without diagnosis

175

636

2.96

35.64

6.2

3.3

24.23

25.05

mmol/l

2.27

170

614

Other local infections of skin and subcutaneous tissue

312

1469

2.22

35.57

6.6

3.4

25.10

25.24

mmol/l

0.32

305

1421

Primary_lymphoid and hematopoietic malignant neoplasms

740

4566

1.67

35.54

4.2

3.5

24.94

25.12

mmol/l

0.78

722

4425

Respiratory insufficiency

286

1303

2.30

35.37

6.1

3.0

28.77

24.70

mmol/l

27.87

267

1261

Nonorganic sleeping disorders

468

2535

1.89

35.37

3.7

3.4

25.12

25.22

mmol/l

0.27

449

2449

Fibrosis and cirrhosis of liver

262

1158

2.40

35.24

6.2

3.1

24.31

25.27

mmol/l

3.04

252

1119

COPD, hospital admissions 1, only main diagnosis

1112

6385

1.52

35.11

5.2

3.4

26.21

24.97

mmol/l

19.26

1081

6201

Pneumonitis due to solids and liquids

305

1437

2.24

35.05

5.0

3.5

25.63

24.96

mmol/l

2.70

291

1390

Decubitus ulcer and pressure area

230

969

2.54

34.69

8.2

3.2

25.13

25.08

mmol/l

0.07

223

935

Disorders of eyelid, lacrimal system and orbit

2331

13929

1.33

34.65

3.7

3.5

25.32

25.22

mmol/l

0.76

2269

13510

Diabetic neuropathy

513

2900

1.87

34.64

6.9

4.1

25.01

24.99

mmol/l

0.05

498

2826

Osteomyelitis

233

986

2.51

34.64

9.0

3.3

24.63

25.00

mmol/l

0.82

228

954

Other viral diseases, not elsewhere classified

478

2623

1.87

34.39

6.1

3.4

25.35

25.14

mmol/l

0.71

456

2529

Hypothyroidism, other/unspecified

2424

12226

1.32

34.25

3.6

3.4

25.27

25.19

mmol/l

0.52

2330

11884

Embedded and impacted teeth

509

2403

1.83

34.21

4.5

3.5

25.14

25.03

mmol/l

0.36

497

2307

Cholangitis (primary sclerosing, PSC)

219

907

2.56

34.08

5.3

3.2

24.21

25.14

mmol/l

3.48

212

880

Other symptoms and signs involving the nervous and musculoskeletal systems

1096

7430

1.50

34.01

3.6

3.5

25.57

25.17

mmol/l

3.24

1058

7208

Any event in cancer register

2512

11434

1.32

33.75

3.8

3.4

25.18

25.31

mmol/l

0.99

2443

11070

Continuous positive airway pressure

376

1643

2.01

33.62

5.7

2.8

25.41

25.36

mmol/l

0.11

367

1609

Benign neoplasm: Skin of other and unspecified parts of face

349

1754

2.07

33.50

4.3

3.0

25.27

25.26

mmol/l

0.02

341

1687

Vascular syndromes of brain in cerebrovascular disorders

197

788

2.70

33.44

3.5

3.3

25.53

25.13

mmol/l

0.85

189

759

Diseases of the myoneural junction and muscle

387

2020

2.00

33.34

4.3

3.5

25.29

25.22

mmol/l

0.14

377

1954

Transport accidents

1181

7204

1.47

33.22

3.5

3.3

25.23

25.15

mmol/l

0.34

1144

6988

Hypothyreosis and Thyroxine purchase for inclusion criteria

2496

12691

1.31

33.21

3.6

3.4

25.28

25.20

mmol/l

0.60

2397

12338

Use of disulfiram, acamprosate or naltrexone

264

1196

2.30

33.14

4.0

3.6

25.39

25.28

mmol/l

0.15

254

1158

Injuries to the shoulder and upper arm

2305

14811

1.32

33.12

3.8

3.5

25.19

25.25

mmol/l

0.40

2240

14361

Zoster [herpes zoster]

537

3103

1.79

33.12

4.3

3.3

25.29

25.20

mmol/l

0.26

527

3011

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

311

1511

2.15

32.85

5.5

3.3

25.10

25.26

mmol/l

0.30

304

1466

Viral pneumonia (unknown virus, not influenza)

207

850

2.56

32.61

7.0

3.4

25.18

25.10

mmol/l

0.13

201

819

Thyroiditis, ILD-related definition

304

1462

2.15

32.60

3.7

3.2

25.40

25.32

mmol/l

0.15

295

1413

Cystitis

2252

10469

1.33

32.51

4.1

3.2

25.22

25.20

mmol/l

0.09

2175

10142

Other systemic involvement of connective tissue (FG)

715

4439

1.64

32.31

3.6

3.2

25.53

25.23

mmol/l

1.47

694

4308

Other symptoms and signs involving the digestive system and abdomen

413

2215

1.91

32.28

4.9

2.9

25.30

25.34

mmol/l

0.08

398

2157

Maltreatment syndromes

142

484

3.07

32.01

3.6

3.4

24.89

25.12

mmol/l

0.35

136

471

Fentanyl

359

1854

2.02

31.89

4.6

3.2

25.51

25.13

mmol/l

1.09

349

1806

Visual disturbances

1242

8743

1.44

31.68

4.5

3.4

25.25

25.23

mmol/l

0.05

1196

8485

Other diseases of liver

481

2726

1.82

31.60

4.0

3.3

24.81

25.31

mmol/l

2.38

470

2637

Acute gastritis

260

1197

2.28

31.55

4.6

3.0

25.08

25.27

mmol/l

0.41

249

1156

Rotator cuff syndrome

1745

9594

1.37

31.48

3.6

3.2

25.22

25.23

mmol/l

0.04

1686

9317

Viral pneumonia (known virus, not influenza)

109

328

3.68

31.05

9.4

3.8

25.57

24.84

mmol/l

0.93

101

321

Other diseases of anus and rectum

827

5392

1.56

31.01

3.9

3.2

25.25

25.19

mmol/l

0.19

810

5224

Acute pancreatitis (for exclusion)

597

3614

1.70

30.97

5.1

3.5

24.72

25.18

mmol/l

2.59

578

3493

Fracture of rib(s), sternum and thoracic spine

863

5698

1.55

30.83

4.1

3.5

25.42

25.10

mmol/l

1.92

839

5531

Visual disturbances and blindness

1344

9641

1.42

30.78

4.6

3.4

25.20

25.23

mmol/l

0.12

1297

9361

Other problems related to primary support group, including family circumstances

261

1177

2.22

30.63

6.6

3.4

24.93

25.13

mmol/l

0.47

256

1135

Cholecystitis

440

2458

1.85

30.53

4.8

3.3

25.14

25.16

mmol/l

0.04

427

2377

702

4205

1.63

30.38

3.7

3.2

25.26

25.21

mmol/l

0.12

686

4090

Assault

310

1541

2.07

30.28

4.3

3.6

24.93

25.10

mmol/l

0.35

300

1496

Insomnia

390

2100

1.91

30.17

4.0

3.3

25.20

25.28

mmol/l

0.18

373

2028

Dermatophytosis

393

2130

1.91

30.15

4.2

3.4

25.12

25.21

mmol/l

0.22

384

2060

Benign neoplasm: Skin of other and unspecified parts of face

349

1828

1.99

29.81

4.3

3.3

25.27

25.25

mmol/l

0.04

341

1764

Other respiratory diseases principally affecting the interstitium

569

3445

1.71

29.72

5.1

3.4

25.60

25.14

mmol/l

1.97

538

3338

Other and unspecified nerve root and plexus disorders, also in other diseases

479

2759

1.78

29.68

3.7

3.4

25.55

25.24

mmol/l

1.12

443

2673

Idiopathic gout

325

1678

2.04

29.30

6.0

3.4

24.62

25.06

mmol/l

1.18

319

1627

L04AX Other immunosuppressants

1376

9988

1.40

29.23

4.8

3.4

25.24

25.25

mmol/l

0.05

1333

9686

Unspecified fall

1322

9465

1.41

29.20

4.0

3.6

25.14

25.20

mmol/l

0.28

1285

9178

Special screening examination for infectious and parasitic diseases

2068

0.30

29.13

3.2

2.8

25.59

25.34

mmol/l

0.38

1989

Unspecified misadventure during surgical and medical care

192

807

2.53

29.11

4.8

3.2

25.27

25.23

mmol/l

0.04

183

776

Gonarthrosis

1900

8221

1.34

28.94

3.2

25.33

25.24

mmol/l

0.57

1842

7985

Other degenerative diseases of the nervous system

742

3609

1.59

28.79

3.2

25.40

25.04

mmol/l

2.17

711

3508

Inflammatory bowel disease

788

5170

1.55

28.75

4.4

3.5

24.93

25.20

mmol/l

1.28

761

5008

Second line medication for Crohn's disease

1402

10242

1.39

28.63

4.7

3.4

25.22

25.25

mmol/l

0.11

1359

9930

Benign neoplasm: Colon, unspecified

713

4576

1.59

28.50

5.2

3.3

25.04

25.21

mmol/l

0.72

694

4430

Allergic contact dermatitis

332

1732

1.97

28.33

3.5

3.1

25.74

25.36

mmol/l

1.47

326

1674

Migraine with aura

460

2646

1.77

28.31

3.0

3.2

25.26

25.18

mmol/l

0.21

445

2564

Parkinson's disease, excluding more controls

401

2172

1.86

28.15

3.6

3.2

25.52

24.89

mmol/l

3.11

379

2112

Disorders of vitreous body and globe

1346

9570

1.39

28.03

5.0

3.4

25.17

25.31

mmol/l

0.84

1315

9307

Endocarditis

128

448

3.05

27.95

8.5

2.4

24.60

24.78

mmol/l

0.21

123

430

Myalgia

544

3300

1.68

27.72

3.6

3.2

25.61

25.18

mmol/l

2.26

528

3214

Vascular diseases of the intestine

152

587

2.78

27.67

5.5

2.8

24.17

25.15

mmol/l

1.91

144

568

928

5626

1.50

27.59

3.8

3.3

25.11

25.21

mmol/l

0.36

901

5471

Alcohol-induced chronic pancreatitis

216

979

2.32

27.41

5.6

3.8

24.85

25.18

mmol/l

0.58

208

948

Degeneration of macula and posterior pole

1383

8366

1.39

27.24

4.1

3.4

25.07

25.25

mmol/l

1.05

1339

8129

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

852

5013

1.51

26.89

3.3

3.0

25.29

25.45

mmol/l

0.70

822

4860

Disorders of vitreous body

1300

9290

1.39

26.89

4.9

3.4

25.20

25.31

mmol/l

0.52

1271

9032

Polycystic ovarian syndrome, consortium definition

1548

6911

1.36

26.87

3.3

3.0

25.74

25.36

mmol/l

4.26

1511

6697

Coxarthrosis, primary

1721

11355

1.34

26.80

3.4

3.5

25.35

25.25

mmol/l

0.63

1680

11034

Arthrosis

2043

8642

1.31

26.75

3.4

3.2

25.32

25.23

mmol/l

0.61

1976

8390

Hypopituitarism

203

903

2.35

26.74

5.0

4.1

24.81

25.14

mmol/l

0.70

191

876

Cardiodefibrillation

1114

7948

1.43

26.56

4.1

3.5

25.35

25.11

mmol/l

1.71

1086

7720

Agranulocytosis

318

1678

1.97

26.55

5.2

3.2

25.18

25.38

mmol/l

0.46

304

1623

Dental caries 2, only avohilmo

983

11032

0.70

26.54

3.4

3.5

25.23

mmol/l

0.02

954

10670

Papulosquamous disorders

1024

7205

1.45

26.36

3.9

3.5

25.37

25.23

mmol/l

0.62

1008

6998

Arthropathies

2439

9765

1.28

26.35

3.8

3.3

25.19

25.18

mmol/l

0.03

2345

9460

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

565

3461

1.64

26.31

5.2

3.3

25.12

25.16

mmol/l

0.11

543

3341

Other arthritis (FG)

788

5278

1.52

26.16

4.2

3.2

25.33

25.18

mmol/l

0.58

765

5126

Somnolence, stupor and coma

152

602

2.67

26.08

6.2

3.2

25.66

25.14

mmol/l

0.77

144

581

Acute and transient psychotic disorders

297

1539

1.99

25.96

3.4

25.77

25.25

mmol/l

1.38

283

1492

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

418

2414

1.79

25.94

4.7

3.3

24.47

25.03

mmol/l

2.24

407

2323

Cervicalgia

530

3254

1.66

25.90

3.6

3.3

25.47

25.13

mmol/l

1.73

512

3157

Intentional self-harm by sharp object

224

3.84

25.80

3.7

3.3

24.37

24.70

mmol/l

0.32

215

Urolithiasis

923

6405

1.47

25.78

4.1

3.6

24.90

25.11

mmol/l

0.99

902

6207

Total colectomy

139

530

2.78

25.78

6.6

3.2

24.30

25.25

mmol/l

1.98

134

516

Total colectomy operation

139

530

2.78

25.78

6.6

3.2

24.30

25.25

mmol/l

1.98

134

516

Benign neoplasm of other and ill-defined parts of digestive system

487

2941

1.70

25.62

3.7

3.1

25.23

25.29

mmol/l

0.14

475

2830

Other diseases of intestine

354

1957

1.87

25.52

6.0

3.3

24.60

25.22

mmol/l

2.36

339

1897

Aneurysms, operations, SAH

466

2787

1.72

25.43

3.6

3.3

25.28

25.24

mmol/l

0.10

454

2697

Corns and callosities

218

1023

2.23

25.35

6.1

3.1

24.93

25.30

mmol/l

0.71

208

993

Injuries to the ankle and foot

1598

11027

1.33

25.31

4.4

3.4

25.27

25.20

mmol/l

0.41

1554

10662

Psoriasis

729

4847

1.53

25.18

3.9

3.6

25.45

25.21

mmol/l

1.02

719

4696

Purpura and other haemorrhagic conditions

377

2135

1.82

25.06

5.7

3.5

24.82

25.22

mmol/l

1.54

369

2062

Lung diseases due to external agents

436

2578

1.75

24.95

4.6

3.5

25.66

25.06

mmol/l

3.05

418

2491

Parkinson's disease, strict definition, excluding more controls

370

2046

1.83

24.86

3.6

3.2

25.58

24.89

mmol/l

3.49

349

1990

Other diseases of blood and blood-forming organs, wide

579

3673

1.61

24.86

5.0

3.4

25.11

25.23

mmol/l

0.33

557

3557

Dental caries 1 and operation codes, only avohilmo

471

3879

0.60

24.84

3.4

4.2

25.26

25.36

mmol/l

0.25

450

3774

Migraine without aura

351

1945

1.83

24.60

2.7

3.3

25.04

25.18

mmol/l

0.36

335

1878

Disorders of synovium and tendon

1316

8767

1.37

24.58

3.6

3.2

25.42

25.24

mmol/l

1.26

1264

8507

Familial hypercholesterolemia, with ischemic heart disease

311

1677

1.93

24.52

4.5

3.0

24.83

25.24

mmol/l

1.14

299

1631

Mental retardation, excluding more controls

108

362

3.08

24.40

5.6

4.7

25.66

24.89

mmol/l

1.51

103

351

Pleural effusion

478

2916

1.69

24.35

5.6

3.3

25.67

24.97

mmol/l

3.76

470

2823

Status epilepticus

132

507

2.77

24.23

5.6

3.2

24.84

25.10

mmol/l

0.45

127

488

Benign neoplasm: Colon, unspecified

713

4779

1.53

23.99

5.2

3.4

25.04

25.16

mmol/l

0.43

694

4641

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2622

13780

1.25

23.92

4.2

3.3

25.19

25.24

mmol/l

0.29

2555

13359

Other viral hepatitis

162

686

2.45

23.86

4.6

3.6

24.91

25.25

mmol/l

0.59

156

667

Disorders of psychological development

251

1164

2.04

23.81

4.4

4.5

24.87

24.86

mmol/l

0.01

243

1113

Benign neoplasm of other and unspecified endocrine glands

339

1891

1.85

23.73

5.1

3.1

25.16

25.27

mmol/l

0.24

324

1821

Immunodeficiencies

150

618

2.55

23.70

5.3

3.5

25.18

25.27

mmol/l

0.11

144

595

Other systemic involvement of connective tissue

725

4886

1.51

23.54

3.6

3.3

25.53

25.25

mmol/l

1.33

704

4737

Pregnancy hypertension

737

4464

1.51

23.54

3.3

2.9

25.28

25.43

mmol/l

0.61

712

4320

Viral warts

255

1300

2.02

23.49

6.6

3.3

24.87

25.23

mmol/l

1.02

248

1258

Paralytic ileus

139

557

2.65

23.44

6.3

3.0

25.13

25.11

mmol/l

0.02

134

540

Disturbances of skin sensation

607

3953

1.56

23.04

3.5

3.3

25.46

25.27

mmol/l

0.81

586

3820

Ulcerative colitis

596

3870

1.57

22.97

4.4

3.4

24.81

25.19

mmol/l

1.83

572

3747

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

337

1709

1.82

22.88

4.0

4.2

25.03

24.83

mmol/l

0.52

326

1646

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

271

1432

1.98

22.85

5.4

3.1

25.21

25.17

mmol/l

0.05

263

1375

Calculus of kidney and ureter

839

5855

1.46

22.82

4.0

3.6

24.96

25.12

mmol/l

0.64

821

5670

Hypothyroidism, strict autoimmune, 3 medication purchases required

2158

11693

1.27

22.80

3.4

3.3

25.23

25.22

mmol/l

0.05

2087

11366

Colectomy operation

492

3074

1.65

22.75

4.9

3.4

24.70

25.20

mmol/l

2.09

477

2983

Arthropod-borne viral fevers and viral haemorrhagic fevers

283

1516

1.94

22.68

3.7

3.4

24.61

25.29

mmol/l

3.06

271

1463

Exclusions for E4_PCOS_CONSORTIUM

1652

7946

1.32

22.62

3.6

3.3

25.33

25.34

mmol/l

0.02

1603

7696

Cervical disc disorders

937

6672

1.43

22.59

3.4

25.36

25.16

mmol/l

1.05

904

6493

Dental caries 2

1041

11219

0.72

22.57

3.9

3.5

25.16

25.24

mmol/l

0.33

1010

10851

Nontraumatic intracranial haemmorrhage

594

3880

1.57

22.53

3.6

3.4

25.29

25.18

mmol/l

0.37

579

3759

ILD, hospital admissions

450

2766

1.68

22.34

4.6

3.5

25.64

25.13

mmol/l

2.02

425

2681

Other pleural conditions

329

1859

1.84

22.30

6.2

3.3

25.53

24.88

mmol/l

2.40

318

1797

Mixed and other personality disorders

186

864

2.22

21.96

3.5

25.58

25.23

mmol/l

0.62

181

835

Gonarthrosis,primary

2505

12781

1.24

21.85

3.2

3.5

25.39

25.24

mmol/l

1.51

2437

12407

Benign neoplasm of other and ill-defined parts of digestive system

487

3064

1.63

21.85

3.7

3.4

25.23

25.24

mmol/l

0.03

475

2961

Outcome of delivery

962

0.20

21.80

1.8

3.1

26.22

25.19

mmol/l

0.79

926

Other interstitial pulmonary diseases

455

2823

1.66

21.76

4.6

3.4

25.65

25.14

mmol/l

2.04

430

2736

Interstitial lung disease

455

2825

1.66

21.70

4.6

3.4

25.65

25.14

mmol/l

2.07

430

2738

Interstitial lung disease endpoints

455

2825

1.66

21.70

4.6

3.4

25.65

25.14

mmol/l

2.07

430

2738

Tubulo-interstitial nephritis, not specified as acute or chronic

203

984

2.14

21.65

5.7

2.5

24.83

25.58

mmol/l

2.11

195

954

Viral haemorrhagic fevers, not elsewhere classified/unspecified

231

1176

2.04

21.59

3.7

3.4

24.51

25.27

mmol/l

3.07

225

1135

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

394

2363

1.72

21.49

3.7

3.2

25.07

25.22

mmol/l

0.41

385

2277

TMD related operations

368

2161

1.74

21.39

3.9

3.4

25.31

25.35

mmol/l

0.08

358

2092

Left ventricular outflow tract obstruction (LVOTO), broad definition

270

1451

1.92

21.38

6.3

3.9

25.05

25.21

mmol/l

0.30

265

1406

Other mental disorders due to brain damage and dysfunction and to physical disease

353

2062

1.77

21.33

3.4

25.20

25.15

mmol/l

0.09

345

1999

Pruritus

282

1539

1.89

21.21

5.1

3.1

25.26

25.33

mmol/l

0.15

276

1486

Injuries to the knee and lower leg

3144

14956

1.21

21.08

3.8

3.4

25.38

25.19

mmol/l

2.29

3038

14501

COPD-related respiratory insufficiency

368

2182

1.75

21.04

6.3

3.4

27.58

24.95

mmol/l

17.89

347

2112

Dental caries 3 and operation codes, only avohilmo

552

4227

0.65

21.01

3.2

4.1

25.32

25.33

mmol/l

0.03

527

4118

Disorders of sclera, cornea, iris and ciliary body

1333

10143

1.33

20.97

4.7

3.3

25.18

25.24

mmol/l

0.24

1294

9834

Ovarian cyst

819

3281

1.46

20.97

3.3

3.0

25.29

25.35

mmol/l

0.19

792

3188

Vitamin deficiency

148

642

2.42

20.89

4.2

3.1

24.49

25.16

mmol/l

1.45

140

617

Vitamin deficiency, wide

148

642

2.42

20.89

4.2

3.1

24.49

25.16

mmol/l

1.45

140

617

Other necrotizing vasculopathies

231

1193

2.03

20.88

6.7

3.2

25.07

25.32

mmol/l

0.57

224

1154

Benign neoplasm of other and unspecified endocrine glands

339

1967

1.77

20.81

5.1

3.3

25.16

25.28

mmol/l

0.28

324

1904

Diseases of oral cavity, salivary glands and jaws

2620

10969

1.24

20.74

4.2

3.2

25.15

25.22

mmol/l

0.46

2532

10653

Fracture of lower leg, including ankle

1393

10638

1.32

20.71

3.9

3.4

25.61

25.25

mmol/l

3.16

1340

10326

DVT of lower extremities

548

3588

1.56

20.64

4.6

3.3

25.24

25.16

mmol/l

0.22

538

3486

Other specified/unspecified arthritis

671

4572

1.49

20.61

4.2

3.3

25.36

25.19

mmol/l

0.56

651

4446

Crohn disease

311

1762

1.81

20.59

5.0

3.4

25.14

25.28

mmol/l

0.29

305

1706

Chronic viral hepatitis

132

549

2.50

20.31

4.7

3.8

24.87

25.26

mmol/l

0.59

126

534

Hyperkinetic disorders, excluding more controls

149

631

2.34

20.29

3.8

3.4

25.17

25.01

mmol/l

0.26

143

605

Other necrotizing vasculopathies (FG)

201

999

2.11

20.28

6.1

3.0

25.07

25.24

mmol/l

0.31

196

969

Excessive, frequent and irregular menstruation

872

3416

1.44

20.26

3.5

3.0

25.62

25.33

mmol/l

1.64

851

3314

Viral hepatitis

180

854

2.18

20.24

4.6

3.5

24.88

25.20

mmol/l

0.61

174

828

severe traumatic brain injury, does not include concussion

636

4314

1.51

20.21

3.7

3.6

25.34

25.08

mmol/l

1.13

621

4180

Malignant neoplasm of bladder

252

1355

1.94

20.21

5.1

3.5

24.59

24.87

mmol/l

0.56

247

1316

Irregular menses

859

4951

1.42

20.20

3.7

2.9

25.53

25.27

mmol/l

1.55

841

4790

Dental caries 2 and operation codes

1028

11021

0.73

20.12

3.9

3.5

25.15

25.24

mmol/l

0.36

997

10662

Soft tissue disorders related to use, overuse and pressure

675

4634

1.48

20.01

4.1

3.2

25.40

25.19

mmol/l

0.85

654

4513

Dementia, including avohilmo

1325

6962

1.33

19.99

3.3

3.5

25.30

25.11

mmol/l

1.17

1288

6766

Other symptoms and signs involving the circulatory and respiratory systems

166

768

2.24

19.92

4.7

2.6

25.64

25.11

mmol/l

1.12

154

736

Nail disorders

217

1112

2.02

19.85

5.8

3.3

25.16

25.29

mmol/l

0.22

211

1074

Fracture of femur

782

5041

1.44

19.83

4.1

3.4

25.44

25.17

mmol/l

1.12

764

4886

Benign neoplasm: Sigmoid colon

501

3248

1.58

19.82

4.4

3.3

24.89

25.19

mmol/l

1.10

493

3144

ILD, hospital admissions 1, main diag only

401

2473

1.67

19.75

4.4

3.5

25.64

25.15

mmol/l

1.78

383

2391

Any dementia, excluding more controls

1055

5412

1.38

19.58

3.5

3.3

25.36

25.04

mmol/l

2.19

1023

5266

Superficial injury of lower leg

576

3856

1.52

19.35

4.1

3.4

25.37

25.16

mmol/l

0.68

566

3752

Coagulation defects, purpura and other haemorrhagic conditions

476

3063

1.59

19.32

5.6

3.5

24.91

25.20

mmol/l

1.13

462

2965

Contact with and exposure to communicable diseases

215

3998

0.53

19.22

3.9

3.5

24.66

25.11

mmol/l

0.79

171

3857

Superficial injury of hip and thigh

405

2521

1.65

19.00

4.6

3.3

25.49

25.16

mmol/l

1.02

395

2438

Alcohol withdrawal state with delirium

215

1121

2.00

18.90

4.8

3.7

25.28

25.15

mmol/l

0.16

206

1091

Anterior Iridocyclitis

504

3301

1.56

18.89

5.2

3.3

25.05

25.22

mmol/l

0.48

488

3198

Chronic gastritis

761

5414

1.43

18.69

4.0

3.2

25.15

25.22

mmol/l

0.21

738

5239

Iridocyclitis

560

3759

1.52

18.67

5.0

3.3

25.02

25.23

mmol/l

0.71

540

3639

Cerebral aneurysm, nonruptured

236

1272

1.92

18.64

3.7

3.2

25.26

25.48

mmol/l

0.55

231

1224

Cardiac murmurs and other cardiac sounds

206

1044

2.00

18.62

5.9

3.2

24.96

25.01

mmol/l

0.07

189

1003

Oesophagitis

166

793

2.19

18.58

5.3

3.1

25.29

25.21

mmol/l

0.10

161

764

Malnutrition

269

3.18

18.42

5.1

4.2

25.16

25.12

mmol/l

0.03

262

Hepatic failure, not elsewhere classified

124

530

2.48

18.32

6.0

3.0

24.09

25.11

mmol/l

2.27

115

514

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

457

2900

1.58

18.30

3.2

3.0

25.43

25.66

mmol/l

0.74

449

2819

Malignant neoplasm of digestive organs

1086

8075

1.35

18.27

3.5

24.65

25.18

mmol/l

4.91

1048

7845

Nonischemic cardiomyopathy

165

794

2.17

18.12

4.4

3.2

24.57

25.12

mmol/l

1.07

158

772

Injuries to the neck

509

3373

1.53

17.99

3.8

3.5

25.42

25.15

mmol/l

1.26

493

3257

Deforming dorsopathies

647

4497

1.46

17.96

3.8

3.4

25.52

25.15

mmol/l

1.85

624

4370

Injuries to the wrist and hand

2468

14811

1.22

17.95

3.9

3.4

25.19

25.23

mmol/l

0.23

2396

14348

Other benign neoplasms of skin

927

6722

1.37

17.92

4.1

3.2

25.26

25.33

mmol/l

0.27

902

6516

Herpesviral [herpes simplex] infections

282

1622

1.78

17.86

4.9

3.2

25.08

25.23

mmol/l

0.29

275

1565

Other symptoms and signs involving general sensations and perceptions

124

535

2.44

17.85

3.9

3.2

25.59

25.21

mmol/l

0.57

119

516

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

640

8955

0.70

17.83

3.2

3.3

25.27

25.31

mmol/l

0.10

628

8672

Superficial injury of abdomen, lower back and pelvis

366

2259

1.66

17.74

4.2

3.4

25.39

25.22

mmol/l

0.41

355

2188

Psoriasis vulgaris

460

2998

1.57

17.69

3.9

3.5

25.59

25.21

mmol/l

1.43

452

2891

Other noninflammatory disorders of uterus, except cervix

576

2654

1.51

17.64

3.2

3.0

25.69

25.50

mmol/l

0.63

561

2590

Abnormal serum enzyme levels

859

6221

1.39

17.62

4.3

3.6

24.98

25.06

mmol/l

0.25

831

6038

Disorders of ocular muscles, binocular movement, accommodation and refraction

1029

7674

1.34

17.60

4.5

3.5

25.29

25.19

mmol/l

0.43

1001

7437

Other embolism and thrombosis

361

2230

1.66

17.59

5.0

3.2

24.94

25.20

mmol/l

0.68

348

2164

Use of biperiden

155

738

2.19

17.51

3.4

3.2

25.95

25.31

mmol/l

1.10

150

715

Superficial injury of thorax

384

2409

1.63

17.48

4.2

3.5

25.47

25.16

mmol/l

1.10

374

2335

Benign neoplasm: Adrenal gland

201

1052

1.99

17.47

3.9

3.0

25.41

25.43

mmol/l

0.02

194

1017

Migraine with aura and triptan purchases

267

1517

1.79

17.45

3.0

3.2

25.30

25.25

mmol/l

0.09

260

1457

Alcoholic liver disease

284

1653

1.78

17.44

4.4

3.6

24.28

25.14

mmol/l

3.10

270

1604

Other sleep disorders

278

1606

1.78

17.36

4.5

3.3

25.52

25.03

mmol/l

1.67

264

1550

Superficial injury of wrist and hand

414

2643

1.59

17.33

4.0

3.4

25.20

25.24

mmol/l

0.09

401

2552

Follow-up examination after treatment for conditions other than malignant neoplasms

1027

5024

1.35

17.31

3.6

3.0

25.23

25.27

mmol/l

0.15

1002

4874

Benign neoplasm: Sigmoid colon

501

3350

1.53

17.25

4.4

3.5

24.89

25.22

mmol/l

1.31

493

3250

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

725

5166

1.42

17.24

3.8

3.5

25.37

25.22

mmol/l

0.64

707

4985

Lesion of ulnar nerve

343

2105

1.67

17.08

4.1

3.4

25.19

mmol/l

0.00

331

2036

Umbilical hernia

681

4834

1.43

16.97

5.2

3.5

25.29

25.16

mmol/l

0.43

667

4688

Congenital malformations of heart and great arteries

300

1724

1.72

16.88

4.8

3.9

25.44

25.12

mmol/l

0.89

293

1668

Secondary right heart disease

145

686

2.23

16.86

5.4

3.2

25.95

25.04

mmol/l

1.59

138

664

Seborrhoeic dermatitis

259

1482

1.80

16.84

4.1

3.4

25.28

25.22

mmol/l

0.10

252

1433

Diseases of male genital organs

1501

5964

1.29

16.80

4.7

3.6

25.04

25.05

mmol/l

0.04

1439

5790

Arterial embolism and thrombosis

192

1005

1.99

16.74

6.3

3.0

24.91

25.03

mmol/l

0.17

183

974

Chronic periodontitis, complicated

263

1517

1.79

16.70

6.8

3.5

24.56

25.27

mmol/l

2.52

253

1469

Generalized anxiety disorder

267

1539

1.76

16.61

3.0

3.1

25.23

25.21

mmol/l

0.03

262

1482

Drug-induced neutropenia

195

1028

1.97

16.61

4.5

3.2

25.19

25.43

mmol/l

0.38

190

1000

Acute and subacute iridocyclitis

470

3122

1.53

16.57

5.2

3.2

25.11

25.23

mmol/l

0.28

456

3023

Pyogenic arthritis

204

1092

1.94

16.57

5.3

3.5

25.11

25.09

mmol/l

0.02

197

1060

Asthma and allergy, excluding more controls

220

1183

1.86

16.50

2.7

2.8

25.42

25.15

mmol/l

0.68

215

1143

Other diseases of jaws

180

924

2.01

16.47

3.8

3.2

25.08

25.19

mmol/l

0.15

170

899

Persistent mood disorders

437

2859

1.55

16.46

4.2

3.2

25.29

25.25

mmol/l

0.08

417

2782

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

217

1186

1.90

16.46

3.3

3.2

25.44

25.19

mmol/l

0.53

212

1141

Disorders of vestibular function (Vertigo)

1183

9108

1.31

16.44

3.5

3.4

25.56

25.29

mmol/l

2.13

1157

8840

Dementia

1232

6595

1.31

16.42

3.3

3.5

25.30

25.11

mmol/l

1.16

1200

6410

Extrapyramidal and movement disorders

963

7267

1.35

16.38

4.1

3.4

25.42

25.18

mmol/l

1.58

925

7047

Allergic conjunctivitis

695

9457

0.72

16.32

3.2

3.4

25.25

25.30

mmol/l

0.18

682

9156

Pedal cyclist injured in other and unspecified transport accidents

270

1576

1.76

16.29

4.5

3.4

25.48

25.21

mmol/l

0.57

263

1521

Hyperplasia of prostate

1102

4783

1.33

16.26

4.4

3.6

25.08

24.99

mmol/l

0.35

1057

4656

Injuries to the elbow and forearm

1665

12139

1.25

16.21

3.9

3.4

25.34

25.27

mmol/l

0.35

1616

11773

Other and unspecified tonsillitis

644

3846

1.43

16.20

3.9

3.4

25.03

25.12

mmol/l

0.29

617

3703

Assault by bodily force

163

812

2.06

16.13

4.3

3.6

24.72

25.25

mmol/l

1.15

155

790

Colorectal cancer, excluding all cancers (controls excluding all cancers)

762

5379

1.39

16.13

3.7

3.3

24.70

25.26

mmol/l

3.93

737

5216

Fracture of lumbar spine and pelvis

593

4145

1.46

16.12

3.9

3.3

25.48

25.22

mmol/l

0.98

573

4023

Benign neoplasm: Ascending colon

355

2236

1.63

16.10

4.7

3.1

24.89

25.23

mmol/l

1.09

348

2160

Other pulmonary heart/vessel disease

156

773

2.12

16.05

5.3

3.2

25.91

25.00

mmol/l

1.61

149

751

Emphysema

209

1144

1.89

15.87

4.9

3.3

25.39

24.84

mmol/l

1.16

203

1109

Other arthrosis

1380

7790

1.28

15.86

3.4

3.2

25.39

25.25

mmol/l

0.77

1334

7574

Suppurative and necrotic conditions of lower respiratory tract

169

865

2.04

15.81

5.0

3.3

25.63

25.10

mmol/l

0.97

164

834

Pre-eclampsia

347

2172

1.62

15.78

3.9

2.9

25.19

25.48

mmol/l

0.82

338

2098

Foreign body in alimentary tract

159

796

2.08

15.77

3.4

3.5

25.13

25.03

mmol/l

0.13

154

768

Radiculopathy

434

2868

1.54

15.75

3.4

25.34

25.04

mmol/l

1.03

423

2779

Fracture of skull and facial bones

486

3290

1.50

15.59

4.3

3.6

25.37

25.21

mmol/l

0.44

470

3178

Other diseases of arteries and capillaries

249

1442

1.78

15.58

5.2

3.1

24.89

25.28

mmol/l

1.01

242

1396

Correction of physiology of bite - demanding therapy visit

156

776

2.07

15.57

4.8

3.4

25.61

25.33

mmol/l

0.52

150

751

Other condition

328

2040

1.64

15.52

4.6

3.4

25.45

25.27

mmol/l

0.40

317

1971

Sarcoidosis

331

2069

1.64

15.39

4.1

3.4

25.15

25.33

mmol/l

0.45

313

2010

Heartburn

234

1333

1.80

15.37

4.1

3.1

25.27

25.28

mmol/l

0.01

228

1291

Preparation and fitting of bite rail to mouth

285

1714

1.70

15.34

4.0

3.4

25.35

25.30

mmol/l

0.09

278

1654

Retinal vascular occlusion

354

2258

1.61

15.28

4.1

3.3

25.13

25.21

mmol/l

0.16

342

2189

Myocardial infarction, with ST-elevation

526

3641

1.48

15.28

4.3

3.6

25.19

25.05

mmol/l

0.40

512

3523

Other disorders of nervous system

184

981

1.95

15.19

4.4

3.3

25.58

25.37

mmol/l

0.29

178

950

Reimbursement for rheumatic diseases

1391

11079

1.26

15.14

3.9

3.4

25.37

25.27

mmol/l

0.53

1344

10748

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

689

4999

1.40

15.10

3.6

25.13

25.17

mmol/l

0.12

667

4839

Asthma and allergy

220

1218

1.81

15.05

2.6

3.0

25.42

25.14

mmol/l

0.73

215

1175

Other diseases of lip and oral mucosa

404

2659

1.55

14.97

3.9

3.3

25.24

25.23

mmol/l

0.02

397

2591

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

250

1469

1.76

14.97

3.6

3.0

24.79

25.19

mmol/l

0.92

242

1414

Orchitis and epididymitis

263

1564

1.73

14.96

5.3

3.6

25.17

24.99

mmol/l

0.34

252

1516

Haemorrhoids and perianal venous thrombosis

740

5439

1.38

14.93

3.6

3.2

25.22

25.23

mmol/l

0.01

716

5274

Diplopia

329

2071

1.63

14.90

4.8

3.3

25.19

25.28

mmol/l

0.18

316

2004

Appendectomy

1459

11291

1.25

14.86

3.4

25.18

25.25

mmol/l

0.34

1422

10921

Other factor of the environment

168

3.52

14.76

7.4

3.2

25.33

24.72

mmol/l

0.69

163

Retinal vascular disorders

357

2301

1.60

14.73

4.1

3.3

25.12

25.21

mmol/l

0.20

345

2232

Rheumatoid arthritis

812

5511

1.36

14.64

3.7

3.2

25.30

25.25

mmol/l

0.16

789

5362

Seborrhoeic keratosis

580

4122

1.43

14.54

4.2

3.2

25.12

25.24

mmol/l

0.38

561

4010

Any dementia

1118

6141

1.30

14.46

3.4

25.37

25.10

mmol/l

1.73

1084

5969

Parodontitis, operation under 40 years and operation codes

136

659

2.10

14.44

4.4

3.8

24.49

24.84

mmol/l

0.61

131

630

Adverse effects, not elsewhere classified

403

2668

1.53

14.43

4.6

3.3

25.08

25.25

mmol/l

0.51

393

2582

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

342

2195

1.60

14.38

5.0

3.2

24.38

25.22

mmol/l

4.59

332

2116

Disorders of lacrimal system

982

7565

1.31

14.38

4.0

3.3

25.27

25.31

mmol/l

0.13

954

7334

Diseases of inner ear

1367

10735

1.26

14.35

3.5

3.4

25.48

25.28

mmol/l

1.53

1335

10426

Coxarthrosis, primary, with hip surgery

1270

9581

1.27

14.33

3.3

3.5

25.26

25.23

mmol/l

0.11

1235

9313

Polyuria

578

4115

1.43

14.33

4.3

3.3

25.47

25.14

mmol/l

1.61

564

3998

Phlebitis and thrombophlebitis (not including DVT)

561

3973

1.44

14.29

4.7

3.3

25.28

25.22

mmol/l

0.18

550

3856

Non-follicular lymphoma, hilmo, excluding all cancers

265

1602

1.71

14.26

3.8

3.1

25.12

25.21

mmol/l

0.18

259

1541

Childhood asthma (age<16), excluding more controls

183

772

1.90

14.23

3.2

3.0

24.80

24.97

mmol/l

0.35

178

745

Parodontitis, under 40 years and operation codes

135

657

2.09

14.18

4.4

3.8

24.48

24.83

mmol/l

0.61

130

628

Strabismus

581

4133

1.42

14.17

4.5

3.6

25.25

25.16

mmol/l

0.28

566

4000

Mental retardation

108

485

2.32

14.15

5.6

5.0

25.66

24.77

mmol/l

1.93

103

469

Open wound of lower leg

363

2365

1.57

14.14

4.6

3.4

25.23

25.20

mmol/l

0.06

351

2299

Diaphragmatic hernia

920

7048

1.32

14.12

3.9

3.3

24.99

25.28

mmol/l

1.92

896

6847

Pre-eclampsia or eclampsia

367

2390

1.56

14.12

3.9

2.9

25.24

25.49

mmol/l

0.70

356

2315

Acute suppurative otitis media

474

3031

1.48

14.11

5.7

3.5

24.90

25.09

mmol/l

0.65

461

2913

Lifestyle-related condition

158

3.54

14.08

7.0

3.4

25.48

24.75

mmol/l

0.80

153

Nontoxic multinodular goitre

502

3496

1.46

14.07

3.5

3.0

25.76

25.38

mmol/l

1.86

481

3400

Dental operations

1924

8145

1.22

13.99

3.9

3.3

25.27

25.21

mmol/l

0.31

1854

7911

Artrosis, including avohilmo

2263

10413

1.20

13.93

3.3

3.6

25.29

25.20

mmol/l

0.57

2186

10099

Intracerebral haemorrhage

357

2329

1.57

13.91

3.9

3.3

25.40

25.20

mmol/l

0.62

349

2257

Abnormal results of function studies

212

1212

1.80

13.90

6.4

3.4

25.18

25.27

mmol/l

0.13

206

1171

Other disorders of bone

432

2926

1.50

13.88

3.8

3.2

25.14

25.26

mmol/l

0.35

412

2831

Alzheimer’s disease (Atypical or mixed), excluding more controls

239

1218

1.75

13.84

2.9

3.2

25.42

24.87

mmol/l

1.80

226

1182

Complications of internal orthopaedic prosthetic devices, implants and grafts

592

4260

1.42

13.83

4.0

3.2

25.22

25.24

mmol/l

0.05

575

4132

Benign neoplasm: Adrenal gland

201

1136

1.83

13.83

3.9

3.2

25.41

25.38

mmol/l

0.04

194

1102

Other follicular disorders

157

818

1.97

13.79

5.1

3.4

24.98

25.17

mmol/l

0.33

157

791

Nontoxic goitre/thyroid nodule

717

5324

1.37

13.69

3.4

3.2

25.54

25.36

mmol/l

0.79

694

5175

Benign neoplasm: Ascending colon

355

2325

1.57

13.67

4.7

3.4

24.89

25.20

mmol/l

0.94

348

2258

Follicular cysts of skin and subcutaneous tissue

428

2906

1.50

13.67

4.7

3.4

25.19

25.23

mmol/l

0.07

416

2810

Parodontitis or operation codes

2292

14258

1.19

13.67

4.0

3.4

25.08

25.31

mmol/l

2.50

2212

13844

Melanocytic naevi

606

4378

1.40

13.65

4.7

3.2

25.11

25.26

mmol/l

0.59

585

4229

Urticaria and erythema

764

5721

1.35

13.65

3.8

3.5

25.41

25.20

mmol/l

1.02

744

5547

Gestational [pregnancy-induced] hypertension

394

2618

1.52

13.63

3.0

25.22

25.38

mmol/l

0.41

377

2526

Ulcerative colitis, NAS

316

2011

1.60

13.61

4.8

3.4

24.48

25.28

mmol/l

3.29

303

1945

Childhood asthma (age<16)

183

784

1.87

13.61

3.2

3.1

24.80

25.00

mmol/l

0.42

178

758

Osteoporosis with pathological fracture (FG)

210

1210

1.80

13.60

5.0

2.9

26.23

25.39

mmol/l

2.40

203

1184

Parodontitis

2287

14256

1.19

13.45

4.0

3.4

25.07

25.31

mmol/l

2.56

2207

13842

Dislocation, sprain and strain of joints and ligaments at neck level

296

1859

1.62

13.43

3.5

3.3

25.39

25.27

mmol/l

0.34

287

1793

Redundant prepuce, phimosis and paraphimosis

501

3505

1.45

13.30

5.1

3.7

25.11

25.06

mmol/l

0.12

486

3401

Persons with potential health hazards related to communicable diseases

355

5284

0.66

13.30

9.1

3.5

24.49

25.15

mmol/l

2.43

297

5112

Diabetes mellitus in pregnancy

433

1889

1.50

13.27

3.5

2.9

24.92

25.27

mmol/l

1.32

414

1814

Cyst of kidney

201

1153

1.81

13.22

5.7

3.1

24.99

25.15

mmol/l

0.27

195

1118

Parodontitis, under 40 years, or operation codes

140

711

2.00

13.11

4.3

3.8

24.49

24.84

mmol/l

0.65

135

682

Other disorders of conjunctiva

369

2458

1.54

13.08

4.5

3.4

25.48

25.21

mmol/l

0.80

355

2387

Speech disturbances, not elsewhere classified

242

1463

1.70

13.06

4.6

3.3

25.22

25.23

mmol/l

0.02

234

1415

Other benign neoplasms of skin

927

7187

1.31

13.03

4.1

3.4

25.26

25.22

mmol/l

0.11

902

6968

Artificial opening status

149

783

1.98

12.96

5.8

2.9

24.60

25.04

mmol/l

0.64

141

755

Chronic periodontitis, including avohilmo

2273

14265

1.19

12.94

4.0

3.4

25.06

25.31

mmol/l

2.75

2193

13851

Pain associated with micturition

275

1718

1.64

12.90

4.2

3.0

25.83

25.28

mmol/l

1.79

265

1667

Congenital malformations of the circulatory system

311

1937

1.58

12.79

4.9

3.9

25.33

25.11

mmol/l

0.59

305

1873

Disorders of muscles

241

1460

1.69

12.78

5.0

3.4

24.87

25.16

mmol/l

0.73

235

1417

Trigger finger

324

2106

1.57

12.77

3.8

3.2

25.40

25.27

mmol/l

0.32

315

2049

Parodontitis, under 40 years

139

711

1.99

12.76

4.3

3.8

24.48

24.84

mmol/l

0.64

134

682

Neuromuscular dysfunction of bladder

236

1425

1.70

12.75

3.9

3.1

25.80

25.23

mmol/l

1.56

220

1381

Alzheimer disease, excluding more controls

478

2220

1.46

12.74

3.0

3.2

25.44

24.94

mmol/l

2.46

458

2163

Pyothorax

131

665

2.06

12.69

5.1

3.4

25.77

25.14

mmol/l

1.16

126

644

Subarachnoid haemorrhage

279

1759

1.63

12.68

3.3

25.33

25.25

mmol/l

0.13

272

1699

Pulmonary oedema

274

2.74

12.68

7.3

3.3

24.43

24.90

mmol/l

0.36

267

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

292

1864

1.61

12.65

5.1

3.1

24.46

25.23

mmol/l

3.50

285

1792

Open wound of forearm

224

1338

1.72

12.57

3.5

3.4

25.11

25.12

mmol/l

0.01

214

1291

Conjunctivitis (acute, non atopic)

593

4316

1.39

12.55

4.1

3.6

25.29

25.17

mmol/l

0.36

579

4182

Other and unspecified visual disturbances

232

1402

1.70

12.49

4.7

3.3

25.44

25.36

mmol/l

0.15

225

1357

Non-follicular lymphoma

265

1662

1.64

12.40

3.8

3.4

25.12

25.22

mmol/l

0.20

259

1608

Haemangioma and lymphangioma, any site

205

1200

1.75

12.39

3.4

3.1

25.47

25.31

mmol/l

0.30

200

1154

Colorectal cancer

631

4682

1.37

12.27

3.6

3.5

24.61

25.15

mmol/l

3.05

610

4549

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

148

793

1.95

12.25

5.1

2.8

25.83

25.29

mmol/l

0.81

143

761

Fracture of shoulder and upper arm

861

6662

1.31

12.24

4.1

3.5

25.38

25.26

mmol/l

0.46

834

6460

Diseases of salivary glands

443

3095

1.45

12.21

3.7

3.2

25.46

25.23

mmol/l

0.74

432

3013

IBD patients in KELA-register

477

3377

1.43

12.16

4.2

3.5

24.75

25.24

mmol/l

2.20

461

3269

Benign paroxysmal vertigo

698

5263

1.35

12.12

3.4

25.62

25.25

mmol/l

2.38

685

5109

Car occupant injured in other and unspecified transport accidents

392

2679

1.48

12.10

2.9

3.5

25.46

25.24

mmol/l

0.72

378

2582

Benign neoplasm: Stomach

245

1516

1.66

12.07

3.2

3.0

25.04

25.35

mmol/l

0.86

239

1466

Dental pulpitis 3

189

769

1.79

12.01

6.0

4.1

24.26

24.55

mmol/l

0.58

179

741

Wet age-related macular degeneration

510

3608

1.42

11.98

3.5

3.2

24.82

25.26

mmol/l

1.70

492

3517

Glaucoma

1480

10718

1.22

11.88

3.8

3.4

25.13

25.26

mmol/l

0.76

1428

10416

Bell's palsy

276

1763

1.60

11.83

3.6

3.3

25.35

25.23

mmol/l

0.22

266

1707

Mental retardation, wide definition

113

556

2.11

11.82

5.5

4.7

25.64

24.90

mmol/l

1.47

108

538

Gastrojejunal ulcer

176

3.14

11.77

3.9

3.0

24.31

25.07

mmol/l

0.82

171

Open wound of wrist and hand

967

7554

1.28

11.77

3.9

3.5

24.99

25.16

mmol/l

0.91

943

7298

Cervicocranial syndrome

241

1494

1.65

11.69

3.0

3.3

25.56

25.20

mmol/l

1.07

235

1447

Pre-eclampsia or poor fetal growth

462

3267

1.42

11.60

3.7

3.0

25.27

25.37

mmol/l

0.24

447

3158

Gonarthrosis, primary, with knee surgery

1493

10094

1.22

11.51

3.3

3.6

25.26

25.24

mmol/l

0.09

1460

9824

Spondyloarthritis

419

2930

1.45

11.51

4.3

3.4

25.59

25.20

mmol/l

1.34

407

2830

Coeliac disease

269

1725

1.59

11.33

4.9

3.2

25.17

25.33

mmol/l

0.34

260

1659

Early complications of trauma

114

574

2.06

11.26

4.5

3.4

25.41

25.10

mmol/l

0.38

109

553

!Aliquae complicationes praecoces traumatis

114

574

2.06

11.26

4.5

3.4

25.41

25.10

mmol/l

0.38

109

553

Parodontitis and operation codes

2121

14083

1.18

11.25

4.1

3.4

25.08

25.30

mmol/l

2.26

2047

13678

Generalized epilepsy

102

492

2.14

11.24

4.3

4.0

24.81

25.16

mmol/l

0.45

478

Haemangioma, any site

190

1121

1.74

11.22

3.5

3.0

25.58

25.36

mmol/l

0.45

185

1078

Disorders of optic nerve and visual pathways

212

1288

1.68

11.19

4.3

3.5

24.53

25.21

mmol/l

1.98

207

1243

Abnormal involuntary movements

314

2092

1.53

11.16

4.1

3.5

25.27

25.20

mmol/l

0.13

304

2023

Oxicams

785

3424

1.32

11.12

3.1

4.1

25.17

24.95

mmol/l

0.97

765

3319

Use of pramipexole

540

3973

1.38

11.12

4.7

3.4

25.38

25.20

mmol/l

0.61

518

3865

Cerebral palsy and other paralytic syndromes

270

1743

1.58

11.09

4.8

3.6

25.65

25.22

mmol/l

1.10

261

1688

Other aneurysm

160

906

1.83

11.07

4.8

2.9

24.81

25.05

mmol/l

0.41

153

874

Paracetamol of NSAID medication

497

1780

1.42

11.02

3.6

3.5

25.15

25.06

mmol/l

0.21

482

1730

Nondiabetic hypoglycaemic coma

5.98

10.96

7.0

4.0

25.13

24.36

mmol/l

0.39

Other joint disorders

2144

9733

1.18

10.95

3.7

3.3

25.16

25.18

mmol/l

0.12

2055

9429

Crohn's disease NAS

146

804

1.86

10.93

4.7

3.4

24.86

25.30

mmol/l

0.72

141

777

Aortic aneurysm

620

4589

1.35

10.92

4.2

3.3

24.92

25.12

mmol/l

0.71

601

4454

Fracture of foot, except ankle

484

3503

1.40

10.91

5.0

3.4

25.19

25.23

mmol/l

0.10

466

3384

Hypertrophic disorders of skin

123

641

1.97

10.91

3.0

2.9

25.17

25.25

mmol/l

0.10

118

617

Suppurative and unspecified otitis media

689

4648

1.32

10.90

4.9

3.5

25.02

25.09

mmol/l

0.24

669

4482

Mandibular retrognathia

132

704

1.91

10.79

2.7

4.0

25.44

25.30

mmol/l

0.24

127

677

Inflammatory bowel disease, strict (require KELA)

477

3452

1.40

10.77

4.2

3.5

24.75

25.21

mmol/l

1.97

461

3340

Other bursopathies

316

2125

1.52

10.75

4.3

3.4

25.31

25.20

mmol/l

0.20

308

2062

malignant neoplasm of female genital organs

356

2456

1.48

10.68

3.1

3.0

25.38

25.47

mmol/l

0.18

348

2397

Sulfasalazine

629

4757

1.34

10.66

3.6

3.1

25.32

25.19

mmol/l

0.44

608

4618

Superficial injury of forearm

205

1251

1.67

10.63

4.5

3.3

25.32

25.21

mmol/l

0.17

197

1208

Effects of foreign body entering through natural orifice

545

4042

1.37

10.60

3.5

3.8

25.25

25.10

mmol/l

0.48

526

3909

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

505

3712

1.38

10.52

3.8

3.3

24.58

25.20

mmol/l

3.46

492

3595

Idiopathic pulmonary fibrosis

224

1411

1.64

10.44

4.3

3.4

25.73

24.97

mmol/l

2.01

214

1371

Spondylolisthesis/Spondylolysis

400

2827

1.44

10.44

3.4

3.3

25.35

25.14

mmol/l

0.57

385

2745

Menorrhagia

749

3180

1.31

10.41

3.4

3.0

25.60

25.42

mmol/l

0.74

732

3090

Benign neoplasm: Rectum

438

3153

1.42

10.39

3.9

3.3

25.27

25.20

mmol/l

0.15

431

3056

Rheumatism, unspecified

298

1993

1.52

10.37

3.9

2.9

25.91

25.32

mmol/l

2.45

287

1950

Benign lipomatous neoplasm

665

5093

1.32

10.37

3.9

3.2

25.34

25.31

mmol/l

0.07

643

4928

Hydrocephalus

213

1332

1.65

10.19

3.1

3.3

24.91

25.18

mmol/l

0.56

208

1292

Other diseases of oesophagus

247

1596

1.58

10.19

3.9

3.2

25.53

25.20

mmol/l

0.83

240

1539

Fall on same level involving ice and snow

1308

10844

1.22

10.16

3.8

3.5

25.47

25.24

mmol/l

1.80

1272

10513

Squamous cell neoplasms and carcinomas of the skin

354

2471

1.47

10.09

4.6

3.4

24.94

25.11

mmol/l

0.40

347

2390

Adalimumab

173

1024

1.72

10.09

3.8

3.5

25.32

25.26

mmol/l

0.08

163

988

Biological medication for rheuma

292

1955

1.52

10.09

3.8

3.5

25.46

25.22

mmol/l

0.61

279

1892

Other disorders of eyelid

1124

8879

1.24

10.08

3.5

3.4

25.46

25.27

mmol/l

1.29

1102

8624

Other and unspecified follicular disorders

460

2.11

10.06

5.1

3.0

24.91

25.16

mmol/l

0.35

443

Primary gonarthrosis, bilateral

1306

9478

1.22

10.01

3.2

3.5

25.44

25.25

mmol/l

1.27

1267

9227

Paralytic strabismus

188

1146

1.69

9.97

4.4

3.3

25.19

25.16

mmol/l

0.04

182

1106

Acute appendicitis

1585

12623

1.19

9.96

3.4

3.5

25.23

25.20

mmol/l

0.13

1540

12224

Weight loss

240

1551

1.58

9.94

3.5

3.4

25.21

25.24

mmol/l

0.04

228

1502

Pain in joint

1224

6656

1.22

9.82

3.8

3.2

25.19

25.17

mmol/l

0.08

1177

6429

Melanocytic naevi

606

4617

1.33

9.81

4.7

3.4

25.11

25.21

mmol/l

0.36

585

4466

Early lumbar disc prolapse, operated

161

940

1.74

9.81

3.3

3.4

25.11

25.18

mmol/l

0.10

149

909

Keratitis

772

6081

1.28

9.68

4.5

3.3

25.22

25.23

mmol/l

0.02

754

5903

Examination and encounter for administrative purposes

110

578

1.97

9.65

3.5

3.1

25.07

24.92

mmol/l

0.20

102

559

Appendicitis, broad definition

1696

13197

1.18

9.65

3.4

3.5

25.21

mmol/l

0.01

1649

12779

Olecranon bursitis

164

975

1.73

9.57

5.1

3.6

25.25

25.12

mmol/l

0.16

159

946

Arthropathies in other diseases classified elsewhere

102

525

2.02

9.57

10.6

3.3

24.75

24.98

mmol/l

0.25

513

Acute appendicitis, no complications

1182

9736

1.22

9.53

3.3

3.5

25.27

25.20

mmol/l

0.31

1151

9423

Haemangioma and lymphangioma, any site

205

1289

1.63

9.53

3.4

25.47

25.30

mmol/l

0.33

200

1248

Neuralgia and neuritis, unspecified

123

674

1.88

9.47

4.8

3.0

25.67

25.29

mmol/l

0.66

117

655

Migraine without aura and triptan purchases

243

1585

1.55

9.46

2.7

3.2

25.17

25.30

mmol/l

0.33

233

1527

Haemorrhage in early pregnancy

427

3023

1.39

9.46

2.8

3.0

25.19

25.50

mmol/l

1.37

414

2930

Pedal cyclist injured in transport accident

460

3385

1.38

9.46

3.8

3.5

25.43

25.20

mmol/l

0.70

448

3275

Other disorders of lacrimal gland

743

5846

1.28

9.44

4.4

3.3

25.15

25.33

mmol/l

0.69

722

5677

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

354

2503

1.45

9.42

4.6

3.1

24.94

25.15

mmol/l

0.53

347

2417

Malignant neoplasm of colon

396

2855

1.41

9.40

3.6

3.4

24.65

25.18

mmol/l

2.09

387

2765

Perineal laceration during delivery

210

1178

1.60

9.38

2.2

3.1

24.93

25.10

mmol/l

0.32

204

1131

Benign neoplasm: Duodenum

408

2.17

9.38

4.1

2.9

24.79

25.22

mmol/l

0.51

394

Acquired absence of organs, not elsewhere classified

165

2.93

9.36

9.8

2.9

24.23

24.70

mmol/l

0.40

158

259

1721

1.53

9.33

4.8

2.9

25.20

25.27

mmol/l

0.10

243

1665

Attention to artificial openings

106

558

1.97

9.32

5.0

2.7

25.15

25.00

mmol/l

0.16

535

Persistent delusional disorders

181

1113

1.67

9.24

2.7

3.4

26.25

25.21

mmol/l

2.54

172

1079

Diseases of appendix

1705

13285

1.18

9.17

3.4

3.5

25.21

mmol/l

0.00

1658

12865

Benign neoplasm: Duodenum

412

2.15

9.15

4.1

3.2

24.79

25.15

mmol/l

0.41

401

Parodontitis or/and operation codes

1488

7452

1.20

9.09

4.0

3.5

25.07

25.32

mmol/l

1.95

1434

7216

Hypertrophic scar

109

582

1.92

9.07

3.2

3.0

25.40

25.24

mmol/l

0.20

104

559

5-aminosalicylic acid

421

3076

1.38

9.05

4.2

3.2

24.88

25.19

mmol/l

0.95

406

2979

Adhesive capsulitis of shoulder

384

2768

1.41

9.04

4.2

3.2

25.15

25.23

mmol/l

0.18

369

2693

Temporomandibular joint disorders, including avohilmo

742

5858

1.27

8.99

3.1

3.4

25.32

25.26

mmol/l

0.23

719

5676

Burns and corrosions

291

1998

1.48

8.97

4.1

3.7

25.03

25.19

mmol/l

0.35

284

1930

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

182

1130

1.65

8.94

3.2

3.0

25.78

25.45

mmol/l

0.56

173

1091

Benign neoplasm: Stomach

245

1636

1.53

8.80

3.2

25.04

25.36

mmol/l

0.91

239

1585

Acute posthaemorrhagic anaemia

101

534

1.96

8.80

5.8

2.8

24.56

25.23

mmol/l

1.17

515

Thyrotoxicosis

518

3929

1.33

8.74

3.7

3.2

25.60

25.31

mmol/l

1.20

496

3816

Maternal care for known or suspected fetal abnormality and damage

1216

0.47

8.66

2.9

3.2

25.44

25.13

mmol/l

0.30

1164

Melanocytic naevi of trunk

238

1583

1.53

8.62

5.0

3.1

24.82

25.13

mmol/l

0.79

227

1516

Benign neoplasm: Rectum, anus and anal canal

484

3653

1.35

8.56

4.0

3.3

25.24

25.22

mmol/l

0.03

476

3533

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

164

1004

1.67

8.55

3.2

2.9

26.04

25.36

mmol/l

1.54

157

969

Disturbance of activity and attention

142

822

1.73

8.55

3.8

4.1

25.13

24.91

mmol/l

0.37

136

788

Polyarthrosis

488

3533

1.34

8.52

3.7

3.3

25.74

25.31

mmol/l

2.10

481

3440

Vascular dementia

248

1615

1.52

8.50

4.4

3.4

25.61

24.99

mmol/l

2.04

240

1564

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

161

981

1.67

8.49

4.0

2.9

25.35

25.45

mmol/l

0.13

155

952

Tumor necrosis factor alpha inhibitors

256

1733

1.50

8.47

3.7

3.4

25.44

25.23

mmol/l

0.46

244

1677

Haemangioma, any site

190

1210

1.60

8.44

3.5

3.3

25.58

25.31

mmol/l

0.60

185

1171

Glaucoma suspect

878

7146

1.24

8.40

3.6

3.4

25.22

25.26

mmol/l

0.14

848

6945

Pilonidal cyst

161

984

1.66

8.38

3.1

3.2

25.23

25.15

mmol/l

0.11

156

952

Otitis media, unspecified

208

1240

1.57

8.38

5.9

3.4

24.91

24.86

mmol/l

0.06

197

1191

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

1262

7260

1.20

8.37

4.2

3.3

25.07

25.35

mmol/l

2.46

1229

7044

Disorders of continuity of bone

190

1211

1.60

8.36

5.6

3.3

25.41

25.33

mmol/l

0.11

183

1170

Other other unspecified disorders of the circulatory system

102

553

1.91

8.27

5.3

3.2

25.64

25.18

mmol/l

0.51

536

Other maternal disorders predominantly related to pregnancy

918

4687

1.24

8.25

3.1

3.0

25.21

25.48

mmol/l

1.73

882

4550

Autoimmune thyroiditis

193

2.60

8.24

3.4

3.5

25.78

25.08

mmol/l

0.78

187

Abnormal weight loss

215

1419

1.55

8.19

3.6

3.4

25.28

25.18

mmol/l

0.12

204

1372

Alcoholic gastritis

207

2.56

8.16

4.8

3.2

25.02

24.90

mmol/l

0.07

199

Anomalies of dental arch relationship, including avohilmo

338

2174

1.41

8.13

4.1

3.4

25.15

mmol/l

0.01

330

2097

Stomatitis and related lesions

179

1135

1.61

8.08

5.3

3.2

25.20

25.31

mmol/l

0.14

172

1104

Benign neoplasm: Rectum

438

3290

1.35

8.07

3.9

3.5

25.27

25.17

mmol/l

0.24

431

3192

Parkinson's disease

401

2974

1.37

8.07

3.6

3.4

25.52

25.15

mmol/l

1.37

379

2886

Suggestive for eosinophilic asthma

212

1399

1.55

8.06

4.3

3.2

25.77

25.16

mmol/l

2.02

206

1353

Inflammatory diseases of the central nervous system

184

1176

1.60

8.05

3.6

3.3

25.62

25.30

mmol/l

0.61

178

1138

Later onset COPD

811

5154

1.25

8.05

4.9

3.3

25.84

24.91

mmol/l

8.70

781

5004

Other renal tubulo-interstitial diseases

265

2.31

7.93

5.9

2.6

24.31

25.45

mmol/l

1.56

260

Bronchitis, not specified as acute or chronic

202

1323

1.56

7.93

4.5

3.2

25.51

25.05

mmol/l

0.98

195

1283

1083

8513

1.21

7.92

4.2

3.4

25.21

25.19

mmol/l

0.07

1059

8271

Parkinson's disease, including avohilmo

416

3112

1.36

7.92

3.6

3.4

25.53

25.10

mmol/l

1.79

394

3018

Chondropathies

316

2259

1.42

7.86

3.3

3.4

24.94

25.23

mmol/l

0.90

302

2179

Inflammatory diseases of female pelvic organs

1132

7130

1.20

7.86

3.3

3.0

25.41

25.44

mmol/l

0.09

1097

6923

Alkalosis

6.56

7.85

14.8

1.8

26.76

25.44

mmol/l

0.21

Urticaria

564

4393

1.30

7.83

3.7

3.5

25.39

25.22

mmol/l

0.64

552

4251

Fracture at wrist and hand level

710

5683

1.26

7.83

4.9

3.5

25.22

25.19

mmol/l

0.07

691

5499

Puerperal sepsis

226

1518

1.51

7.82

3.6

3.0

25.95

25.58

mmol/l

1.10

220

1471

Thyrotoxicosis, other and/or unspecified

390

2890

1.37

7.77

3.4

3.2

25.34

25.33

mmol/l

0.03

371

2811

Malignant neoplasm of urinary organs

259

1797

1.47

7.75

5.3

3.4

24.14

25.18

mmol/l

5.25

253

1740

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

497

3822

1.32

7.74

3.2

3.3

24.42

25.20

mmol/l

4.51

477

3703

Postmenopausal osteoporosis with pathological fracture

164

1036

1.63

7.71

4.1

2.8

26.56

25.48

mmol/l

3.04

158

1011

conjunctival haemorrhage

189

1234

1.57

7.63

4.7

3.2

25.68

25.29

mmol/l

0.76

183

1193

ILD-related respiratory insufficiency

548

1.89

7.62

8.0

3.1

26.42

25.15

mmol/l

1.74

529

Erosion of teeth

171

2.63

7.59

14.0

3.3

24.86

24.99

mmol/l

0.09

164

Polymyalgia rheumatica

349

2564

1.39

7.51

3.8

3.2

25.82

25.22

mmol/l

2.50

339

2498

Benign lipomatous neoplasm

665

5320

1.26

7.49

3.9

3.5

25.34

25.25

mmol/l

0.28

643

5159

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

165

1050

1.61

7.48

3.7

3.1

23.80

25.15

mmol/l

4.31

159

1007

Fluid overload

5.72

7.45

17.4

2.9

25.53

24.92

mmol/l

0.20

Amyloidosis

269

2.26

7.31

5.7

2.7

24.67

25.29

mmol/l

0.56

259

Impingement syndrome of shoulder

539

4218

1.29

7.30

3.4

3.2

25.43

25.25

mmol/l

0.66

517

4107

Injuries to unspecified part of trunk, limb or body region

220

1495

1.50

7.29

5.3

3.4

25.43

25.25

mmol/l

0.33

213

1445

Dental pulpitis 3, only avohilmo

158

718

1.62

7.28

4.8

4.2

24.28

24.56

mmol/l

0.54

151

691

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

134

814

1.68

7.28

2.9

26.22

25.37

mmol/l

1.88

129

784

Pain and other conditions associated with female genital organs and menstrual cycle

304

2094

1.40

7.27

2.8

2.9

25.43

25.17

mmol/l

0.74

294

2029

Other enthesopathies

614

4884

1.27

7.23

3.6

3.2

25.55

25.24

mmol/l

1.61

593

4762

Somnolence

158

2.67

7.22

5.4

4.2

26.05

24.55

mmol/l

1.43

152

Other strabismus

414

3124

1.33

7.18

4.4

3.5

25.24

25.20

mmol/l

0.08

405

3018

Degenerative macular diseases

317

2313

1.40

7.14

3.8

3.2

25.21

25.23

mmol/l

0.05

304

2252

Oesophageal varices

110

640

1.78

7.12

6.8

3.2

23.66

25.05

mmol/l

3.57

104

616

Acute nasopharyngitis (common cold)

240

1655

1.46

7.09

3.7

3.4

25.33

mmol/l

0.00

231

1593

Hyperkinetic disorders

149

920

1.62

7.08

3.8

4.3

25.17

24.90

mmol/l

0.52

143

884

Benign neoplasm: Rectum, anus and anal canal

484

3757

1.31

7.08

4.0

3.5

25.24

25.16

mmol/l

0.19

476

3642

Subjective visual disturbances

501

3903

1.30

7.05

3.9

3.3

25.21

25.25

mmol/l

0.07

478

3785

Secondary uncertain malignant neoplasm

310

2258

1.40

7.04

3.5

25.01

25.19

mmol/l

0.37

304

2184

Persons encountering health services in circumstances related to reproduction

806

6648

0.82

7.04

3.8

3.7

25.55

25.28

mmol/l

1.67

768

6433

Other keratitis

221

1513

1.48

7.03

4.5

3.2

25.62

25.29

mmol/l

0.73

216

1464

Perforation of tympanic membrane

222

1523

1.48

7.03

5.0

3.3

25.41

25.25

mmol/l

0.23

216

1473

Other and unspecified disorders of vitreous body

921

7633

1.21

7.02

3.6

3.4

25.49

25.32

mmol/l

0.86

904

7426

Other and unspecified vascular occlusions

246

1726

1.46

6.99

4.5

3.2

25.22

25.21

mmol/l

0.01

237

1670

Motor disorders, excluding more controls

103

2.97

6.94

5.1

8.5

24.18

24.22

mmol/l

0.02

Abdominal aortic aneurysm (AAA)

282

2011

1.42

6.92

4.9

3.3

24.30

24.98

mmol/l

2.36

271

1947

Other fall from one level to another

470

3643

1.30

6.87

3.9

3.7

25.24

25.09

mmol/l

0.47

453

3520

Amyloidosis, other/unspecified

218

2.36

6.86

5.9

2.8

24.52

25.26

mmol/l

0.59

211

Sequelae of injuries, of poisoning and of other consequences of external causes

484

3768

1.30

6.86

3.3

3.6

25.54

25.21

mmol/l

1.12

464

3656

Abscess of lung

193

2.45

6.85

4.2

3.9

25.80

24.69

mmol/l

0.77

186

Parkinson's disease, strict definition

370

2788

1.35

6.79

3.6

3.4

25.58

25.14

mmol/l

1.73

349

2707

Recurring oral aphthae

107

625

1.76

6.79

5.2

3.1

25.64

25.19

mmol/l

0.61

102

604

Infarction of spleen

3.38

6.76

6.1

3.8

24.24

24.69

mmol/l

0.21

Collagenous colitis

192

1291

1.52

6.75

5.4

3.3

24.81

25.47

mmol/l

1.58

184

1251

Mouth breathing

895

7459

1.21

6.74

4.1

3.6

25.25

25.18

mmol/l

0.26

869

7229

Localized swelling, mass and lump of skin and subcutaneous tissue

677

5500

1.24

6.67

4.1

3.4

25.16

25.19

mmol/l

0.08

660

5333

Dental pulpitis 4

2799

13072

1.12

6.66

3.8

3.4

25.07

25.26

mmol/l

2.27

2704

12680

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

1344

7900

1.17

6.66

4.0

3.3

25.07

25.34

mmol/l

2.40

1311

7664

Diseases of pulp and periapical tissues, including avohilmo

2794

13050

1.12

6.64

3.8

3.4

25.07

25.26

mmol/l

2.39

2700

12660

Retinal detachments and breaks

836

6949

1.21

6.59

4.1

3.3

25.02

25.26

mmol/l

1.33

814

6752

Malignant neoplasm of kidney, except renal pelvis

232

1632

1.45

6.53

5.4

3.3

24.24

25.14

mmol/l

3.80

227

1584

Other/unspecified synovitis and tenosynovitis

243

1719

1.43

6.53

3.3

25.67

25.27

mmol/l

1.18

238

1667

Exposure to unspecified factor

2308

16003

1.12

6.52

4.1

3.5

25.43

25.19

mmol/l

2.45

2221

15518

Other specified/unspecified necrotizing vasculopathies

211

2.36

6.50

8.0

3.6

24.28

24.98

mmol/l

0.71

205

Dental pulpitis 1

2795

13073

1.12

6.50

3.8

3.4

25.08

25.26

mmol/l

2.22

2700

12683

Otitis externa, unspecified

216

1497

1.46

6.50

4.0

3.6

25.05

25.21

mmol/l

0.25

207

1443

Disorders of refraction and accommodation

476

3709

1.29

6.48

5.4

3.6

25.23

25.21

mmol/l

0.03

463

3584

Blepharochalasis

682

5573

1.24

6.43

3.5

3.3

25.63

25.27

mmol/l

2.31

665

5405

Ulcerative colitis (strict definition, require KELA)

326

2426

1.36

6.42

4.4

3.5

24.83

25.21

mmol/l

1.06

312

2347

Noninflammatory disorders of female genital tract

841

3489

1.22

6.42

3.2

3.0

25.32

25.30

mmol/l

0.06

810

3383

Complications predominantly related to the puerperium

379

2881

1.33

6.39

3.0

25.56

25.40

mmol/l

0.45

369

2795

Visual field defects

201

1382

1.48

6.37

4.3

3.3

25.08

25.30

mmol/l

0.44

191

1339

Diseases of middle ear and mastoid

1163

8145

1.18

6.37

4.5

3.5

25.15

25.12

mmol/l

0.09

1128

7874

Primary coxarthrosis, bilateral

722

5944

1.23

6.35

3.5

25.38

25.18

mmol/l

0.81

700

5769

Other extrapyramidal and movement disorders in other diseases

501

3962

1.28

6.34

4.0

3.5

25.30

25.20

mmol/l

0.27

487

3846

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

315

2337

1.36

6.33

4.4

3.5

24.83

25.22

mmol/l

1.08

302

2259

Melanocytic naevi of trunk

238

1688

1.43

6.33

5.0

3.4

24.82

25.21

mmol/l

1.12

227

1629

Common variable immunodeficiency

3.54

6.33

3.2

3.4

24.84

25.17

mmol/l

0.19

Hypoplasia of dental enamel, prenatal

5.77

6.28

36.1

6.5

23.85

23.27

mmol/l

0.20

Atypical facial pain

110

662

1.70

6.27

3.0

2.9

25.69

25.39

mmol/l

0.50

104

645

Spondylopathies (FG)

269

1950

1.40

6.26

3.6

3.3

25.54

25.22

mmol/l

0.80

262

1890

Symptoms and signs involving speech and voice

713

5866

1.23

6.26

3.7

3.5

25.38

25.23

mmol/l

0.61

693

5689

Other menopausal disorders

317

2451

0.74

6.22

2.7

3.0

26.02

25.49

mmol/l

2.44

304

2389

Vulvovaginal ulceration/inflammation in other diseases

527

1.78

6.20

4.4

2.7

25.23

25.34

mmol/l

0.13

511

Acute laryngitis and tracheitis

184

1225

1.49

6.20

4.2

3.4

24.94

25.16

mmol/l

0.43

177

1178

Ocular pain

153

999

1.56

6.19

4.4

3.3

25.22

25.31

mmol/l

0.14

148

964

Preterm labour and delivery

387

2967

1.31

6.15

3.2

3.1

25.29

25.55

mmol/l

0.93

378

2878

Malignant neoplasm of endocrine gland

151

986

1.56

6.14

3.3

3.2

25.75

25.36

mmol/l

0.65

143

954

Fracture of forearm

1197

9654

1.17

6.13

3.9

3.4

25.47

25.33

mmol/l

0.78

1166

9375

Chronic sinusitis

913

7698

1.19

6.09

3.6

3.4

25.41

25.21

mmol/l

0.98

881

7458

Calcinosis cutis

6.53

6.06

17.2

2.9

23.90

24.17

mmol/l

0.12

Dislocation, sprain and strain of joints and ligaments of head

415

1.87

6.04

3.6

3.9

25.19

25.15

mmol/l

0.05

403

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

516

4116

1.26

6.02

3.9

3.5

25.43

25.23

mmol/l

0.68

500

3977

Abscess of anal and rectal regions

166

1110

1.52

6.01

4.8

3.4

24.83

25.30

mmol/l

0.86

158

1081

Colorectal adenocarcinoma

497

3957

1.27

6.01

3.2

3.5

24.42

25.17

mmol/l

4.27

477

3839

Prolonged pregnancy

1215

0.56

5.99

1.8

3.1

24.43

25.09

mmol/l

1.01

1166

Nonsuppurative otitis media

398

2651

1.31

5.99

5.9

3.6

25.06

25.01

mmol/l

0.10

385

2556

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

463

1.83

5.95

4.1

3.3

25.08

25.07

mmol/l

0.02

449

Abnormal spermatozoa

318

2396

1.35

5.94

4.1

3.9

25.19

24.92

mmol/l

0.80

312

2318

Carbimazole or st.post thyroidectomy, condition for graves disease

388

2997

1.31

5.91

2.9

3.2

26.07

25.34

mmol/l

4.43

361

2904

Henoch-Schönlein purpura nephritis (HSPN)

4.10

5.86

11.6

4.1

23.76

24.37

mmol/l

0.34

Fissure and fistula of anal and rectal regions

499

3981

1.26

5.85

3.4

3.2

25.57

25.21

mmol/l

1.57

480

3854

Acute pharyngitis

239

1706

1.40

5.84

3.6

3.4

25.19

25.14

mmol/l

0.08

225

1652

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

349

2665

1.32

5.80

4.2

3.5

24.79

25.21

mmol/l

1.30

334

2578

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

296

2213

1.36

5.80

3.2

3.1

24.45

25.22

mmol/l

3.13

287

2135

Unspecified event, undetermined intent

295

2.03

5.77

4.2

3.6

25.63

25.24

mmol/l

0.30

286

Recurring oral aphthae, including avohilmo

276

2043

1.37

5.72

4.1

3.3

25.30

25.29

mmol/l

0.02

267

1980

Rare circulating lymphoid malignancy

469

1.81

5.72

4.1

3.9

25.08

24.97

mmol/l

0.13

454

Superficial injury of shoulder and upper arm

233

1679

1.41

5.70

4.2

3.4

25.55

25.28

mmol/l

0.62

228

1617

Superficial injury of ankle and foot

202

1418

1.44

5.70

4.8

3.3

25.03

25.16

mmol/l

0.27

196

1362

Injury of muscle and tendon at wrist and hand level

279

2070

1.37

5.69

2.8

3.5

25.31

25.24

mmol/l

0.14

271

1996

Budesonide

252

1840

1.39

5.67

3.5

3.1

24.70

25.30

mmol/l

1.81

240

1777

Inguinal hernia

1514

8972

1.14

5.63

3.8

3.5

25.09

25.14

mmol/l

0.20

1458

8697

Thoracic aortic aneurysm

327

2493

1.33

5.61

4.0

3.3

25.33

25.17

mmol/l

0.39

320

2417

Seropositive rheumatoid arthritis

559

4531

1.24

5.59

3.7

3.2

25.16

25.24

mmol/l

0.20

542

4400

Malignant neoplasm of thyroid gland

141

928

1.55

5.58

3.3

3.1

25.95

25.39

mmol/l

1.07

134

896

Excessive vomiting in pregnancy

118

744

1.61

5.56

3.2

2.9

25.30

25.33

mmol/l

0.04

112

721

Pneumothorax

166

1132

1.50

5.55

4.4

3.2

25.85

24.75

mmol/l

3.67

155

1092

Short Achilles tendon (acquired)

328

1.95

5.51

3.7

3.2

26.73

25.40

mmol/l

1.03

320

Rheumatoid arthritis, including avohilmo

860

7291

1.19

5.50

3.7

3.4

25.30

25.29

mmol/l

0.01

835

7082

Endometriosis of rectovaginal septum and vagina

156

1051

1.51

5.50

3.3

3.0

25.69

25.43

mmol/l

0.49

150

1026

Accidental poisoning by and exposure to alcohol

199

2.23

5.49

8.1

3.8

26.24

24.57

mmol/l

2.42

187

Otitis externa

434

3436

1.28

5.48

4.0

3.5

25.12

25.20

mmol/l

0.18

419

3331

Fracture of neck

145

966

1.54

5.48

3.9

3.3

25.59

24.98

mmol/l

1.21

140

936

Other shoulder lesions

180

1248

1.46

5.48

3.7

3.3

25.35

25.20

mmol/l

0.27

175

1212

388

1.88

5.47

5.1

3.3

27.28

24.95

mmol/l

3.08

374

Skin changes due to chronic exposure to nonionizing radiation

1003

8152

1.17

5.46

4.3

3.4

25.17

25.19

mmol/l

0.04

979

7921

Lung cancer and mesothelioma

437

2960

1.28

5.42

3.8

2.9

25.99

24.78

mmol/l

10.01

431

2889

Viral infections of the central nervous system

147

982

1.52

5.42

3.6

3.2

25.30

25.21

mmol/l

0.14

137

953

Immunodeficiency associated with other major defects

4.53

5.39

2.4

5.0

26.64

24.33

mmol/l

2.39

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

150

1010

1.52

5.37

3.1

2.9

25.51

25.15

mmol/l

0.63

144

970

Congenital malformations and deformations of the musculoskeletal system

147

978

1.51

5.35

4.6

4.3

25.25

24.98

mmol/l

0.42

142

944

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

300

2276

1.34

5.34

3.3

3.2

24.70

25.23

mmol/l

1.52

287

2198

Other specific joint derangements/joint disorders

1558

9231

1.14

5.30

3.6

3.3

25.23

25.21

mmol/l

0.06

1497

8947

Postprocedural musculoskeletal disorders, not elsewhere classified

160

1096

1.49

5.28

2.8

3.3

25.62

25.29

mmol/l

0.43

153

1060

Vascular dementia (undefined)

108

673

1.63

5.26

4.7

3.1

25.52

25.02

mmol/l

0.87

101

648

Early lumbar disc prolapse operation

164

1126

1.47

5.23

3.2

3.4

25.12

25.27

mmol/l

0.21

152

1085

Lichen planus

272

2045

1.35

5.15

4.0

3.2

25.31

mmol/l

0.01

266

1981

Conjunctivitis

1224

12177

0.87

5.14

3.6

3.5

25.23

25.28

mmol/l

0.18

1197

11780

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1152

9829

1.15

5.13

3.9

3.5

25.48

25.19

mmol/l

2.38

1120

9525

Open wound of shoulder and upper arm

246

2.06

5.11

5.3

3.3

24.52

24.89

mmol/l

0.38

236

Right bundle-branch block

485

1.73

5.09

4.1

2.3

25.15

24.86

mmol/l

0.33

464

Fibroblastic disorders

545

4468

1.23

5.07

3.3

25.11

25.13

mmol/l

0.05

528

4337

Vitamin B12 deficiency anaemia

264

1985

1.35

5.02

4.6

3.2

24.58

25.17

mmol/l

1.87

256

1930

Use of levodopa decarboxylase inhibitor

336

2614

1.31

5.02

3.5

3.3

25.54

25.16

mmol/l

1.32

321

2534

Colon adenocarcinoma

296

2264

1.33

5.02

3.2

3.4

24.45

25.20

mmol/l

3.02

287

2193

Actinic keratosis

976

8004

1.17

5.00

4.3

3.4

25.17

25.19

mmol/l

0.04

954

7775

Inflammatory disease of uterus

212

1538

1.39

4.99

3.1

2.9

25.38

25.35

mmol/l

0.05

207

1489

Other symptoms and signs involving the urinary system

229

1688

1.38

4.97

4.5

3.2

25.14

25.03

mmol/l

0.19

201

1636

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

255

1909

1.35

4.97

4.4

3.2

25.23

25.25

mmol/l

0.03

250

1836

Mixed connective tissue disease

129

856

1.53

4.96

3.7

3.0

25.68

25.44

mmol/l

0.30

124

834

Histrionic personality disorder

3.03

4.92

3.1

2.4

25.65

24.97

mmol/l

0.38

Trochanteric bursitis

274

2077

1.33

4.90

3.9

2.9

25.44

25.30

mmol/l

0.29

265

2030

Conductive hearing loss, unspecified

173

1221

1.44

4.86

4.2

3.4

25.40

25.34

mmol/l

0.10

166

1181

Polyp of the female genital tract

630

3038

1.21

4.85

2.9

3.0

25.78

25.46

mmol/l

1.68

613

2954

Other abnormal uterine and vaginal bleeding

473

2725

1.25

4.85

3.1

3.0

26.02

25.47

mmol/l

2.77

461

2659

Fall on and from stairs and steps

533

4385

1.23

4.81

3.6

3.5

25.04

25.20

mmol/l

0.48

514

4251

Stenosis and insufficiency of lacrimal passages

207

1511

1.39

4.79

3.7

3.1

25.61

25.37

mmol/l

0.46

201

1462

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1416

9916

1.13

4.77

3.9

3.4

25.06

25.24

mmol/l

1.33

1374

9638

Drug-induced systemic lupus erythematosus

2.85

4.74

2.2

3.7

25.90

24.85

mmol/l

0.83

Intentional self-harm by smoke, fire and flames

5.43

4.70

6.3

4.7

25.01

24.59

mmol/l

—

Bulimia nervosa (incl. atypical)

232

2.01

4.68

3.7

2.8

25.34

24.89

mmol/l

0.40

223

Brachial plexus disorders

152

1054

1.46

4.67

3.3

3.2

25.26

25.22

mmol/l

0.05

140

1019

Impotence

130

878

1.51

4.66

6.1

3.8

24.87

24.90

mmol/l

0.02

121

854

Syndrome of inappropriate secretion of antidiuretic hormone

2.92

4.62

4.9

3.0

25.37

24.97

mmol/l

0.25

Conotruncal defects

148

2.32

4.61

6.8

7.3

24.89

24.60

mmol/l

0.25

143

Injury of unspecified body region

160

1126

1.45

4.60

4.9

3.3

25.44

25.23

mmol/l

0.31

154

1092

Benign lipomatous neoplasm of other sites/unspecified

196

1429

1.39

4.59

3.6

2.9

25.66

25.31

mmol/l

0.68

189

1385

Other and unspecified urticaria

347

2737

1.28

4.59

3.7

3.4

25.50

25.24

mmol/l

0.73

341

2647

Injury of eye and orbit

261

1985

1.33

4.57

4.5

3.6

25.23

25.21

mmol/l

0.03

255

1921

Intentional self-harm by jumping from a high place

3.45

4.57

3.2

3.9

25.97

24.32

mmol/l

1.24

Malignant neoplasm of respiratory system and intrathoracic organs

364

4193

0.79

4.56

3.8

3.6

25.91

25.03

mmol/l

4.79

353

4054

Need for immunization against other single viral diseases

272

1.94

4.53

36.1

3.4

23.59

25.05

mmol/l

2.89

267

Occupational exposure to risk-factors

487

1.69

4.53

3.7

3.5

25.80

25.10

mmol/l

0.88

471

Thyrotoxicosis with diffuse goitre

238

1791

1.34

4.49

3.4

3.1

25.65

25.42

mmol/l

0.51

227

1742

Abnormal findings on diagnostic imaging of breast

177

2.18

4.46

4.0

2.5

25.60

25.36

mmol/l

0.15

172

Autoimmune polyglandular failure

10.23

4.45

8.1

8.6

24.00

23.26

mmol/l

—

Female genital prolapse

610

2936

1.21

4.45

2.8

3.0

25.44

25.49

mmol/l

0.14

591

2860

Hidradenitis suppurativa

345

1.80

4.43

5.0

3.3

25.26

25.12

mmol/l

0.12

333

Maternal care for other conditions predominantly related to pregnancy

243

1812

1.33

4.41

2.7

3.0

25.19

25.34

mmol/l

0.31

233

1751

Crowding of teeth, including avohilmo

127

708

1.49

4.35

7.9

3.7

24.57

24.80

mmol/l

0.30

120

681

Burn and corrosion of hip and lower limb, except ankle and foot

291

1.87

4.30

6.0

3.7

25.13

25.09

mmol/l

0.04

282

L02BB Anti-androgens

237

1802

1.34

4.29

3.6

3.7

25.09

24.89

mmol/l

0.29

231

1739

Sequelae of injuries of lower limb

178

1292

1.40

4.29

3.6

3.5

25.46

25.34

mmol/l

0.20

171

1253

UC patients in KELA-register (code 208), prior to 1994

101

659

1.57

4.29

3.4

24.73

25.21

mmol/l

0.49

637

Malignant otitis externa

5.00

4.27

5.2

2.7

23.45

24.89

mmol/l

—

Other abnormalities of plasma proteins

215

2.04

4.25

4.8

3.2

24.76

25.18

mmol/l

0.38

207

Magnesium deficiency

3.90

4.21

6.2

4.7

27.07

24.61

mmol/l

1.28

Vasculitis limited to skin, not elsewhere classified

360

1.77

4.20

5.4

3.1

25.33

25.16

mmol/l

0.15

353

Secondary systemic amyloidosis

3.87

4.20

10.6

2.5

24.00

24.71

mmol/l

0.27

Other specified/unspecified systemic involvement of connective tissue

113

758

1.52

4.19

3.7

2.9

25.89

25.44

mmol/l

0.61

108

738

Other or unspecified common variable immunodeficiency

3.64

4.19

2.7

3.4

25.16

24.92

mmol/l

0.10

In situ neoplasms

747

6117

1.17

4.19

4.2

3.2

25.11

25.36

mmol/l

1.30

728

5920

Other and unspecified vasculitis limited to skin

331

1.81

4.18

5.4

3.1

25.21

25.11

mmol/l

0.08

326

Malignant neoplasm of bronchus and lung

309

3645

0.78

4.18

3.9

3.5

25.98

25.03

mmol/l

4.51

303

3528

Lateral epicondylitis

237

1804

1.33

4.17

3.1

3.2

25.49

25.28

mmol/l

0.45

230

1753

Other peripheral vertigo

202

1506

1.36

4.16

3.5

3.1

25.46

25.38

mmol/l

0.11

195

1456

Malignant neoplasm of skin

1576

10678

1.12

4.16

3.8

3.4

25.08

25.25

mmol/l

1.26

1531

10376

Injury of heart

4.45

4.15

3.3

24.38

23.79

mmol/l

0.30

Hypersensitivity angiitis

2.80

4.15

14.7

3.9

24.57

24.96

mmol/l

0.19

Artificial joint operation, meniscal resection

2284

13914

1.10

4.14

3.4

3.5

25.32

25.25

mmol/l

0.41

2222

13501

Other disorders of the musculoskeletal system and connective tissue

303

2388

1.28

4.13

3.0

3.5

25.41

25.24

mmol/l

0.35

288

2315

ILD medications: acetylcysteine

117

2.41

4.12

3.7

2.8

25.00

25.02

mmol/l

0.01

112

Abnormalities of gait and mobility

269

2091

1.30

4.12

4.3

3.5

25.44

25.10

mmol/l

0.89

260

2026

Other rupture of muscle

2.83

4.11

6.0

3.1

25.42

24.57

mmol/l

0.52

Methotrexate

283

2214

1.29

4.07

3.8

3.0

25.01

25.27

mmol/l

0.67

275

2146

Spondylopathies in diseases classified elsewhere

164

2.17

4.05

8.5

3.3

25.93

25.19

mmol/l

0.52

158

Benign neoplasm of meninges

205

1538

1.35

4.05

3.9

2.9

25.18

25.39

mmol/l

0.43

200

1491

Dental caries 1, only avohilmo

1928

10841

0.91

4.04

3.6

3.5

25.02

25.29

mmol/l

2.99

1859

10536

Deep endometriosis

172

1255

1.39

4.04

3.2

2.9

25.60

25.47

mmol/l

0.25

166

1223

Injury of muscle and tendon at shoulder and upper arm level

808

7011

1.16

4.00

3.5

25.10

25.19

mmol/l

0.34

786

6809

Abnormal findings in secretions and smears from cervix uteri vagina vulva

550

5137

0.84

4.00

2.8

3.0

25.30

25.38

mmol/l

0.23

526

4986

Flat foot [pes planus] (acquired)

185

1370

1.37

3.97

3.3

3.1

25.65

25.31

mmol/l

0.65

180

1333

Leiomyoma of uterus

846

4125

1.16

3.96

3.0

2.9

25.55

mmol/l

0.01

825

3993

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

239

1836

1.31

3.94

3.3

3.0

25.44

25.28

mmol/l

0.34

233

1776

Congenital malformation of biliary tract

3.90

3.91

11.9

9.1

24.84

24.59

mmol/l

0.06

Ulcerative colitis (strict definition, all Crohn cases excluded)

265

2068

1.29

3.90

3.8

3.5

24.78

25.21

mmol/l

1.13

255

1997

Victim of lightning

13.92

3.90

5.5

1.2

24.47

24.92

mmol/l

—

Hereditary hypogammaglobulinemia

3.60

3.88

3.7

3.3

25.78

24.97

mmol/l

0.41

MS-disease / Multiple Sclerosis

120

828

1.47

3.87

3.3

26.00

25.24

mmol/l

2.09

112

799

Inflammatory diseases of prostate (prostatitis)

301

2394

1.27

3.85

3.5

25.13

24.97

mmol/l

0.37

287

2323

Myopia

194

1454

1.35

3.83

5.2

3.4

25.26

25.20

mmol/l

0.10

187

1398

Specific developmental disorder of motor function

144

2.17

3.82

5.1

7.7

24.18

24.24

mmol/l

0.04

135

Renal agenesis and other reduction defects of kidney

2.98

3.81

10.9

3.5

23.48

24.42

mmol/l

0.53

Alzheimer’s disease, wide definition

464

4645

0.83

3.81

2.6

3.4

25.21

25.09

mmol/l

0.32

448

4517

Food allergy

4.32

3.79

4.3

2.4

24.57

23.82

mmol/l

—

Demyelinating diseases of the central nervous system

142

1015

1.42

3.79

3.3

3.2

25.85

25.31

mmol/l

1.27

134

981

Alzheimer’s disease (Atypical or mixed)

244

1893

1.31

3.78

2.9

3.3

25.40

24.98

mmol/l

1.25

231

1837

Selective deficiency of immunoglobulin M [IgM]

13.76

3.78

10.8

12.2

25.25

26.12

mmol/l

—

Dental caries 3, only avohilmo

2015

11265

0.91

3.76

3.5

25.02

25.28

mmol/l

2.88

1943

10954

Degeneration of nervous system due to alcohol

358

1.73

3.75

4.6

3.3

24.46

24.81

mmol/l

0.35

346

Abrasion of teeth

375

3372

0.81

3.75

2.9

3.2

25.52

25.27

mmol/l

0.78

360

3275

Motor disorders

148

2.15

3.72

5.1

8.1

24.18

24.30

mmol/l

0.08

140

Transepidermal elimination disorders

6.16

3.70

9.4

2.8

26.26

24.97

mmol/l

—

Postmenopausal bleeding

587

2730

1.19

3.69

3.4

3.0

25.53

mmol/l

0.00

571

2666

Other (seronegative) rheumatoid arthritis, wide

403

3323

1.22

3.69

3.7

3.3

25.25

mmol/l

0.01

392

3231

Spontaneous rupture of synovium and tendon

170

1261

1.37

3.66

4.0

3.4

25.44

25.31

mmol/l

0.18

161

1223

Varicose veins

1521

10407

1.11

3.62

3.4

3.3

25.39

25.26

mmol/l

0.76

1476

10105

Degeneration of the brain due to alcohol

362

1.71

3.62

4.6

3.4

24.46

24.92

mmol/l

0.50

349

Alzheimer’s disease (Late onset)

423

4351

0.83

3.61

2.6

3.4

25.23

25.07

mmol/l

0.44

408

4232

Giant cell arteritis

101

688

1.50

3.59

4.7

3.1

25.43

25.23

mmol/l

0.28

667

Vasomotor and allergic rhinitis

690

5882

1.16

3.55

3.1

3.6

25.48

25.18

mmol/l

1.70

667

5699

Human immunodeficiency virus [HIV] disease resulting in other conditions

212

0.28

3.55

2.7

3.2

24.90

24.72

mmol/l

—

207

Peritonsillar abscess

373

3062

1.23

3.54

3.2

3.6

24.99

25.11

mmol/l

0.30

364

2955

Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle]

11.02

3.48

7.5

3.0

26.08

24.06

mmol/l

—

Other obstetric conditions, not elsewhere classified

351

1851

1.24

3.47

2.8

2.9

24.52

25.18

mmol/l

3.62

337

1780

Other diseases of upper respiratory tract

2853

13834

1.08

3.47

3.5

25.28

25.19

mmol/l

0.77

2765

13405

Excessive and redundant skin and subcutaneous tissue

10.12

3.41

1.8

2.3

26.48

25.63

mmol/l

—

Other female pelvic inflammatory diseases

273

2180

1.26

3.39

3.5

2.8

25.54

25.50

mmol/l

0.09

262

2122

Allergic urticaria

140

1020

1.39

3.38

3.4

25.01

25.24

mmol/l

0.40

135

984

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

205

1.93

3.37

3.6

2.5

25.53

25.64

mmol/l

0.08

196

Malignant neoplasm of pancreas

147

1085

1.38

3.34

3.5

3.1

24.30

25.09

mmol/l

2.09

140

1051

Allergic rhinitis

498

4183

1.18

3.33

3.2

3.6

25.50

25.18

mmol/l

1.46

481

4046

Other/unspecified rheumatoid arthritis

273

2188

1.26

3.33

4.1

3.2

25.14

25.32

mmol/l

0.33

266

2122

Papillary adenocarcinoma of thyroid gland

674

1.48

3.31

3.2

26.07

25.45

mmol/l

0.91

653

Other osteochondropathies

131

949

1.40

3.30

3.0

3.6

24.55

25.21

mmol/l

1.24

122

914

Hypertrophy of breast in women and men

306

2482

1.24

3.30

3.5

3.1

25.25

25.38

mmol/l

0.33

293

2396

Melanoma in situ

681

0.56

3.25

3.6

3.2

25.47

25.31

mmol/l

0.15

661

Non-Hodgkin lymphoma, all

687

1.47

3.24

3.9

3.2

24.99

mmol/l

0.01

668

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

228

1796

1.29

3.24

3.6

3.1

24.45

25.18

mmol/l

1.92

217

1731

Acute appendicitis, with complications

403

3370

1.20

3.23

3.5

3.6

25.13

25.18

mmol/l

0.11

389

3258

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

3.36

3.21

16.4

2.9

24.48

24.62

mmol/l

0.05

Other disorders of eye and adnexa

249

1983

1.27

3.20

4.0

3.3

25.40

25.25

mmol/l

0.31

239

1913

Female infertility, associated with anovulation

538

1.52

3.19

3.4

2.9

24.33

24.91

mmol/l

1.10

510

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

3.31

3.19

9.7

3.1

25.13

24.79

mmol/l

0.13

Use of levodopa decarbox-comt-inhibitor

559

1.52

3.18

3.8

3.3

25.64

25.24

mmol/l

0.62

539

Supervision of normal pregnancy

173

1302

0.76

3.18

2.3

3.0

25.61

25.18

mmol/l

1.15

167

1258

Faecal incontinence

163

1231

1.34

3.16

3.6

2.9

25.36

25.40

mmol/l

0.05

156

1199

Enteropathogenic Escherichia coli infection

3.50

3.16

5.6

3.8

23.64

24.31

mmol/l

0.26

Idiopathic progressive neuropathy

4.92

3.16

3.9

4.1

26.96

23.20

mmol/l

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

3.78

3.15

2.5

2.8

24.74

24.42

mmol/l

—

Salpingitis and oophoritis

293

2381

1.24

3.13

3.6

2.9

25.59

25.53

mmol/l

0.13

285

2322

Other specified and unspecified disorders of eye and adnexa

546

0.52

3.11

2.7

3.3

25.69

25.05

mmol/l

0.56

527

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

1141

7083

1.12

3.11

3.9

3.3

25.07

25.36

mmol/l

2.35

1110

6869

Autoimmune hepatitis

2.45

3.06

5.5

2.9

24.77

24.98

mmol/l

0.14

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

336

1790

1.22

3.05

2.8

2.9

24.50

25.17

mmol/l

3.48

323

1720

Fenamates

268

2232

0.80

3.02

3.4

4.1

25.55

25.00

mmol/l

2.17

260

2164

Rapidly progressive nephritic syndrome

3.67

3.02

7.5

5.2

24.53

24.44

mmol/l

—

Other peripheral vascular diseases

151

1138

1.34

3.00

4.4

2.8

25.13

25.35

mmol/l

0.25

146

1103

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

255

2056

1.25

2.98

4.4

3.4

25.23

25.36

mmol/l

0.23

250

1988

Posteruptive colour changes of dental hard tissues

8.54

2.98

21.8

2.1

24.62

23.21

mmol/l

—

Factitial dermatitis

2.64

2.96

7.8

2.3

25.19

24.22

mmol/l

0.80

Tooth eruption problems

176

1341

1.31

2.96

4.8

3.8

24.79

24.96

mmol/l

0.28

168

1294

Benign neoplasm of meninges

205

1615

1.28

2.94

3.9

3.1

25.18

25.48

mmol/l

0.68

200

1569

Benign lipomatous neoplasm of other sites/unspecified

196

1536

1.29

2.94

3.6

3.3

25.66

25.32

mmol/l

0.66

189

1491

Multiple sites

8.00

2.93

6.5

6.3

25.00

25.16

mmol/l

—

Colonic or urogenital fistula

550

4765

1.16

2.90

3.4

3.6

25.53

25.18

mmol/l

1.59

530

4615

Other diseases of hard tissues of teeth

1388

9442

1.10

2.90

4.9

3.2

25.14

25.25

mmol/l

0.57

1344

9174

Benign neoplasm: Pituitary gland, craniopharyngeal duct

643

1.45

2.90

3.2

2.9

24.69

25.38

mmol/l

1.36

620

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

230

1.78

2.89

4.7

3.0

23.91

25.17

mmol/l

1.59

221

Ulcerative rectosigmoiditis

146

1101

1.34

2.89

4.8

3.3

25.04

25.36

mmol/l

0.49

140

1066

Meniscus derangement

1311

8163

1.10

2.88

3.3

3.2

25.44

25.24

mmol/l

1.49

1270

7932

Vascular dementia (mixed)

254

1.75

2.88

2.2

3.1

26.66

24.92

mmol/l

2.54

245

Endometriosis ASRM stages 3,4

376

3161

1.20

2.87

3.1

3.0

25.56

25.43

mmol/l

0.36

365

3066

Drug phototoxic response

7.22

2.85

1.2

6.2

25.88

24.52

mmol/l

—

Other disorders of the genitourinary system

251

2036

1.25

2.81

4.2

3.1

25.31

25.44

mmol/l

0.26

244

1983

Disorders of optic nerve, not elsewhere classified

318

1.65

2.78

4.5

3.3

24.81

25.08

mmol/l

0.18

310

3.17

2.77

17.5

3.5

23.49

24.25

mmol/l

0.39

Glycosuria

6.48

2.76

3.0

1.6

25.13

24.17

mmol/l

—

Tonsillectomy and adenotomy

934

5831

1.12

2.75

3.5

3.7

25.18

25.20

mmol/l

0.06

903

5619

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

218

1747

1.26

2.74

3.6

3.1

24.43

25.18

mmol/l

1.88

207

1682

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

1147

7157

1.11

2.74

3.9

3.3

25.09

25.36

mmol/l

2.17

1116

6942

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

295

1.66

2.74

4.9

2.9

25.60

25.53

mmol/l

0.05

285

Juvenile rheumatoid arthirtis

204

1.80

2.73

6.2

3.5

24.14

25.15

mmol/l

0.68

198

Vestibular neuronitis

178

1395

1.29

2.70

3.6

3.4

25.26

25.31

mmol/l

0.07

171

1348

Chorioretinal inflammation

359

1.59

2.70

3.3

3.1

24.48

25.31

mmol/l

0.96

351

Polyglandular dysfunction

3.89

2.66

7.9

5.5

23.22

24.62

mmol/l

—

Benign neoplasm: Liver/bile ducts (ICD-9)

8.14

2.64

2.6

1.9

24.66

26.24

mmol/l

—

Unspecified urinary incontinence

171

1338

1.29

2.63

3.6

2.8

25.67

25.46

mmol/l

0.28

163

1301

Nanophthalmos, microphthalmos and macrophthalmos

6.73

2.63

5.3

2.8

24.92

23.48

mmol/l

—

Nasal polyp

415

3553

1.18

2.62

3.4

3.6

25.41

25.07

mmol/l

1.44

403

3437

Other and unspecified corneal deformities and disorders

410

1.54

2.61

3.4

3.1

25.17

25.43

mmol/l

0.23

399

Single spontaneous delivery

629

3808

0.88

2.61

2.6

3.3

25.58

25.40

mmol/l

0.66

608

3717

Q fever

8.91

2.60

3.4

7.9

26.34

23.76

mmol/l

—

Digeorge syndrome

6.41

2.59

3.5

8.2

26.22

24.19

mmol/l

—

Orthopaedic devices associated with adverse incidents

286

0.41

2.59

3.3

3.2

24.94

25.44

mmol/l

0.22

278

Benign neoplasm of urinary organs

684

1.41

2.59

4.9

2.7

25.36

25.23

mmol/l

0.14

662

Other specified/unspecified hearing loss

172

1351

1.29

2.58

5.2

3.5

25.29

mmol/l

0.00

163

1305

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

545

4769

1.15

2.56

3.6

3.3

25.10

25.28

mmol/l

0.57

528

4626

Other and unspecified acne

115

2.05

2.55

7.0

2.9

25.06

24.82

mmol/l

0.17

109

Maternal care related to the fetus and amniotic cavity and possible delivery problems

476

3241

0.86

2.54

2.8

3.1

25.30

25.34

mmol/l

0.11

465

3133

Oter anti-inflammatory and antirheumatic agents, non-steroids

668

3272

1.14

2.54

3.2

4.0

25.08

24.97

mmol/l

0.31

649

3174

Melanoma in situ

633

0.60

2.52

3.6

2.7

25.47

25.20

mmol/l

0.29

610

Ganglion

354

3000

1.19

2.51

3.6

3.2

25.28

25.24

mmol/l

0.09

338

2916

Bacterial agents resistant to antibiotics

4.92

2.51

4.6

3.0

27.99

25.60

mmol/l

—

Palmar fascial fibromatosis [Dupuytren]

367

3125

1.18

2.51

3.5

3.4

25.01

25.09

mmol/l

0.18

356

3028

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

108

801

1.37

2.49

3.9

3.3

23.70

25.09

mmol/l

3.14

103

776

Benign mammary dysplasia

266

2202

1.22

2.48

3.9

3.0

25.56

25.47

mmol/l

0.19

259

2144

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

795

4645

1.12

2.47

2.8

3.0

25.72

25.66

mmol/l

0.21

777

4508

Toxic effect of other noxious substances eaten as food

3.09

2.47

2.4

3.6

23.80

23.93

mmol/l

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

795

4647

1.12

2.46

2.8

3.0

25.72

25.66

mmol/l

0.21

777

4510

Donors of organs and tissues

131

1.96

2.45

2.7

25.83

24.78

mmol/l

1.15

126

Basal cell carcinoma

1389

10199

1.09

2.43

3.7

3.4

25.05

25.24

mmol/l

1.41

1350

9911

Contact with machinery

224

1828

1.24

2.43

4.1

3.6

24.59

25.08

mmol/l

1.33

217

1766

Use of donepezil

499

4195

1.15

2.42

2.9

3.4

25.62

25.14

mmol/l

2.70

485

4074

Other congenital musculoskeletal deformities

3.82

2.41

5.9

4.4

27.11

23.69

mmol/l

—

Embedded teeth, including avohilmo

117

880

1.34

2.40

4.1

3.5

25.04

mmol/l

0.00

111

849

Atopic dermatitis, strict definition with reimbursement

451

3790

1.16

2.40

3.5

25.04

25.15

mmol/l

0.32

437

3651

Need for immunization against other single infectious diseases

5.43

2.40

16.3

3.0

25.02

23.62

mmol/l

—

Myeloproliferative diseases

180

1438

1.27

2.39

3.2

24.67

25.31

mmol/l

1.64

172

1390

Certain conditions originating in the perinatal period

112

741

1.35

2.38

6.2

4.0

24.93

24.75

mmol/l

0.25

107

713

Lichen planus, including avohilmo

350

2982

1.18

2.38

3.7

3.4

25.38

25.28

mmol/l

0.21

341

2897

Other/unspecified seropositive rheumatoid arthritis

553

4872

1.14

2.37

3.7

3.4

25.14

25.28

mmol/l

0.42

536

4726

Other and unspecified rosacea

150

1172

1.29

2.37

4.6

3.2

24.68

25.39

mmol/l

1.81

143

1136

Hereditary nephropathy, not elsewhere classified

2.90

2.37

6.5

2.5

25.08

24.63

mmol/l

0.23

Exposure to other specified factors

1551

13486

1.08

2.35

3.9

3.5

25.19

25.21

mmol/l

0.10

1494

13075

Bullous pemphigoid

357

1.55

2.35

3.5

3.3

25.79

25.19

mmol/l

0.64

345

Bullous disorders

124

947

1.33

2.35

4.2

3.3

25.54

25.21

mmol/l

0.54

124

917

Malignant neoplasm of rectum

211

1719

1.24

2.35

3.4

24.60

25.12

mmol/l

1.10

200

1669

Endometriosis

616

3237

1.14

2.35

3.0

25.48

25.37

mmol/l

0.35

599

3144

Urethral stricture

130

1000

1.32

2.34

4.9

3.3

25.08

24.97

mmol/l

0.09

125

970

Testicular dysfunction

454

1.48

2.33

3.9

4.1

25.94

25.03

mmol/l

1.34

439

Pemphigoid

439

1.49

2.33

3.5

3.2

25.76

25.24

mmol/l

0.56

423

Seropositive rheumatoid arthritis, wide

559

4937

1.14

2.32

3.7

3.4

25.16

25.27

mmol/l

0.29

542

4791

Tracheo-bronchomalasia

4.74

2.29

4.2

1.2

25.73

26.69

mmol/l

—

Drug-induced dystonia

3.29

2.28

4.1

2.6

25.21

23.84

mmol/l

—

Unspecific neurodegenerative disorder

1048

6600

1.10

2.26

2.8

3.5

25.34

25.10

mmol/l

1.53

1012

6420

Basal cell carcinoma, including avohilmo

1416

10320

1.08

2.26

3.7

3.4

25.06

25.25

mmol/l

1.45

1377

10029

Personal history of other diseases and conditions

146

1138

1.29

2.26

7.6

2.6

24.98

25.05

mmol/l

0.09

141

1096

Delivery

643

3821

0.89

2.24

2.7

3.3

25.54

25.40

mmol/l

0.47

622

3728

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

217

1784

1.23

2.23

3.2

3.5

24.41

25.13

mmol/l

1.76

206

1730

Systemic atrophies primarily affecting the central nervous system

647

1.38

2.18

3.9

3.3

26.03

25.13

mmol/l

1.25

623

Postmenopausal atrophic vaginitis

496

2618

1.15

2.17

3.2

3.1

25.64

25.53

mmol/l

0.35

482

2558

Postviral fatigue syndrome

2.43

2.15

4.8

3.7

25.82

24.68

mmol/l

0.87

Sexual assault by bodily force

3.40

2.15

5.8

2.7

25.18

24.56

mmol/l

—

Aphakia

205

1.69

2.15

7.1

3.0

26.00

25.04

mmol/l

0.64

197

Hereditary angioödema type 1

5.60

2.14

1.6

3.0

24.00

23.51

mmol/l

—

Bilateral sagittal split ramus osteotomy operation

323

1.54

2.14

2.6

3.2

25.25

25.42

mmol/l

0.17

311

Enthesopathies of lower limb, excluding foot

380

3289

1.16

2.13

4.6

3.3

25.51

25.16

mmol/l

1.27

368

3198

Human immunodeficiency virus [HIV] disease

236

0.42

2.12

2.7

3.2

25.02

24.77

mmol/l

—

231

Benign neoplasm of urinary organs

711

1.36

2.10

4.9

3.2

25.36

25.29

mmol/l

0.08

688

Labyrinthitis

2.56

2.10

7.6

3.1

24.24

24.77

mmol/l

0.21

Other and unspecified hypertrophic disorders of skin

2.26

2.09

2.0

2.7

23.40

24.34

mmol/l

0.78

Endometriosis of pelvic peritoneum

218

1779

1.22

2.09

2.5

3.0

25.57

25.32

mmol/l

0.54

212

1723

Other bullous disorders

400

1.48

2.07

4.4

3.5

25.23

25.18

mmol/l

0.05

387

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

2.64

2.07

7.2

2.8

25.45

24.90

mmol/l

0.29

Subacute thyroiditis

466

1.44

2.07

3.2

3.1

25.34

25.41

mmol/l

0.08

453

Other specified/unspecified disorders of middle ear and mastoid

3.03

2.07

3.7

5.1

24.01

24.32

mmol/l

—

Familial erythrocytosis

2.33

2.07

3.4

3.0

24.70

24.99

mmol/l

0.14

Uterine polyps

160

1284

1.26

2.06

2.6

3.0

26.08

25.41

mmol/l

1.96

154

1253

Fall on and from ladder

164

1322

1.26

2.06

3.6

3.7

25.38

25.07

mmol/l

0.57

158

1279

Lichen ruber planus, wide definition including periferal and oral lichen planus

399

3478

1.15

2.06

3.6

3.4

25.35

25.31

mmol/l

0.09

388

3386

Alzheimer’s disease, wide definition, excluding more controls

350

2047

1.17

2.06

2.7

3.1

25.25

24.91

mmol/l

1.18

343

1993

Need for other prophylactic measures

803

0.69

2.05

3.5

3.4

24.22

25.24

mmol/l

0.87

778

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

595

1.39

2.04

3.1

2.9

25.64

25.06

mmol/l

0.85

572

Malignant neoplasm of testis

209

1.66

2.02

4.2

3.7

23.71

25.01

mmol/l

1.56

200

Recurrent dislocation of patella

443

1.43

2.00

3.7

3.1

25.02

25.12

mmol/l

0.08

429

Drug-induced autoimmune haemolytic anaemia

4.12

2.00

4.3

2.9

25.42

24.83

mmol/l

—

Foreign body on external eye

274

2327

1.19

2.00

3.7

3.8

25.05

25.16

mmol/l

0.21

263

2251

Toxic colitis

2.60

2.00

6.8

4.3

24.31

24.50

mmol/l

0.09

Melanocytic naevi of upper limb, including shoulder

289

1.55

1.99

3.2

2.9

24.88

25.46

mmol/l

0.54

281

Rash and other nonspecific skin eruption

179

1462

1.23

1.99

4.6

3.2

25.20

25.32

mmol/l

0.21

174

1417

Complications of anaesthesia during pregnancy

4.76

1.97

2.4

2.7

24.10

23.35

mmol/l

—

LeFortI or BSSRO operation

387

1.46

1.97

2.6

3.3

25.54

25.39

mmol/l

0.14

373

Benign neoplasm: Pituitary gland, craniopharyngeal duct

694

1.34

1.95

3.2

3.3

24.69

25.23

mmol/l

0.95

666

Melanocytic naevi of upper limb, including shoulder

291

1.54

1.94

3.2

3.1

24.88

25.11

mmol/l

0.17

282

Hyperchylomicronaemia

3.09

1.93

5.1

2.6

25.88

25.15

mmol/l

—

Hallux valgus (acquired)

702

4593

1.11

1.92

3.1

3.2

25.37

25.34

mmol/l

0.08

675

4470

Dental pulpitis 2, only avohilmo

1781

9713

0.94

1.91

3.6

3.4

25.08

25.30

mmol/l

1.80

1719

9440

Other inflammation of eyelid

236

1989

1.20

1.90

4.1

3.3

25.22

25.26

mmol/l

0.08

227

1921

N06DA Anticholinesterases

815

6020

1.10

1.90

2.7

3.4

25.46

25.11

mmol/l

2.39

790

5844

Use of anticholinesterases

815

6020

1.10

1.90

2.7

3.4

25.46

25.11

mmol/l

2.39

790

5844

Radial styloid tenosynovitis [de Quervain]

636

1.35

1.89

2.5

2.9

25.60

25.37

mmol/l

0.24

622

Other maltreatment syndromes

325

1.50

1.88

3.3

3.7

25.03

25.13

mmol/l

0.07

314

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

138

1104

1.26

1.87

3.7

2.9

25.29

25.36

mmol/l

0.08

133

1062

Other enthesopathy of foot (+metatarsalgia)

166

1355

1.23

1.87

3.7

3.2

25.69

25.29

mmol/l

1.05

159

1316

Isolated patent ductus arteriosus

3.68

1.86

2.3

2.8

27.43

24.46

mmol/l

—

Glaucoma-related operations

1005

0.74

1.86

3.4

3.2

24.96

25.26

mmol/l

0.20

974

Metatarsalgia

157

1275

1.24

1.86

3.7

3.2

25.69

25.28

mmol/l

1.02

152

1236

Exposure to other and unspecified inanimate mechanical forces

114

892

1.29

1.86

3.6

3.5

25.28

25.20

mmol/l

0.08

108

860

Other acquired deformities of musculoskeletal system and connective tissue

674

1.34

1.85

2.9

3.4

25.24

25.17

mmol/l

0.08

649

Hypertrichosis

160

1.71

1.83

3.2

2.8

25.44

25.37

mmol/l

0.04

155

Acquired atrophy of ovary and fallopian tube

2.90

1.83

2.9

2.1

27.63

24.57

mmol/l

—

Atopic dermatitis

789

7368

0.91

1.83

3.3

3.5

25.18

25.21

mmol/l

0.09

765

7118

Disorders of breast

831

7048

1.10

1.83

3.5

3.0

25.49

25.48

mmol/l

0.04

809

6847

Haemophagocytic lymphohistiocytosis

3.67

1.81

15.3

3.7

25.67

24.54

mmol/l

—

Excessive attrition of teeth

766

3781

1.10

1.80

4.3

3.2

25.00

25.23

mmol/l

1.09

743

3665

Diseases of external ear

674

6119

1.11

1.80

4.2

3.6

25.03

25.15

mmol/l

0.41

655

5934

Ménière disease

196

1636

1.21

1.79

3.3

3.1

25.63

25.36

mmol/l

0.51

190

1584

Benign neoplasm: Penis

2.88

1.79

1.8

3.9

26.54

24.58

mmol/l

—

Intracranial injury with prolonged coma

4.36

1.79

2.6

2.2

25.40

23.96

mmol/l

—

Other nonautoimmune haemolytic anaemias

3.18

1.78

4.6

3.2

21.10

24.02

mmol/l

—

Carcinoma in situ of skin

174

1438

1.22

1.78

4.7

3.0

25.06

25.27

mmol/l

0.39

169

1389

Benign neoplasm: Liver/bile ducts (ICD-9)

4.33

1.78

2.6

3.4

24.66

25.76

mmol/l

—

Myeloproliferative diseases (CML excluded)

159

1302

1.23

1.78

3.2

24.64

25.30

mmol/l

1.49

151

1260

Patellar tendinitis

155

1.70

1.75

4.5

3.7

24.15

25.13

mmol/l

0.78

148

Other disorders of veins

648

7127

0.91

1.75

3.7

3.2

25.60

25.30

mmol/l

1.38

638

6922

Adenocarcinoma and papilloma adenocarcinoma of rectum

204

1715

1.20

1.74

3.2

3.5

24.39

25.15

mmol/l

1.81

193

1662

Premature rupture of membranes

174

1542

0.83

1.70

2.1

3.1

25.26

25.20

mmol/l

0.09

167

1481

Other acute skin changes due to ultraviolet radiation

529

1.36

1.68

2.6

3.3

25.57

25.21

mmol/l

0.42

512

Myeloid leukaemia

385

1.43

1.68

3.3

3.1

24.64

25.43

mmol/l

0.97

369

Pleural plaque

238

2037

1.18

1.67

3.5

3.4

25.83

24.70

mmol/l

4.39

227

1971

Ankyloglossia

134

1.74

1.66

3.3

7.3

23.57

24.37

mmol/l

0.48

127

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

2.22

1.65

3.9

2.9

23.78

24.72

mmol/l

0.40

Crohn's disease (strict) with PSC

3.79

1.65

11.2

4.6

23.18

24.48

mmol/l

—

Other disorders of skin and subcutaneous tissue related to radiation

2.91

1.64

2.6

3.1

26.51

25.01

mmol/l

—

Testicular hypofunction

395

1.41

1.63

4.1

25.82

24.99

mmol/l

0.98

382

HSIL lesion of the vulva

214

1.57

1.63

3.5

2.8

25.28

25.46

mmol/l

0.13

209

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

190

1.61

1.63

5.1

3.9

25.06

24.68

mmol/l

0.22

181

D07AA Corticosteroids, weak (group I)

244

2091

1.17

1.63

3.3

3.7

24.97

25.14

mmol/l

0.33

237

2021

L02BA Anti-estrogens

204

2404

0.84

1.63

2.8

3.0

26.13

25.45

mmol/l

2.18

198

2343

therapeutic use

448

0.64

1.62

5.6

2.9

25.07

25.21

mmol/l

0.09

437

Cytomegaloviral hepatitis

2.82

1.61

3.0

2.8

25.87

25.44

mmol/l

—

Viral agents as the cause of diseases classified to other chapters

280

1.49

1.60

4.5

3.8

24.51

25.18

mmol/l

0.76

275

Disorder of external ear, unspecified

448

1.38

1.60

6.1

3.3

24.59

25.26

mmol/l

0.97

437

Benign neoplasm: Heart

2.39

1.58

7.9

3.3

28.33

24.26

mmol/l

—

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

3.66

1.57

4.4

3.4

25.48

23.62

mmol/l

—

Nephropathy induced by other drugs, medicaments and biological substances

2.80

1.57

25.3

4.5

24.63

23.81

mmol/l

—

Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)

2.29

1.56

4.9

2.1

24.51

25.45

mmol/l

0.62

Hallux rigidus

209

2448

0.85

1.56

2.7

3.3

25.65

25.26

mmol/l

1.03

200

2378

Lichen planopilaris

0.00

1.56

0.0

2.0

—

25.27

—

Plantar fascial fibromatosis

159

1321

1.21

1.56

2.4

3.1

25.49

25.31

mmol/l

0.29

153

1286

Opening and dilatation of root channel of tooth

737

1.29

1.55

6.7

3.3

24.68

25.20

mmol/l

0.62

715

Abnormal findings in peritoneal fluid saliva

2.26

1.55

4.3

2.9

27.18

24.77

mmol/l

1.18

Cryoglobulinemia

3.07

1.55

8.5

4.3

23.78

24.64

mmol/l

—

Other bursitis of hip

299

1.47

1.55

3.4

2.9

26.30

25.38

mmol/l

0.64

293

Interstitial emphysema and related conditions originating in the perinatal period

3.53

1.55

36.0

11.8

23.88

23.03

mmol/l

—

Dislocation, sprain and strain of joints and ligaments of elbow

729

1.29

1.54

5.3

3.5

24.66

25.22

mmol/l

0.90

707

Assault by other specified means

1.87

1.54

4.4

4.0

25.85

24.51

mmol/l

1.19

Dislocation, sprain and strain of joints and ligaments of knee

1141

9902

1.07

1.54

3.2

3.4

25.33

25.20

mmol/l

0.71

1099

9609

Primary open-angle glaucoma

752

6747

1.09

1.53

3.7

3.4

25.11

25.24

mmol/l

0.43

722

6563

Dementia in Alzheimer disease

429

3284

1.12

1.53

2.7

3.5

25.31

25.01

mmol/l

1.13

419

3186

Unspecified human immunodeficiency virus [HIV] disease

125

0.39

1.53

3.0

3.6

25.80

25.15

mmol/l

—

120

283

1.47

1.52

3.4

25.83

25.19

mmol/l

0.68

276

Vascular dementia (multiple infarctions)

210

1.55

1.50

4.7

3.1

24.66

24.87

mmol/l

0.11

202

Deformity of finger(s)

1.90

1.50

4.6

3.2

24.95

25.06

mmol/l

0.06

Mantle cell lymphoma

148

1.68

1.50

5.0

3.3

25.34

24.43

mmol/l

1.03

142

Exposure to controlled fire, not in building or structure

2.49

1.49

2.9

4.1

26.08

24.57

mmol/l

—

Benign neoplasm: Liver/bile ducts

276

1.47

1.49

2.8

3.0

25.32

25.41

mmol/l

0.06

267

Pervasive developmental disorders excl. Autism + Asperger

101

1.81

1.49

6.2

8.4

25.63

24.45

mmol/l

1.08

Adenomyosis (Endometriosis of uterus)

167

1983

0.84

1.48

3.0

25.52

25.45

mmol/l

0.11

160

1937

Hypertrophy of breast

229

1973

1.17

1.48

3.0

25.22

25.48

mmol/l

0.64

220

1908

Disorders of parathyroid gland, other and/or unspecified

110

1.79

1.48

4.4

3.0

22.73

25.12

mmol/l

1.16

110

Carcinoma in situ of larynx

2.92

1.47

2.8

2.9

27.63

24.97

mmol/l

—

Toxic erythema

2.89

1.47

2.0

3.6

24.58

24.84

mmol/l

—

Undescended testicle

117

1.74

1.46

4.3

6.9

25.63

24.34

mmol/l

0.79

112

Nightmares

3.27

1.46

1.4

4.6

25.78

24.43

mmol/l

—

Striking against or struck by other objects

581

5298

1.10

1.46

3.7

3.9

25.19

25.13

mmol/l

0.15

563

5113

Carcinoma in situ of other and unspecified genital organs

204

1.55

1.46

3.5

2.6

24.65

25.58

mmol/l

1.09

197

Benign neoplasm: Rectum/anal canal icd-9

141

1.67

1.45

6.1

2.8

24.98

25.71

mmol/l

0.68

136

Benign neoplasm: Heart

2.28

1.44

7.9

2.5

28.33

24.57

mmol/l

—

Chronic laryngitis and laryngotracheitis

196

2289

0.85

1.44

3.8

3.4

25.82

25.21

mmol/l

1.79

185

2214

Other benign neoplasms of connective and other soft tissue

163

1370

1.20

1.44

3.3

3.1

25.11

25.34

mmol/l

0.38

155

1321

Endocrine disorders, other/unspecified

251

0.55

1.43

2.9

3.4

24.14

25.15

mmol/l

0.48

244

Femoral hernia

730

1.28

1.43

4.3

3.1

25.50

25.28

mmol/l

0.23

708

Other, unspecified and serous retinal detachments

458

1.35

1.43

4.1

3.1

25.17

25.28

mmol/l

0.08

443

Chloasma

2.32

1.42

1.8

2.9

25.71

24.35

mmol/l

—

Calcification and ossification of muscle

2.53

1.42

5.1

3.2

22.59

24.16

mmol/l

—

Optic atrophy

263

1.47

1.42

7.4

4.3

25.24

24.91

mmol/l

0.17

256

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

764

4305

1.09

1.41

3.8

3.5

24.92

25.02

mmol/l

0.35

738

4169

Hydrocele

256

2235

1.15

1.41

4.9

3.6

25.04

24.90

mmol/l

0.26

245

2172

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

536

1.32

1.41

3.5

2.9

26.05

25.63

mmol/l

0.63

520

Medical abortion

1023

5957

0.93

1.40

3.0

3.1

25.34

25.45

mmol/l

0.47

992

5782

Presence of other devices

475

4303

1.11

1.39

3.4

3.1

25.20

25.16

mmol/l

0.08

457

4169

FESS (DNB20)

154

1829

0.84

1.39

3.0

3.4

25.54

25.28

mmol/l

0.51

149

1767

Abuse of non-dependence-producing substances

3.16

1.39

7.4

3.4

27.46

24.91

mmol/l

—

Dysplastic lesion of the vulva of unknown severity

3.14

1.39

4.8

2.2

23.58

24.64

mmol/l

—

Benign lipomatous neoplasm of of intra-abdominal organs

2.25

1.38

2.6

3.1

23.33

24.89

mmol/l

—

Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)

2.00

1.38

2.9

3.5

24.72

24.62

mmol/l

0.04

Carcinoma in situ of skin

174

1480

1.19

1.38

4.7

3.3

25.06

25.17

mmol/l

0.18

169

1434

Benign neoplasm of middle ear and respiratory system

146

1222

1.20

1.37

3.9

3.0

25.74

25.21

mmol/l

1.02

141

1177

Other congenital malformations of tongue, mouth and pharynx

127

1.67

1.36

3.9

5.3

23.45

24.36

mmol/l

0.55

122

Disorders of conjunctiva

1530

13514

0.95

1.36

3.8

3.5

25.28

25.25

mmol/l

0.14

1491

13083

Restless leg syndrome

220

1907

1.16

1.35

4.2

3.2

25.44

25.35

mmol/l

0.16

215

1848

Mandibular retrognathia AND surgery (BSSRO)

257

1.46

1.35

2.2

3.3

25.56

25.36

mmol/l

0.18

249

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

541

1.31

1.35

5.6

3.1

25.41

25.45

mmol/l

0.04

522

Other/unspecified disorders of vestibular function

603

1.29

1.35

4.7

3.1

25.81

25.34

mmol/l

0.66

585

In situ neoplasms

747

6922

1.08

1.34

4.2

3.3

25.11

25.25

mmol/l

0.58

728

6702

Benign neoplasm: Other and unspecified parts of mouth

463

1.33

1.34

3.0

2.8

25.08

25.48

mmol/l

0.42

445

Delivery, wide proxy

569

3311

0.91

1.33

2.6

3.3

25.45

25.35

mmol/l

0.27

550

3225

Cyst of spleen

2.64

1.33

10.2

2.9

23.77

23.93

mmol/l

—

Perichondritis of external ear

267

1.45

1.33

4.8

3.2

25.32

25.02

mmol/l

0.26

262

Failure in dosage during surgical and medical care

3.00

1.32

3.6

3.2

24.18

24.98

mmol/l

—

Endometriosis ASRM stages 1,2

225

1956

1.15

1.32

2.6

2.9

25.54

25.43

mmol/l

0.21

219

1886

Injury of nerves at wrist and hand level

455

1.33

1.32

5.5

3.5

25.66

24.98

mmol/l

0.79

443

Myeloid leukaemia

404

1.36

1.31

3.3

3.7

24.64

25.28

mmol/l

0.74

391

Benign neoplasm: Central nervous system, other parts/unspecified

2.18

1.31

4.6

2.7

24.78

24.40

mmol/l

—

Other sideroblastic anaemias

2.17

1.31

5.3

3.1

23.89

24.57

mmol/l

—

Rosacea

183

1569

1.17

1.31

5.0

3.2

24.99

25.35

mmol/l

0.72

176

1509

Torsion of ovary, ovarian pedicle and fallopian tube

193

1.52

1.30

4.1

3.0

25.34

25.51

mmol/l

0.11

187

Parapsoriasis

260

1.45

1.30

3.1

3.2

25.00

25.04

mmol/l

0.03

250

Sequelae of injuries of neck and trunk

396

1.36

1.29

2.0

3.3

26.87

25.07

mmol/l

1.49

383

Convalescence

659

1.27

1.29

6.7

2.6

24.85

25.35

mmol/l

0.50

633

Seropositive rheumatoid arthritis, strict definition

273

2411

1.14

1.29

3.7

3.3

25.42

25.30

mmol/l

0.25

265

2337

Carcinoma in situ of breast, other/unspecified

204

0.53

1.29

2.5

26.01

25.60

mmol/l

0.19

199

Dental caries 3 and operation codes

2192

11758

0.95

1.29

3.9

3.4

25.10

25.26

mmol/l

1.32

2115

11433

Disorders of eyelid in diseases classified elsewhere

449

1.33

1.28

4.3

3.0

25.65

25.25

mmol/l

0.48

430

Maxillary retrognathism

178

1.54

1.28

2.5

3.8

25.70

24.93

mmol/l

0.72

169

Carcinoma in situ of larynx

2.56

1.28

2.8

4.1

27.63

24.79

mmol/l

—

Malignant neoplasm of vagina

2.55

1.28

7.0

2.2

23.83

24.95

mmol/l

—

Achilles tendinitis

172

1472

1.18

1.26

4.7

3.4

25.68

25.12

mmol/l

1.37

165

1422

Separation of retinal layers (serosa)

564

1.29

1.26

4.3

3.2

25.39

25.36

mmol/l

0.03

549

Moderate mental retardation

1.91

1.26

5.8

4.4

24.10

23.97

mmol/l

0.08

Valgus deformity, not elsewhere classified

100

1.74

1.26

3.8

3.7

25.38

24.94

mmol/l

0.22

100

Autoimmune hyperthyroidism

733

1.25

1.26

2.9

2.7

25.02

25.47

mmol/l

0.61

710

Monoamine oxidase A inhibitors

205

1780

1.16

1.25

3.7

3.2

25.77

25.30

mmol/l

1.15

205

1723

Disorders of vagus nerve

2.84

1.25

30.2

5.2

25.00

24.26

mmol/l

—

Assault by drugs, medicaments and biological substances

2.78

1.24

2.4

4.7

26.34

23.78

mmol/l

—

Nutritional marasmus

2.78

1.24

4.4

3.3

24.22

24.81

mmol/l

—

Spontaneous abortion

692

4356

1.08

1.23

3.0

25.41

25.46

mmol/l

0.15

671

4218

Glaucoma, exfoliation

259

2290

1.14

1.23

3.8

3.2

24.94

25.18

mmol/l

0.53

252

2233

Bitten or struck by other mammals

154

1311

1.18

1.21

3.5

25.34

25.16

mmol/l

0.23

146

1268

Benign neoplasm: Liver/bile ducts

289

1.40

1.21

2.8

3.3

25.32

25.35

mmol/l

0.02

283

Congenital malformations of genital organs

116

958

1.21

1.20

4.4

3.5

25.18

25.24

mmol/l

0.06

109

925

Maternal care for other known or suspected fetal problems

247

1392

1.14

1.20

2.6

3.1

24.82

25.11

mmol/l

0.74

234

1334

Chalazion

193

1676

1.16

1.19

3.1

3.3

25.50

25.24

mmol/l

0.40

184

1614

Ethmoidectomy

166

1927

0.86

1.18

3.6

3.4

25.52

25.31

mmol/l

0.42

161

1862

Benign neoplasm: Lip

308

1.38

1.18

2.5

2.9

25.68

25.23

mmol/l

0.41

298

Palatinal maxillary operation

1.96

1.18

7.5

4.2

23.74

24.37

mmol/l

0.26

Sequelae of inflammatory diseases of the central nervous system

2.13

1.18

3.4

3.5

26.96

24.58

mmol/l

—

Acute epiglottitis

182

1.51

1.18

3.6

3.2

25.67

25.25

mmol/l

0.29

175

Inflammatory myopathy

2.66

1.18

1.8

4.8

25.58

24.08

mmol/l

—

Use of ropinirole

589

1.27

1.18

3.2

3.5

25.73

25.11

mmol/l

1.02

571

Malignant neoplasm of oral cavity

542

0.73

1.17

3.9

3.4

26.83

25.10

mmol/l

1.91

527

Periodontosis

2.62

1.17

3.4

2.8

25.90

25.31

mmol/l

—

Kissing spine

2.61

1.17

2.8

3.9

26.72

24.99

mmol/l

—

Melanoma in situ of trunk

209

0.56

1.16

5.9

3.0

24.40

25.42

mmol/l

1.03

203

Malignant immunoproliferative diseases

151

1.56

1.15

4.2

3.4

25.20

24.77

mmol/l

0.19

146

Dyslexia and other symbolic dysfunctions, not elsewhere classified

2.06

1.14

4.8

4.3

27.10

25.20

mmol/l

—

Benign neoplasm: Liver

242

1.42

1.13

2.9

3.1

25.28

25.45

mmol/l

0.10

233

Radiodermatitis

2.37

1.13

2.6

2.7

24.49

24.50

mmol/l

—

Alzheimer’s disease (Late onset), excluding more controls

324

1942

1.12

1.13

2.7

3.1

25.20

24.91

mmol/l

0.87

317

1891

Dental caries 1

1948

10395

0.96

1.12

3.7

3.4

25.05

25.30

mmol/l

2.47

1878

10101

Operations 1 for CAVS

2.04

1.12

5.3

3.9

25.89

24.65

mmol/l

—

Obstructive hydrocephalus

218

1.45

1.11

4.0

3.5

25.04

24.98

mmol/l

0.03

213

Carcinoma in situ of oropharynx, excluding all cancers

2.52

1.11

1.8

3.1

25.46

24.96

mmol/l

—

Drug-induced acute pancreatitis

2.51

1.11

3.6

2.2

25.28

23.99

mmol/l

—

conjunctival scars

2.51

1.11

6.0

2.5

23.86

24.17

mmol/l

—

Alcohol induced polyneuropathy

136

1.58

1.11

8.6

3.8

26.41

24.93

mmol/l

0.91

131

Disorders of sexual preference

2.30

1.11

3.9

4.6

25.61

24.43

mmol/l

—

Neurofibromatosis, type 2

2.49

1.11

3.2

4.4

27.04

23.90

mmol/l

—

False labour

334

1889

1.11

1.10

2.6

3.2

24.95

25.21

mmol/l

0.88

324

1816

Exfoliative dermatitis

161

1.52

1.09

3.8

3.7

23.91

24.82

mmol/l

0.52

155

Other disorders of bladder

241

2141

1.13

1.09

3.9

3.3

25.53

25.08

mmol/l

1.00

229

2068

Benign neoplasm: Central nervous system, other parts/unspecified

2.00

1.09

4.6

4.1

24.78

24.36

mmol/l

—

Malignant neoplasm of anus and anal canal

1.86

1.08

1.9

3.4

24.92

24.87

mmol/l

0.01

Gestational diabetes (for exclusion)

387

2491

1.10

1.07

3.0

2.9

24.88

25.25

mmol/l

1.50

378

2395

Other and unspecified acute skin changes due to ultraviolet radiation

419

1.31

1.07

2.4

3.3

25.13

25.23

mmol/l

0.08

407

Myocardial infarction, unclassifiable

562

4646

1.08

1.06

4.5

3.5

24.99

25.05

mmol/l

0.13

536

4502

Postdysenteric arthropathy

125

0.47

1.06

2.3

4.0

26.22

25.16

mmol/l

—

125

Dental caries 1 and operation codes

2135

11395

0.96

1.06

3.9

3.4

25.06

25.27

mmol/l

2.00

2064

11076

Hypothyroidism, autoimmune, DX-based

2.02

1.06

3.8

2.9

26.13

23.99

mmol/l

—

Atrophy of thyroid (acquired)

2.41

1.06

4.2

3.0

23.16

24.66

mmol/l

—

Photocontact dermatitis [berloque dermatitis]

2.40

1.06

4.8

5.2

27.70

24.76

mmol/l

—

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

315

1.35

1.05

4.5

2.8

26.33

25.19

mmol/l

0.94

307

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

2.37

1.05

1.8

3.8

25.24

25.23

mmol/l

—

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

238

1.41

1.05

3.1

25.53

25.51

mmol/l

0.01

228

Endometriosis of ovary

249

2217

1.12

1.04

3.0

2.9

25.56

25.39

mmol/l

0.35

242

2153

Seronegative rheumatoid arthritis

217

1923

1.13

1.03

3.3

3.1

25.11

25.18

mmol/l

0.11

212

1868

Medicines for HER+ breast cancer

562

5892

0.93

1.03

2.8

3.2

25.85

25.55

mmol/l

1.43

552

5736

Benign neoplasm: Pharynx, unspecified

1.65

1.02

6.1

3.5

25.00

25.26

mmol/l

0.14

Secondary sideroblastic anaemia

2.07

1.02

5.3

2.9

20.49

23.85

mmol/l

—

Benign neoplasm: Skin of eyelid, including canthus

281

2532

1.11

1.01

3.7

3.1

25.25

25.27

mmol/l

0.03

270

2446

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

257

1.39

1.01

2.0

2.8

24.47

25.28

mmol/l

0.73

250

Use of rivastigmine

268

2968

0.90

1.01

2.4

3.3

25.40

25.11

mmol/l

0.80

258

2883

Inguinal of femoral hernia, unilateral

406

1.30

0.99

3.5

2.9

25.10

25.25

mmol/l

0.11

394

Inguinal hernia, unilateral

406

1.30

0.99

3.5

2.9

25.10

25.25

mmol/l

0.11

394

Femoral hernia, unilateral

406

1.30

0.99

3.5

2.9

25.10

25.25

mmol/l

0.11

394

Carcinoma in situ of lip, oral cavity and pharynx

2.03

0.99

7.7

2.8

26.69

24.76

mmol/l

—

Contraceptive management

576

4353

0.93

0.99

3.7

3.5

25.35

25.27

mmol/l

0.22

556

4218

Rheumatic fever incl heart disease

504

1.26

0.99

6.9

3.2

24.53

25.14

mmol/l

0.80

488

Complications of anaesthesia during the puerperium

0.00

0.99

0.0

3.0

—

23.88

—

Dislocation of lens

224

1.41

0.99

3.9

3.1

25.05

25.17

mmol/l

0.06

218

Dental caries, including avohilmo

1951

10376

0.96

0.98

3.7

3.4

25.05

25.30

mmol/l

2.56

1881

10081

Primary open-angle glaucoma, strict

594

5535

1.07

0.96

3.7

3.4

25.06

25.23

mmol/l

0.53

567

5380

Other general symptoms and signs

509

1.25

0.96

4.1

3.4

25.51

24.91

mmol/l

0.72

489

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

138

1195

1.16

0.95

3.7

3.3

25.29

25.36

mmol/l

0.08

133

1156

Anoxic brain damage

192

1.43

0.94

11.0

3.4

24.02

25.25

mmol/l

1.32

186

Postpartum hemorraghe, parous women as controls

221

2164

0.89

0.93

2.5

2.7

25.00

25.35

mmol/l

1.22

216

2086

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

113

965

1.18

0.93

2.7

3.1

25.30

25.31

mmol/l

0.01

108

932

Contact with other sharp object(s)

762

1.20

0.93

4.0

3.7

25.34

25.02

mmol/l

0.40

737

Carcinoma in situ of skin, other sites/unspecified

193

1.43

0.93

4.8

2.7

26.11

25.41

mmol/l

0.70

188

Hirsutism in women

134

1.51

0.92

3.4

2.7

25.70

25.14

mmol/l

0.39

129

Dental caries 3

2045

10847

0.96

0.92

3.9

3.4

25.01

25.29

mmol/l

2.97

1974

10544

Pedestrian injured in transport accident

114

975

1.18

0.92

3.5

3.3

24.70

25.29

mmol/l

1.01

104

944

Voice disturbances

478

4438

1.08

0.91

3.3

3.4

25.44

25.23

mmol/l

0.69

464

4305

Other mosquito-borne viral fevers

2.16

0.91

1.3

3.7

25.60

24.29

mmol/l

—

Burn and corrosion of ankle and foot

185

1.43

0.91

7.5

3.8

25.04

24.87

mmol/l

0.10

180

Overjet

226

1.38

0.91

14.9

5.1

24.34

24.68

mmol/l

0.39

213

Use of peginterferon beta-1a

2.12

0.90

2.2

4.0

27.03

23.82

mmol/l

—

Qualitative platelet defects

1.85

0.90

1.8

3.8

27.14

24.48

mmol/l

—

Malignant neoplasm of other and unspecified female genital organs

186

1.42

0.89

2.2

2.7

24.81

25.40

mmol/l

0.49

181

Colitis due to radiation

161

1.46

0.89

5.3

3.4

25.54

24.75

mmol/l

0.22

154

Other disorders of penis

181

1606

1.13

0.89

5.2

3.7

24.49

24.97

mmol/l

1.17

174

1560

Pityriasis rubra pilaris

2.07

0.89

3.3

3.5

24.45

25.30

mmol/l

—

Other disorders of patella

269

2439

1.11

0.89

3.7

3.1

25.10

25.22

mmol/l

0.21

256

2371

Malignant neoplasm of breast, HER-positive

533

5625

0.93

0.88

2.7

3.1

25.89

25.56

mmol/l

1.51

523

5480

Disorders of other and unspecified cranial nerves

1.76

0.88

8.4

3.7

25.17

24.82

mmol/l

0.17

Internuclear ophthalmoplegia

1.87

0.87

2.5

3.7

27.00

24.16

mmol/l

—

Benign neoplasm: Other and unspecified parts of mouth

495

1.24

0.87

3.0

3.2

25.08

25.32

mmol/l

0.22

479

Procreative management

417

3800

0.92

0.87

4.2

3.7

25.54

25.24

mmol/l

1.10

392

3676

Other benign neoplasm of uterus: Cervix uteri

1.71

0.87

3.3

2.7

24.52

25.63

mmol/l

0.82

Malignant neoplasm of breast, HER-negative

318

3466

0.91

0.87

3.0

25.59

25.49

mmol/l

0.22

310

3372

Carcinoma in situ of breast, other/unspecified

179

0.61

0.86

2.5

26.01

25.66

mmol/l

0.16

171

Benign neoplasm: Connective and other soft tissue of abdomen

1.99

0.86

3.5

2.3

25.35

25.06

mmol/l

—

Injury of muscle and tendon at hip and thigh level

157

1385

1.14

0.85

2.8

3.5

25.29

25.21

mmol/l

0.11

151

1341

Burn and corrosion of head and neck

274

1.33

0.85

3.8

3.7

24.08

24.81

mmol/l

0.57

265

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

163

1.44

0.84

7.3

2.7

23.93

25.24

mmol/l

1.19

158

Toxic encephalopathy

1.95

0.84

5.0

3.4

27.00

25.38

mmol/l

—

Melanoma in situ of ear and external auricular canal

0.00

0.83

0.0

2.6

—

24.20

—

Infection due to other mycobacteria

206

1.38

0.83

3.2

2.6

26.41

25.13

mmol/l

0.90

201

Benign neoplasm: Lip

329

1.29

0.82

2.5

3.3

25.68

25.12

mmol/l

0.53

321

Pregnancy examination and test

168

928

1.13

0.81

3.2

25.03

25.09

mmol/l

0.10

160

894

Cardiomyopathy due to drugs and other external agents

1.89

0.81

6.8

3.2

23.30

24.66

mmol/l

—

Family history of malignant neoplasm

130

1138

1.15

0.80

3.0

2.6

25.08

25.37

mmol/l

0.41

121

1097

Atopic dermatitis, strict definition

409

3724

1.08

0.79

3.6

3.7

25.01

25.14

mmol/l

0.38

396

3587

Kaposi sarcoma

2.27

0.78

4.6

2.7

27.52

25.14

mmol/l

—

Congenital retinoschisis

1.82

0.78

4.5

4.3

24.48

24.30

mmol/l

—

Need for immunization against single bacterial diseases

2.25

0.77

43.8

10.2

26.56

24.26

mmol/l

—

Other specific arthropathies, wide

288

1.30

0.76

3.2

24.73

25.34

mmol/l

0.63

280

Aortic arch syndrome [Takayasu]

2.17

0.76

2.8

3.8

25.32

24.34

mmol/l

—

Frostbite involving multiple body regions and unspecified frostbite

2.16

0.76

4.0

5.0

26.46

24.47

mmol/l

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

735

4177

1.06

0.76

3.8

3.5

24.96

25.03

mmol/l

0.20

709

4048

Generalized pustular psoriasis

1.68

0.75

2.3

4.6

24.72

24.81

mmol/l

—

Injury of blood vessels at forearm level

1.90

0.75

7.9

5.5

24.41

24.44

mmol/l

—

Acquired keratosis [keratoderma] palmaris et plantaris

1.67

0.75

7.0

2.9

26.27

25.04

mmol/l

—

Interstitial cystitis (chronic), drug-induced

1.66

0.74

1.9

3.4

24.34

25.03

mmol/l

—

Corneal pigmentations and deposits

1.72

0.74

3.0

3.8

25.74

24.85

mmol/l

—

Erosion and ectropion of cervix uteri

370

1.25

0.74

4.0

3.0

25.14

25.49

mmol/l

0.34

362

Other and unspecified atrophic disorders of skin

1.66

0.74

11.1

2.6

23.99

24.98

mmol/l

0.53

Lesion of plantar nerve

857

1.16

0.74

3.3

3.0

25.51

25.52

mmol/l

0.01

837

Macular hole

105

914

1.16

0.73

3.5

3.1

25.32

25.36

mmol/l

0.05

100

887

Contact with blunt object, undetermined intent

1.65

0.73

2.2

4.2

24.64

24.42

mmol/l

0.08

Carcinoma in situ of oral cavity and pharynx

2.02

0.72

1.8

2.5

25.46

24.10

mmol/l

—

Rhabdomyosarcoma, excluding all cancers (controls excluding all cancers)

2.00

0.72

2.8

6.7

24.24

24.67

mmol/l

—

Brain glioblastoma

177

1.38

0.72

2.8

3.4

25.82

25.17

mmol/l

0.57

172

Osteochondrodysplasia with defects of growth of tubular bones and spine

1.99

0.72

1.2

6.6

25.96

23.68

mmol/l

—

Other and specified injuries of hip and thigh

336

1.26

0.72

6.3

3.3

25.05

24.96

mmol/l

0.05

323

Relapsing polychondritis

1.98

0.72

3.6

3.4

24.68

24.75

mmol/l

—

Melanoma in situ of other and unspecified parts of face

193

0.66

0.71

1.8

2.8

26.00

25.39

mmol/l

0.65

187

Hypertensive encephalopathy

1.59

0.71

10.9

2.6

24.46

24.90

mmol/l

—

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

221

1.33

0.71

2.6

2.8

25.50

25.17

mmol/l

0.28

216

Cleft lip and palate

1.57

0.70

2.8

3.9

25.66

24.43

mmol/l

—

Disorders of orbit

592

1.19

0.70

2.9

3.1

25.57

25.29

mmol/l

0.29

568

Other benign neoplasm of uterus: Cervix uteri

1.59

0.70

3.3

2.4

24.52

25.12

mmol/l

0.39

Carcinoma in situ of skin of scalp and neck

401

1.24

0.70

5.8

2.8

24.62

25.01

mmol/l

0.33

387

Other hyperalimentation

1.71

0.70

3.4

2.9

26.69

24.91

mmol/l

—

Discharge from other and unspecified firearms

1.70

0.69

5.0

3.7

24.91

24.59

mmol/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

334

3081

1.08

0.69

3.1

2.9

25.53

25.33

mmol/l

0.64

324

2974

Chronic rhinitis, nasopharyngitis and pharyngitis

494

5245

0.94

0.69

3.4

3.5

25.38

25.22

mmol/l

0.47

485

5085

Carcinoma in situ of skin, other sites/unspecified

205

1.34

0.69

4.8

3.2

26.11

24.99

mmol/l

1.37

200

Gonococcal infection

375

0.77

0.69

3.1

26.01

25.42

mmol/l

0.32

365

Oral lichen ruber planus wide, hypothyreosis or thyroxin

760

1.17

0.69

2.8

3.1

25.06

25.54

mmol/l

0.65

741

Melanoma of uvea

153

1.40

0.69

1.5

3.2

24.64

25.41

mmol/l

0.65

148

Other abnormal products of conception

358

2218

1.08

0.68

2.5

3.0

25.18

25.32

mmol/l

0.35

342

2131

L02BG Aromatase inhibitors

451

4797

0.94

0.68

2.8

3.1

25.73

25.55

mmol/l

0.61

445

4674

Presbycusis

264

2847

0.92

0.68

2.6

3.3

25.03

25.14

mmol/l

0.19

244

2771

Benign neoplasm of middle ear and respiratory system

146

1307

1.12

0.68

3.9

3.3

25.74

25.23

mmol/l

0.98

141

1266

Drug-induced interstitial lung disorders, unspecified

1.86

0.68

3.0

4.2

24.62

25.01

mmol/l

—

Brain glioblastoma and astrocytoma

223

1.32

0.68

2.6

3.5

25.50

25.03

mmol/l

0.43

217

Erythrasma

1.84

0.67

8.8

4.5

23.74

24.21

mmol/l

—

Granulosa cell carcinoma of ovary

1.83

0.67

3.2

2.2

27.40

25.15

mmol/l

—

Benign neoplasm: Skin of lip

189

1.34

0.66

4.1

3.0

24.94

25.48

mmol/l

0.32

184

Chronic drug-induced interstitial lung disorders

1.80

0.65

2.4

3.2

24.88

25.06

mmol/l

—

Other benign neoplasms of connective and other soft tissue

163

1472

1.11

0.65

3.3

25.11

25.31

mmol/l

0.32

155

1423

Malignant neoplasm of tongue

292

0.74

0.65

3.6

3.3

27.52

24.96

mmol/l

2.16

285

Pregnancy with abortive outcome

1114

6058

0.96

0.64

2.9

3.1

25.30

25.45

mmol/l

0.82

1080

5879

Persons encountering health services in other circumstances

677

6444

1.05

0.64

4.7

3.1

24.84

25.17

mmol/l

1.73

638

6255

Postpartum hemorraghe, all women as controls

221

2397

0.92

0.64

2.5

2.9

25.00

25.22

mmol/l

0.64

216

2307

Other melanin hyperpigmentation

333

1.24

0.64

5.3

2.9

25.13

25.40

mmol/l

0.17

321

Injury of muscle and tendon at forearm level

252

1.28

0.63

2.7

3.1

24.24

24.98

mmol/l

0.44

246

Carcinoma in situ of endometrium

1.63

0.63

1.6

3.2

24.86

25.73

mmol/l

—

Malignant neoplasm of other and unspecified major salivary glands

1.65

0.63

3.1

3.0

26.07

24.52

mmol/l

—

Medical treatment for female infertility

167

1837

0.91

0.63

2.6

2.9

25.34

25.27

mmol/l

0.10

154

1771

Other hearing loss

582

5434

1.06

0.62

3.7

3.5

25.10

25.18

mmol/l

0.23

550

5278

Unspecified hairloss

0.00

0.62

0.0

3.2

—

24.81

—

Erosion of teeth, including avohilmo

307

2761

1.08

0.62

5.4

3.2

25.22

25.23

mmol/l

0.02

298

2679

Glucosamine medication

1157

8904

1.04

0.62

3.0

3.4

25.47

25.30

mmol/l

1.02

1133

8644

Acquired coagulation factor deficiency

0.00

0.61

0.0

3.1

—

23.96

—

Use of bromocriptine

0.00

0.61

0.0

2.9

—

23.26

—

Haematosalpinx/Haematoma of broad ligament

0.00

0.61

0.0

2.0

—

24.10

—

Scar conditions and fibrosis of skin

453

1.20

0.61

4.4

3.0

25.57

25.36

mmol/l

0.19

439

Deviated nasal septum

676

6446

1.05

0.61

3.4

3.6

25.62

25.14

mmol/l

3.59

663

6250

Graves disease, strict definition

133

1193

1.12

0.61

2.6

2.9

25.61

25.35

mmol/l

0.42

123

1146

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

245

1.28

0.61

3.6

2.8

24.16

25.37

mmol/l

1.20

240

Crushing injury of ankle and foot

1.57

0.61

1.5

3.5

27.38

24.92

mmol/l

—

Other disorders of cornea

157

1423

1.11

0.60

3.1

3.2

24.90

25.41

mmol/l

0.94

147

1378

Single delivery by caesarean section

200

1057

1.10

0.59

3.0

3.5

24.61

25.12

mmol/l

1.20

192

1021

Benign neoplasm: Skin of eyelid, including canthus

281

2615

1.08

0.59

3.7

3.4

25.25

25.28

mmol/l

0.05

270

2545

Nonadministration of surgical and medical care

0.00

0.59

0.0

4.5

—

24.60

—

Rheumatic valve diseases

373

1.22

0.59

8.4

3.3

24.60

25.11

mmol/l

0.46

362

Melanoma in situ of other and unspecified parts of face

184

0.70

0.58

1.8

3.1

26.00

25.14

mmol/l

1.02

179

Exposure to ignition or melting of other clothing and apparel

1.72

0.58

4.0

4.9

24.33

23.94

mmol/l

—

Other specified/unspecified nutritional deficiencies

1.50

0.58

7.8

3.2

25.13

24.81

mmol/l

0.17

Gingivitis and periodontal diseases

2152

10822

1.03

0.58

3.6

3.2

25.12

25.23

mmol/l

0.76

2064

10512

Diseases of thymus

1.71

0.58

1.5

3.6

25.43

24.34

mmol/l

—

Other articular cartilage disorders

374

1.21

0.57

2.8

3.5

25.38

24.99

mmol/l

0.27

363

Carcinoma in situ of skin of ear and external auricular canal

230

1.28

0.57

7.2

2.8

24.56

25.07

mmol/l

0.37

223

Other and unspecified disorders of orbit

1.57

0.57

3.6

4.2

26.90

24.63

mmol/l

—

Benign neoplasm: Extrahepatic bile ducts

1.66

0.56

2.5

2.9

25.53

25.12

mmol/l

—

Single delivery by forceps and vacuum extractor

122

829

0.89

0.56

2.1

3.6

24.72

24.96

mmol/l

0.33

115

800

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

918

7780

0.96

0.56

3.4

3.3

25.33

25.23

mmol/l

0.42

883

7541

Obstructed labour due to malposition and malpresentation of fetus

188

1928

0.92

0.56

2.6

3.2

25.14

25.42

mmol/l

0.82

179

1859

Supervision of high-risk pregnancy

193

1271

0.92

0.55

2.4

3.0

24.89

25.21

mmol/l

0.68

185

1230

Benign neoplasm: Vertebral column

1.62

0.55

5.5

4.9

25.22

24.81

mmol/l

—

Other congenital malformations of circulatory system

312

1.23

0.55

3.8

3.7

25.40

25.14

mmol/l

0.21

306

Early syphilis

159

0.68

0.55

4.5

3.5

25.29

24.97

mmol/l

0.24

154

Other disorders of white blood cells

824

1.13

0.55

4.6

3.4

25.27

25.17

mmol/l

0.09

794

Pregnancy, childbirth and the puerperium

564

3099

0.95

0.55

2.8

3.3

25.39

25.38

mmol/l

0.02

547

3017

Benign neoplasm: Vagina

160

1.33

0.54

2.8

2.7

25.81

25.57

mmol/l

0.08

153

Carcinoma in situ of vagina

1.48

0.54

3.4

2.4

25.30

25.44

mmol/l

—

Biliary cirrhosis, NAS

1.57

0.54

4.0

4.5

23.82

24.86

mmol/l

—

Benign neoplasm: Connective and other soft tissue of abdomen

1.57

0.54

3.5

3.7

25.35

24.88

mmol/l

—

Secondary malignant neoplasm of other and unspecified sites

223

1.27

0.54

3.5

3.4

25.59

24.92

mmol/l

0.31

216

Benign neoplasm: Skin of lip

196

1.29

0.53

4.1

3.1

24.94

25.11

mmol/l

0.09

191

Use of memantine

607

5051

1.05

0.53

2.5

3.4

25.43

25.11

mmol/l

1.73

584

4902

Use of other anti-dementia drugs

607

5051

1.05

0.53

2.5

3.4

25.43

25.11

mmol/l

1.73

584

4902

Carcinoma in situ of skin of upper limb, including shoulder

379

1.20

0.52

4.5

2.7

24.29

25.23

mmol/l

1.27

366

Androgenic alopecia

1.43

0.51

3.2

2.7

26.68

25.23

mmol/l

0.64

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

187

1726

1.09

0.51

3.6

3.2

26.06

25.19

mmol/l

2.37

182

1664

Dental operations, only avohilmo

1863

9303

1.03

0.50

3.7

3.5

25.21

25.22

mmol/l

0.06

1790

9047

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

234

1.25

0.50

3.6

2.7

24.71

25.27

mmol/l

0.43

228

Simple and mucopurulent chronic bronchitis

679

1.14

0.50

4.4

3.2

25.48

24.78

mmol/l

0.88

660

Thyrotoxicosis with toxic multinodular goitre

104

935

1.12

0.50

4.5

3.2

26.21

25.49

mmol/l

1.76

910

L01XX Other antineoplastic agents

105

945

1.12

0.50

3.3

3.1

24.47

25.28

mmol/l

1.36

915

Other primary thrombocytopenia

1.55

0.49

1.6

2.9

25.47

25.00

mmol/l

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

1.55

0.49

3.9

3.8

25.61

24.52

mmol/l

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

181

1.29

0.49

8.1

3.0

25.64

25.03

mmol/l

0.30

176

Haemorrhagic and haematological disorders of fetus and newborn

190

1.27

0.48

4.6

9.7

24.95

23.91

mmol/l

0.97

179

Juvenile Open Angle Glaucoma

1.49

0.48

15.6

3.7

25.53

24.74

mmol/l

—

Cutis laxa senilis

111

1.37

0.48

1.9

2.9

24.86

25.31

mmol/l

0.14

111

Benign neoplasm of ovary

273

2565

1.07

0.47

3.2

2.9

25.67

25.60

mmol/l

0.11

267

2486

Malignant neoplasm of other and unspecified parts of biliary tract

200

1.26

0.47

3.6

3.1

23.51

25.05

mmol/l

1.01

195

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

538

4177

1.05

0.47

2.7

3.0

25.89

25.69

mmol/l

0.72

528

4060

Benign leiomyoma with endometriosis

232

2478

0.93

0.46

2.8

3.0

25.74

25.46

mmol/l

0.73

226

2412

Pathological resorption of teeth

356

1.19

0.46

4.7

3.0

26.25

25.04

mmol/l

1.39

351

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

406

0.83

0.45

3.2

2.7

27.28

25.22

mmol/l

2.49

396

Adult-onset Still disease

1.42

0.45

5.9

2.1

26.91

24.82

mmol/l

—

Memory loss

154

1668

0.92

0.45

4.1

3.3

25.82

25.16

mmol/l

1.83

148

1620

Antenatal screening

226

1363

0.93

0.45

3.2

3.0

25.32

25.19

mmol/l

0.33

219

1317

Carcinoma in situ of skin of ear and external auricular canal

238

1.23

0.45

7.2

3.4

24.56

25.20

mmol/l

0.51

229

Carcinoma in situ of skin of upper limb, including shoulder

386

1.18

0.44

4.5

3.2

24.29

25.25

mmol/l

1.30

373

Other infective otitis externa

852

0.89

0.44

4.3

3.3

24.50

25.26

mmol/l

1.24

822

Other and unspecified cicatricial alopecia

1.65

0.44

1.6

2.4

23.38

24.91

mmol/l

—

Lipomatosis, not elsewhere classified

1.64

0.43

1.8

1.7

26.22

24.68

mmol/l

—

Non-small cell lung cancer, squamous, helper endpoint

871

0.89

0.43

3.8

3.6

26.98

24.86

mmol/l

4.77

846

Non-small cell lung cancer, squamous

871

0.89

0.43

3.8

3.6

26.98

24.86

mmol/l

4.77

846

Complications specific to multiple gestation

1.63

0.43

1.2

2.7

25.20

25.63

mmol/l

—

Leiomyoma of uterus

1133

6259

1.03

0.43

3.1

3.0

25.65

25.51

mmol/l

0.72

1104

6074

Onychogryphosis

1.59

0.43

2.4

2.8

23.30

25.21

mmol/l

—

Phlebitis and thrombophlebitis of femoral vein, drug-induced

0.00

0.43

0.0

2.9

—

24.90

—

Other hypertrichosis

1.59

0.42

1.4

2.6

22.84

24.21

mmol/l

—

Ophthalmic devices associated with adverse incidents

0.00

0.42

0.0

2.5

—

24.76

—

Pemphigus erythematosus

0.00

0.42

0.0

3.6

—

24.72

—

Pemphigus foliaceus

0.00

0.42

0.0

2.6

—

24.39

—

Macular pucker

257

2723

0.94

0.42

4.9

3.3

25.00

25.24

mmol/l

0.64

252

2639

Pedestrian injured in collision with railway train or railway vehicle

0.00

0.42

0.0

2.5

—

24.22

—

Severe mental retardation

1.55

0.42

1.6

7.4

24.20

24.34

mmol/l

—

Amputation of ankle

0.00

0.42

0.0

4.6

—

24.69

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

147

0.73

0.42

6.4

9.5

24.28

23.88

mmol/l

0.18

141

Brain mixed glioma, excluding all cancers (controls excluding all cancers)

0.00

0.42

0.0

3.7

—

26.07

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

113

1033

1.10

0.42

2.7

3.4

25.30

25.26

mmol/l

0.06

108

1002

Malignant neoplasm of placenta, excluding all cancers (controls excluding all cancers)

0.00

0.42

0.0

2.0

—

23.16

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

0.42

0.0

3.4

—

24.24

—

Familial chondrocalcinosis

0.00

0.41

0.0

3.7

—

25.36

—

Perioral dermatitis, drug-induced

0.00

0.41

0.0

2.2

—

24.19

—

Ulcer of vagina/vulva

277

1.20

0.41

2.3

2.7

25.28

25.39

mmol/l

0.07

268

Eccrine sweat disorders

1.50

0.41

3.4

3.5

30.26

25.04

mmol/l

—

Brain mixed glioma

0.00

0.40

0.0

5.6

—

25.08

—

Poor fetal growth

109

996

1.10

0.40

2.9

3.0

25.42

25.17

mmol/l

0.34

103

952

Dermatitis due to ingested food

312

1.18

0.40

7.0

5.8

24.31

24.38

mmol/l

0.06

299

Other predominantly sexually transmitted diseases, not elsewhere classified

180

1927

0.93

0.40

3.4

3.2

25.23

25.25

mmol/l

0.03

174

1857

Internal derangement of knee

723

6975

1.04

0.40

3.7

3.2

24.95

25.19

mmol/l

1.20

697

6775

Enteritis due to Yersinia enterocolitica

1.33

0.40

11.5

4.0

26.00

24.27

mmol/l

—

Mesothelioma

226

0.79

0.40

3.9

3.6

25.71

24.77

mmol/l

0.74

218

Other hereditary haemolytic anaemias

1.43

0.40

4.2

3.9

27.48

24.86

mmol/l

—

Granulosa cell carcinoma of ovary, excluding all cancers (controls excluding all cancers)

1.41

0.39

3.2

2.2

27.40

25.71

mmol/l

—

Macular cyst

402

1.15

0.38

8.6

3.0

24.08

25.35

mmol/l

1.85

389

Carcinoma in situ of skin of scalp and neck

431

1.15

0.37

5.8

3.4

24.62

24.96

mmol/l

0.28

416

Cleft lip and cleft lip and palate

1.28

0.36

2.8

4.2

25.66

24.60

mmol/l

—

Benign neoplasm: Extrahepatic bile ducts

1.46

0.36

2.5

3.9

25.53

24.61

mmol/l

—

Retinal detachment with retinal break

241

2284

1.06

0.36

4.9

3.4

24.37

25.23

mmol/l

3.48

236

2210

Other and unspecified disease of Bartholin gland

395

0.86

0.36

3.0

2.8

26.01

25.57

mmol/l

0.27

385

Special screening examination for neoplasms

641

1.11

0.35

4.2

3.1

24.90

24.99

mmol/l

0.09

622

Sequelae of injuries of upper limb

144

1343

1.07

0.35

3.0

3.6

25.67

25.29

mmol/l

0.59

135

1300

Sacrococcygeal disorders, not elsewhere classified

329

1.16

0.35

2.4

2.9

24.54

25.31

mmol/l

0.74

315

Injury of blood vessels of thorax

1.38

0.35

1.5

3.5

23.67

24.39

mmol/l

—

Rubella [German measles]

479

0.87

0.35

4.4

4.0

25.77

25.28

mmol/l

0.47

465

Postpartum haemorrhage

221

2032

0.95

0.34

2.5

3.1

25.00

25.38

mmol/l

1.35

216

1961

Benign neoplasm: Floor of mouth

1.35

0.34

1.5

3.6

23.28

24.30

mmol/l

—

Injury of muscle and tendon at lower leg level

264

2513

1.05

0.34

4.2

3.6

25.06

25.13

mmol/l

0.13

257

2434

Triptan medication for migraine, single purchase ok

1328

9181

0.98

0.33

3.0

3.5

25.31

25.35

mmol/l

0.21

1290

8886

Migraine, single triptan purchase ok & required. ICD-code if available is included

1328

9181

0.98

0.33

3.0

3.5

25.31

25.35

mmol/l

0.21

1290

8886

Benign neoplasm: Floor of mouth

1.29

0.32

1.5

3.1

23.28

24.58

mmol/l

—

Maternal care for known or suspected malpresentation of fetus

151

1201

0.94

0.32

2.6

3.1

25.49

25.16

mmol/l

0.85

145

1147

Use of antiglaucoma preparations and miotics

169

1593

1.06

0.32

4.8

3.2

24.58

25.17

mmol/l

1.10

160

1553

Benign neoplasm: Mediastinum

1.37

0.32

3.1

3.7

23.37

25.61

mmol/l

—

Benign neoplasm of male genital organs

314

1.15

0.32

2.4

2.9

25.13

25.07

mmol/l

0.03

304

Complications of labour and delivery

923

5017

1.03

0.31

2.9

3.1

25.37

25.52

mmol/l

0.74

902

4869

Benign neoplasm: Mediastinum

1.34

0.31

3.1

5.0

23.37

25.23

mmol/l

—

Acquired pure red cell aplasia [erythroblastopenia]

1.31

0.31

5.4

4.0

25.81

24.91

mmol/l

—

Diving or jumping into water causing injury other than drowning or submersion

1.31

0.31

2.9

3.5

26.00

24.67

mmol/l

—

Long labour

218

2000

0.95

0.30

1.9

3.2

25.10

25.37

mmol/l

0.68

203

1933

Chronic Coagulation defects

278

1.16

0.30

5.7

3.8

25.99

25.05

mmol/l

0.87

271

Acetic acid derivatives and related substances

676

3622

0.97

0.30

3.2

4.1

25.32

24.93

mmol/l

2.13

647

3511

Neonatal jaundice from other and unspecified causes

152

1.22

0.29

5.1

10.3

24.86

23.80

mmol/l

0.72

143

Burn and corrosion of wrist and hand

449

1.12

0.29

4.0

3.5

24.54

25.10

mmol/l

0.48

435

Unspecified privation

155

1641

0.94

0.29

5.2

3.4

25.00

25.25

mmol/l

0.46

147

1581

Transitory endocrine and metabolic disorders specific to fetus and newborn

148

0.79

0.29

5.9

9.5

23.99

23.93

mmol/l

0.03

142

All dysplastic lesions of the vagina

298

1.15

0.28

4.7

2.9

25.02

25.70

mmol/l

0.90

288

Follow-up examination after treatment for malignant neoplasms

161

1700

0.95

0.28

3.8

3.1

25.90

25.11

mmol/l

1.49

153

1651

Benign neoplasm: Skin of trunk

538

1.10

0.27

4.0

2.7

25.63

25.38

mmol/l

0.24

521

Other hammer toe(s) (acquired)

339

3066

1.04

0.27

3.4

3.2

25.46

25.37

mmol/l

0.22

327

2989

Benign neoplasm: Eye, unspecified

1.20

0.27

4.3

3.8

23.58

24.90

mmol/l

—

Contact with lifting and transmission devices, not elsewhere classified

246

0.85

0.26

3.1

3.6

25.72

24.90

mmol/l

0.71

239

Chronic conjunctivitis

394

0.88

0.26

3.3

26.29

25.12

mmol/l

1.40

382

Alzheimer disease, including avohilmo

835

5895

1.02

0.26

2.8

3.4

25.37

25.12

mmol/l

1.42

798

5735

Coxibs

702

3645

1.03

0.26

3.2

4.1

25.09

24.93

mmol/l

0.56

673

3533

Other orthopaedic follow-up care

713

1.08

0.25

3.4

2.7

25.79

25.21

mmol/l

0.76

688

Mumps

319

0.87

0.25

4.3

3.3

25.31

25.17

mmol/l

0.08

312

Malignant neoplasm of heart, mediastinum and pleura

191

0.83

0.25

4.5

4.0

25.63

24.84

mmol/l

0.58

183

Benign neoplasm: Cranial nerves

433

0.90

0.24

3.3

25.56

25.36

mmol/l

0.16

422

Labour and delivery complicated by fetal stress [distress]

207

1322

1.05

0.23

2.4

3.1

24.48

25.19

mmol/l

2.58

195

1269

Vertical strabismus

447

1.10

0.23

2.8

3.1

25.54

25.25

mmol/l

0.25

426

Malignant neoplasm of breast, HER2-negative

851

6379

0.98

0.23

2.8

3.1

25.77

25.55

mmol/l

1.17

833

6203

Behçet disease

1.30

0.23

2.0

3.0

25.88

24.42

mmol/l

—

Inflammation of lacrimal passages (chronic)

266

1.13

0.23

3.6

3.2

24.95

24.86

mmol/l

0.05

259

Carcinoma in situ of breast, lobular

0.75

0.23

4.1

2.6

25.56

25.48

mmol/l

—

Degenerative diseases of the nervous system

805

5939

1.02

0.22

3.0

3.4

25.30

25.12

mmol/l

0.80

771

5774

Pemphigus vegetans

0.00

0.22

0.0

4.5

—

24.72

—

Adrenomedullary hyperfunction

1.23

0.22

1.8

4.1

25.36

25.11

mmol/l

—

Benign neoplasm: Female genital organ, unspecified

1.23

0.22

1.6

2.3

26.54

24.68

mmol/l

—

Neuroendocrine tumor and carcinoma of rectum, excluding all cancers (controls excluding all cancers)

1.23

0.22

2.6

2.5

24.20

25.42

mmol/l

—

Plasmodium vivax malaria

0.00

0.22

0.0

4.1

—

23.21

—

Lichen ruber moniliformis

0.00

0.22

0.0

1.9

—

24.31

—

Glanders and melioidosis

0.00

0.22

0.0

2.4

—

25.28

—

Carcinoma in situ of liver, gallbladder and bile ducts

0.00

0.22

0.0

3.6

—

23.64

—

Disorders of conjunctiva in diseases classified elsewhere

0.00

0.22

0.0

3.8

—

25.66

—

Palsy of conjugate gaze

0.00

0.22

0.0

2.5

—

24.91

—

Crushing injuries involving multiple body regions

0.00

0.22

0.0

5.0

—

25.08

—

Degeneration of iris and ciliary body

0.00

0.22

0.0

4.5

—

24.33

—

Infections with a predominantly sexual mode of transmission

374

3846

0.97

0.22

4.8

3.3

25.30

25.19

mmol/l

0.25

361

3717

Other congenital malformations of integument

0.00

0.22

0.0

3.9

—

25.63

—

Complicated migraine, drug-induced

0.00

0.21

0.0

3.8

—

23.68

—

Exposure to excessive cold of man-made origin

0.00

0.21

0.0

5.2

—

24.93

—

Macular pucker, drug-induced

0.00

0.21

0.0

2.6

—

25.84

—

Hydroxyapatite deposition disease

0.00

0.21

0.0

3.6

—

23.33

—

Loose body in joint

367

0.90

0.21

3.2

24.59

24.90

mmol/l

0.24

355

Compression of brain

0.00

0.21

0.0

2.7

—

25.30

—

Chronic bullous disease of childhood

0.00

0.21

0.0

3.4

—

24.18

—

Schistosomiasis [bilharziasis]

0.00

0.21

0.0

4.4

—

25.30

—

Erectile dysfunction

155

1621

0.95

0.21

5.0

3.7

24.94

24.87

mmol/l

0.08

146

1563

Coccidioidomycosis

0.00

0.21

0.0

2.3

—

24.31

—

Status post-ami

145

1246

0.95

0.21

4.5

2.9

25.14

24.97

mmol/l

0.22

133

1208

Occupant of railway train or railway vehicle injured in transport accident

0.00

0.21

0.0

2.9

—

25.68

—

Genetic anomalies of leukocytes

0.00

0.21

0.0

3.2

—

24.95

—

Degenerative myopia

1.25

0.21

4.6

3.5

25.77

24.73

mmol/l

0.87

Encephalocele

0.00

0.21

0.0

3.0

—

24.52

—

Other coagulation defects

102

964

1.06

0.21

5.3

3.2

25.54

25.25

mmol/l

0.42

931

Other specified diseases of spinal cord, drug-induced

0.00

0.20

0.0

3.6

—

23.96

—

Caries in Clefts patients

1.26

0.20

6.7

5.1

25.48

24.83

mmol/l

—

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

376

0.90

0.20

3.8

2.9

26.93

25.18

mmol/l

1.60

365

Benign neoplasm of mesothelial tissue

0.00

0.20

0.0

4.6

—

24.32

—

Unspecified pneumoconiosis

0.00

0.20

0.0

7.4

—

25.14

—

Polydactyly

0.00

0.20

0.0

6.5

—

22.72

—

Benign leiomyoma with endometriosis

232

2402

0.96

0.20

2.8

3.1

25.74

25.62

mmol/l

0.24

226

2327

Acquired stenosis of external ear canal

144

0.83

0.20

6.4

3.5

24.31

24.97

mmol/l

0.29

138

Epiphora

317

1.11

0.20

2.5

3.2

26.02

25.06

mmol/l

1.01

305

Systemic disorders of connective tissue in diseases classified elsewhere

1.18

0.19

2.0

3.2

24.50

24.71

mmol/l

—

Other and unspecified glaucoma

131

1251

1.05

0.19

3.9

3.2

25.01

25.25

mmol/l

0.32

123

1219

Benign neoplasm of ovary

273

2647

1.03

0.19

3.2

3.1

25.67

25.50

mmol/l

0.31

267

2578

Malignant neoplasm of breast

877

6433

0.98

0.19

2.8

3.1

25.76

25.55

mmol/l

1.10

859

6255

Congenital lens malformations

1.14

0.19

15.2

3.9

24.45

24.68

mmol/l

—

Benign neoplasm: Long bones of lower limb

367

1.09

0.18

2.6

3.1

25.42

25.17

mmol/l

0.21

352

Defect, injury or illness of neck

1.17

0.18

4.6

3.6

26.54

24.29

mmol/l

—

Benign neoplasm of male genital organs

329

1.10

0.18

2.4

3.8

25.13

25.02

mmol/l

0.07

316

Other superficial injuries of ankle and foot

1.15

0.17

13.3

3.9

24.03

24.70

mmol/l

—

Dysplasia of cervi uteri

282

2244

0.97

0.17

2.7

3.0

25.46

25.25

mmol/l

0.54

273

2173

Apocrine sweat disorders, other sweat gland disorders

1.14

0.17

5.1

2.9

26.36

25.36

mmol/l

—

Use of galantamine

134

1396

0.96

0.17

2.1

3.3

25.02

25.05

mmol/l

0.04

129

1350

Malignant neoplasm of prostate

963

6169

0.98

0.17

3.9

3.8

24.92

24.96

mmol/l

0.12

932

5982

Malignant neoplasm of oropharynx

234

1.12

0.17

4.2

3.3

26.88

25.11

mmol/l

1.18

229

Anti-inflammatory and antirheumatic products, non-steroids

741

3788

0.98

0.17

3.2

4.2

25.12

24.93

mmol/l

0.69

714

3669

Retinal breaks without detachment

250

2573

0.97

0.17

3.4

3.3

24.99

25.27

mmol/l

0.64

244

2493

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

329

0.91

0.16

2.9

2.7

27.17

25.43

mmol/l

1.74

322

Tinnitus

401

3923

1.02

0.16

3.0

3.5

25.41

25.29

mmol/l

0.36

383

3809

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

507

4171

1.02

0.16

3.8

3.3

25.95

25.17

mmol/l

5.20

492

4042

Lagophthalmos

188

1.12

0.15

4.3

3.5

24.95

25.00

mmol/l

0.03

183

Carcinoma in situ of vulva

1.19

0.14

6.5

2.5

24.00

25.70

mmol/l

1.09

Alzheimer disease

696

5324

0.98

0.14

2.8

3.4

25.40

25.12

mmol/l

1.39

663

5175

Benign neoplasm: Cranial nerves

419

0.93

0.14

3.3

2.8

25.56

25.26

mmol/l

0.25

405

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

380

3579

1.02

0.14

3.0

25.56

25.68

mmol/l

0.34

371

3478

Dental pulpitis 2

1815

9376

0.99

0.13

3.7

3.3

25.06

25.30

mmol/l

2.17

1751

9110

Invasive ventilation

110

1142

0.96

0.13

4.1

3.5

25.34

24.99

mmol/l

0.36

102

1105

Other congenital malformations of ear

1.17

0.13

2.5

4.0

25.98

24.48

mmol/l

0.82

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

148

0.87

0.12

1.4

3.0

25.00

25.18

mmol/l

0.10

143

Habitual aborter

123

1.14

0.12

4.1

3.4

24.10

25.11

mmol/l

0.71

118

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

100

963

1.04

0.12

3.2

25.21

25.12

mmol/l

0.08

934

Other disorders of amniotic fluid and membranes

123

1180

1.03

0.11

3.2

3.1

25.26

25.18

mmol/l

0.09

115

1130

Other endophthalmitis

1.17

0.11

11.0

3.6

24.23

25.05

mmol/l

—

Benign neoplasm: Female genital organ, unspecified

1.14

0.10

1.6

2.2

26.54

25.60

mmol/l

—

Pedestrian injured in collision with car, pick-up truck or van

349

1.06

0.10

4.3

3.1

24.74

25.24

mmol/l

0.34

338

Spermatocele

145

1414

1.03

0.10

3.6

24.15

24.93

mmol/l

1.96

139

1374

Labyrinthine fistula

1.09

0.10

4.4

3.3

24.68

24.18

mmol/l

—

Malignant neoplasm of tonsil

213

1.08

0.09

4.1

3.4

26.59

25.11

mmol/l

0.81

208

Triptan medication for migraine, min. 3 purchases

778

6199

0.99

0.09

2.8

3.3

25.21

25.31

mmol/l

0.42

753

5999

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

431

3642

0.99

0.09

3.8

3.3

25.95

25.18

mmol/l

4.26

422

3528

Selective deficiency of immunoglobulin A [IgA]y

1.04

0.09

13.4

5.3

23.02

24.45

mmol/l

—

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

262

1.07

0.09

3.7

2.9

26.64

25.23

mmol/l

0.94

256

Dental pulpitis 4, only avohilmo

2632

13668

1.01

0.09

3.6

3.5

25.09

25.26

mmol/l

1.88

2541

13266

Adenocarcinomas of cervix

1.14

0.09

2.5

2.9

24.77

24.49

mmol/l

—

Mucinous and mucinous cystic tumor

1.12

0.09

2.5

2.4

26.42

25.16

mmol/l

—

Maternal care for known or suspected abnormality of pelvic organs

252

1769

0.98

0.09

2.2

3.1

24.98

25.28

mmol/l

0.71

244

1701

Lesion of medial popliteal nerve

1.07

0.09

2.7

3.6

24.27

25.21

mmol/l

—

Chronic diseases of tonsils and adenoids

1564

9959

0.99

0.08

3.5

25.23

25.22

mmol/l

0.03

1516

9641

Other fibroblastic disorders

1.10

0.08

2.7

26.43

24.86

mmol/l

—

Benign neoplasm: Long bones of lower limb

381

1.05

0.08

2.6

3.3

25.42

25.13

mmol/l

0.25

369

Disorder of the sleep-wake schedule

195

1.08

0.08

2.3

4.2

25.63

25.09

mmol/l

0.50

187

Propionic acid derivatives

747

3788

0.99

0.08

3.0

4.2

24.98

24.93

mmol/l

0.13

719

3669

Bacterial meningitis

480

1.04

0.08

3.2

3.3

25.58

25.21

mmol/l

0.28

465

Benign neoplasm: Spinal cord

186

1.08

0.07

3.0

3.4

25.64

24.92

mmol/l

0.39

181

LSIL lesion of the cervix uteri, vagina or vulva

146

1431

1.02

0.07

3.3

2.8

25.77

25.38

mmol/l

0.82

140

1375

Female infertility, cervigal, vaginal, other or unspecified origin

335

2215

1.01

0.07

3.0

2.9

25.23

25.30

mmol/l

0.14

326

2144

Female infertility

376

2295

1.01

0.07

3.2

2.9

25.18

25.29

mmol/l

0.28

366

2224

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

802

0.97

0.07

3.8

2.8

26.98

24.96

mmol/l

4.40

774

Oral leukoplakia and related diseases, including avohilmo

142

1395

1.02

0.06

3.7

3.3

25.42

25.35

mmol/l

0.09

137

1349

Mucosal proctocolitis

170

1725

0.99

0.05

4.4

3.4

24.51

25.23

mmol/l

1.56

162

1673

Pollen allergy

209

2094

0.99

0.05

3.0

3.8

25.35

25.08

mmol/l

0.59

195

2019

Benign neoplasm: Tonsil

171

0.93

0.05

2.8

2.5

25.59

25.33

mmol/l

0.12

166

Dermatitis herpetiformis

262

0.95

0.05

3.8

3.4

25.42

24.92

mmol/l

0.36

256

malignant neoplasm of male genital organs

992

6276

1.00

0.03

3.9

3.8

24.89

24.97

mmol/l

0.26

961

6084

Benign neoplasm: Skin of trunk

579

1.02

0.02

4.0

3.3

25.63

25.11

mmol/l

0.60

560

Oral leukoplakia

279

0.97

0.02

4.6

3.2

25.42

25.14

mmol/l

0.14

271

Disorders of lacrimal system and orbit in diseases classified elsewhere

309

0.97

0.02

2.9

3.1

25.07

25.52

mmol/l

0.34

302

Circumscribed brain atrophy

311

1.03

0.02

3.9

3.4

25.27

25.13

mmol/l

0.09

304

Postpartum care and examination

127

802

1.01

0.02

3.0

3.2

24.95

25.09

mmol/l

0.21

119

770

Benign neoplasm: Other parts of oropharynx

113

1.06

0.02

5.0

3.5

26.68

24.86

mmol/l

1.05

113

All dysplastic lesions of the cervix uteri

257

2577

1.00

0.01

2.8

2.9

25.52

25.29

mmol/l

0.61

249

2485

Normotensive glaucoma

155

1540

1.01

0.01

2.8

3.0

25.32

25.30

mmol/l

0.02

144

1507

Sexual dysfunction

193

1.04

0.01

5.1

3.1

25.66

24.70

mmol/l

0.77

186

Dental pulpitis 1, only avohilmo

2623

13705

1.00

0.01

3.5

25.11

25.26

mmol/l

1.52

2531

13302

Artificial joint re-operation

119

1197

0.99

0.00

4.8

3.2

25.02

25.33

mmol/l

0.38

114

1160

Benign neoplasm: Spinal cord

194

1.03

0.00

3.1

2.5

25.64

25.28

mmol/l

0.17

186

Sudden idiopathic hearing loss

162

1626

1.00

0.00

3.4

3.5

24.92

25.35

mmol/l

0.88

157

1581

Inguinal hernia, bilateral

205

2053

1.00

0.00

3.5

3.7

25.27

25.00

mmol/l

0.49

196

1991

Endometriosis of intestine

106

1.04

0.00

2.3

3.2

25.35

24.87

mmol/l

0.25

101

Other disorders of breast and lactation associated with childbirth

127

1.02

0.00

2.3

3.2

25.64

24.93

mmol/l

0.70

121

Other inflammation of vagina/vulva

324

0.99

0.00

1.6

3.0

25.55

25.30

mmol/l

0.17

318

Benign neoplasm: Prostate

108

1.02

0.00

1.9

3.6

24.11

25.00

mmol/l

0.39

103

Deep bite that required surgery

128

1.02

0.00

3.8

3.1

25.95

25.22

mmol/l

0.39

122

Tic disorders

111

0.99

0.00

5.2

4.3

24.58

24.59

mmol/l

0.00

106

Inguinal or femoral hernia, bilateral

209

2085

1.00

0.00

3.5

3.7

25.27

24.99

mmol/l

0.52

200

2021

Malignant neoplasm of retroperitoneum and peritoneum

116

1.04

0.00

1.9

2.9

25.70

25.41

mmol/l

0.13

116

Other benign neoplasm of uterus: Corpus uteri

106

1.04

0.00

2.2

2.9

25.47

25.49

mmol/l

0.01

106

Accident to nonpowered aircraft causing injury to occupant

0.00

0.0

3.8

—

23.28

—

Vaginal lichen planus

0.92

0.00

6.0

2.4

26.00

25.76

mmol/l

—

Systemic sclerosis induced by drugs and chemicals

0.00

0.0

1.8

—

25.28

—

Biliary cirrhosis, secondary

0.00

0.0

2.5

—

24.07

—

Thalassaemia trait

0.00

0.0

2.2

—

22.60

—

Heredofamilial amyloidosis, unspecified

0.00

0.0

1.8

—

24.78

—

Other hypersecretion of intestinal hormones

0.00

0.0

3.7

—

24.83

—

Plague

0.00

0.0

3.1

—

24.72

—

Imbalance of constituents of food intake

0.00

0.0

2.4

—

25.24

—

Disorders of plasma-protein metabolism, not elsewhere classified, drug-induced

0.00

0.0

1.4

—

23.08

—

Mosquito-borne viral encephalitis

0.00

0.0

1.9

—

23.84

—

Carcinoma in situ of other/unspecified male genital organs

0.00

0.0

3.6

—

23.80

—

Chlamydial lymphogranuloma (venereum)

0.00

0.0

7.7

—

25.56

—

Acute hepatitis B

0.97

0.00

1.3

4.1

26.02

24.47

mmol/l

—

Carcinoma in situ of liver, gallbladder and bile ducts

0.00

0.0

3.9

—

26.27

—

Disorders of visual cortex

0.00

0.0

8.1

—

25.27

—

Other and unspecified disorders of sclera

0.00

0.0

2.4

—

23.47

—

Sequelae of toxic effects of substances chiefly nonmedicinal as to source

0.00

0.0

4.7

—

23.54

—

Immobility syndrome (paraplegic)

0.00

0.0

3.0

—

23.88

—

Bilateral

0.00

0.0

1.6

—

23.14

—

Traumatic amputations involving multiple body regions

0.00

0.0

2.4

—

24.96

—

Trichuriasis

0.00

0.0

4.0

—

21.58

—

Other fluke infections

0.00

0.0

3.4

—

26.44

—

Pneumoconiosis associated with tuberculosis

0.00

0.0

4.6

—

20.50

—

Strongyloidiasis

0.00

0.0

7.0

—

24.50

—

Familial dysautonomia

0.00

0.0

3.3

—

23.88

—

Pedal cyclist injured in collision with train or tram

0.00

0.0

1.0

—

24.70

—

Delta-beta thalassaemia

0.00

0.0

3.5

—

24.90

—

Carcinoma in situ of other/unspecified female genital organs

0.00

0.0

3.4

—

24.44

—

Dietary calcium deficiency

0.00

0.0

2.8

—

24.20

—

Malignant neoplasm of placenta

0.00

0.0

2.2

—

23.17

—

Drug photoallergic response

0.00

0.0

3.2

—

23.75

—

Pseudomembranous colitis, drug-induced

0.00

0.0

2.1

—

24.11

—

Fetal blood loss

0.00

0.0

8.0

—

24.94

—

Drug-induced chorea

0.00

0.0

2.6

—

21.60

—

Neuroendocrine tumor and carcinoma of rectum

0.92

0.00

2.6

3.3

24.20

24.74

mmol/l

—

Malnutrition in pregnancy

0.00

0.0

1.7

—

24.79

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

0.0

5.3

—

24.73

—

Malignant neoplasm of floor of mouth

0.91

0.00

2.3

3.4

24.13

24.54

mmol/l

—

Carcinoma in situ, thyroid and other endocrine glands

0.00

0.0

3.5

—

23.33

—

Enophthalmos

0.00

0.0

3.0

—

24.98

—

Carcinoma in situ of other/unspecified male genital organs

0.00

0.0

6.0

—

23.06

—

Carcinoma in situ of other/unspecified female genital organs

0.00

0.0

3.3

—

23.82

—

Diastrofic dysplasy

0.00

0.0

3.0

—

22.33

—

Spotted fever [tick-borne rickettsioses]

0.00

0.0

2.3

—

24.18

—

Malignant neoplasm of meninges

0.00

0.0

3.0

—

23.84

—

Benign neoplasm: Pluriglandular involvement

0.00

0.0

6.0

—

25.32

—

Carcinoma in situ, other and unspecified urinary organs

0.00

0.0

3.1

—

24.57

—

Benign neoplasm: Endocrine gland, other/unspecified

0.98

0.00

2.4

2.6

26.22

24.43

mmol/l

—

Neurological devices associated with adverse incidents

0.00

0.0

4.6

—

24.77

—

Laboratory evidence of human immunodeficiency virus [HIV]

0.00

0.0

2.9

—

25.41

—

Acquired keratosis follicularis

0.00

0.0

9.7

—

23.42

—

Bacterial vaccines

0.00

0.0

1.5

—

25.32

—

Use of tolcapone

0.00

0.0

4.1

—

23.39

—

Scleritis and episcleritis (ICD-9) only

0.00

0.0

6.2

—

23.42

—

Linear scleroderma

0.00

0.0

2.4

—

22.89

—

Pulmonary haemorrhage originating in the perinatal period

0.00

0.0

2.6

—

22.42

—

Obstetric and gynaecological devices associated with adverse incidents

0.00

0.0

2.0

—

23.09

—

Ascariasis

0.00

0.0

3.7

—

24.03

—

Operations of war

0.00

0.0

3.1

—

24.42

—

Androgen resistance syndrome

0.00

0.0

4.0

—

22.80

—

Echinococcosis

0.00

0.0

7.3

—

24.61

—

Anhidrosis

0.00

0.0

3.7

—

24.16

—

Deformity of orbit

0.00

0.0

1.8

—

24.25

—

Other chronic figurate erythema

0.00

0.0

2.8

—

24.02

—

Toxic myoneural disorders

0.00

0.0

3.2

—

25.20

—

Exposure to high-pressure jet

0.00

0.0

2.6

—

23.30

—

Other neonatal haemorrhages

0.00

0.0

9.0

—

22.54

—

Traumatic amputation at neck level

0.00

0.0

2.1

—

26.26

—

Air embolism (traumatic)

0.00

0.0

10.2

—

25.33

—

Testicular hyperfunction

0.00

0.0

8.7

—

22.66

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

-0.00

0.0

3.1

—

23.49

—

Retained (old) foreign body following penetrating wound of orbit

0.00

-0.00

0.0

8.1

—

22.40

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Bicarbonate [Moles/volume] in Venous blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS